Transient global amnesia

AMN2

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G45.4 Cause of death: ICD-10 — G45.4 2 out of 7 registries used, show all original rules.	3753
4. Check minimum number of events None	3753
5. Include endpoints None	3753
6. Filter based on genotype QC (FinnGen only)	3673

Control definitions (FinnGen only)

Control exclude: F5_DEMENTIA, G6_ALZHEIMER, G6_AD_STRICT

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G45
Name in latin: Amnesia globalis transitoria

NAME	AMN2
CONTROL_EXCLUDE	F5_DEMENTIA\|G6_ALZHEIMER\|G6_AD_STRICT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G454
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G454
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Transient global amnesia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3673	2312	1361
Unadjusted period prevalence (%)	0.75	0.82	0.62
Median age at first event (years)	64.68	64.75	64.57

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3753: Matched controls
37530

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06DA02

ATC

donepezil; oral

30.8

318.8

210

N06DX01

ATC

memantine; oral

45.7

307.7

236

R41.3

ICD-10 Finland

Other amnesia

12.0

307.7

462

434

G45.4

ICD-10 Finland

Transient global amnesia

+∞

307.7

3753

AA1AD

NOMESCO Finland

CT of head and brain

3.8

307.7

2027

8782

G30.1

ICD-10 Finland

Alzheimer disease with late onset

28.7

264.3

178

N06DA03

ATC

rivastigmine; oral, transdermal

31.8

216.9

141

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

52.9

171.5

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.5

149.9

595

1924

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.3

138.9

591

1991

N06DA04

ATC

galantamine; oral

52.4

125.6

P20

ICPC

Memory disturbance

2.8

120.3

736

3028

G30.8

ICD-10 Finland

Other Alzheimer disease

42.0

103.0

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

21.7

88.6

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

113.8

72.1

R41.0

ICD-10 Finland

Disorientation, unspecified

4.2

67.6

186

461

F03

ICD-10 Finland

Unspecified dementia

6.4

65.4

109

174

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

64.8

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

61.4

434

1878

P70

ICPC

Dementia

7.4

44.9

SPAT1053

SPAT

Memory test

1.9

43.4

622

3523

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

41.4

366

1735

R42

ICD-10 Finland

Dizziness and giddiness

1.6

33.9

1000

6894

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.3

33.6

280

1292

A98

ICPC

Health maint/preventive medicine

2.7

32.8

3605

33778

R51.80

ICD-10 Finland

Headache

1.8

31.7

557

3337

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

31.1

1196

8729

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

104.2

28.7

XA400

NOMESCO Finland

EEG

7.1

28.0

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

27.5

214

959

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

26.9

199

872

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

5.2

23.8

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

23.4

200

931

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

23.2

236

1176

R53

ICD-10 Finland

Malaise and fatigue

1.5

20.9

856

6238

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.2

20.8

174

804

PA6AD

NOMESCO Finland

CT of neck arteries

2.2

20.3

176

825

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.5

20.2

128

523

C10AA05

ATC

atorvastatin; oral

1.4

19.9

1764

14703

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

19.6

218

1123

A04

ICPC

Weakness/tiredness general

1.6

19.5

562

3796

R41.2

ICD-10 Finland

Retrograde amnesia

21.7

19.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

19.1

304

1760

F06.7

ICD-10 Finland

Mild cognitive disorder

2.6

18.7

111

440

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

18.7

830

6128

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

18.7

117

476

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

18.3

164

779

103

Kela drug reimbursment

Diabetes, insulin-treated

0.7

17.9

572

8023

N06AX11

ATC

mirtazapine; oral

1.4

17.1

1177

9355

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

17.1

145

674

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.9

17.1

270

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

17.0

1073

8409

A10BA02

ATC

metformin; oral

0.7

16.7

635

8632

N03AF02

ATC

oxcarbazepine; oral

2.4

16.7

113

477

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

170.7

16.5

B01AC07

ATC

dipyridamole; systemic

2.1

16.3

162

802

G44.2

ICD-10 Finland

Tension-type headache

1.6

16.1

454

3045

S06.0

ICD-10 Finland

Concussion

1.6

15.8

344

2168

R55

ICD-10 Finland

Syncope and collapse

1.6

15.7

408

2685

F01.9

ICD-10 Finland

Vascular dementia, unspecified

7.0

15.3

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

15.0

281

1702

G04CB01

ATC

finasteride; oral

1.6

14.9

347

2223

N02BE01

ATC

paracetamol; systemic, rectal

1.5

14.9

3309

31182

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.6

14.8

315

G30

ICD-10 Finland

Alzheimer disease

56.9

14.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

14.7

1875

16212

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.7

14.7

545

7472

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

14.4

1205

9810

AXX01, ,

SPAT

2.0

14.3

161

833

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

14.2

743

5618

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

13.7

762

5814

TAB00

NOMESCO Finland

Lumbar puncture

2.1

13.7

129

626

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

13.5

1021

8178

N06AX26

ATC

vortioxetine; oral

1.9

13.4

182

1003

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

13.2

382

2571

C10AA07

ATC

rosuvastatin; oral

1.3

13.1

1308

10881

N03AX14

ATC

levetiracetam; systemic

2.2

13.0

105

479

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

13.0

142

728

T90

ICPC

Diabetes non-insulin dependent

0.7

12.9

569

7591

N17

ICPC

Vertigo/dizziness

1.5

12.9

505

3618

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

12.7

395

2700

A10AC01

ATC

insulin (human); parenteral

0.4

12.7

1509

SPAT1263

SPAT

Sampling

1.3

12.6

1396

11761

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

12.6

1691

14606

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.5

12.3

131

2435

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

12.0

3124

29358

A02BC02

ATC

pantoprazole; systemic

1.3

12.0

2551

23290

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

5.7

11.9

SPAT1301

SPAT

No procedures

1.3

11.9

1077

8821

A02BC05

ATC

esomeprazole; systemic

1.3

11.8

1461

12461

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.7

11.6

545

7215

SPAT1325

SPAT

Vaccination

1.3

11.3

1213

10141

G47.3

ICD-10 Finland

Sleep apnoea

1.3

11.3

748

5850

L08

ICPC

Shoulder symptom/complaint

1.3

11.2

841

6696

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

11.2

1046

8587

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.2

1466

12565

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

5.6

11.2

N06AB10

ATC

escitalopram; oral

1.4

11.1

519

3833

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

11.1

2322

21038

B01AC04

ATC

clopidogrel; oral

1.4

11.0

638

4886

L57.0

ICD-10 Finland

Actinic keratosis

1.4

11.0

479

3495

N03AG01

ATC

valproic acid; systemic, rectal

1.8

11.0

151

837

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

10.9

434

3115

R01AD09

ATC

mometasone; nasal

1.3

10.8

1413

12089

C09CA06

ATC

candesartan; oral

1.3

10.8

868

6978

A10AE04

ATC

insulin glargine; parenteral

0.5

10.7

120

2200

WW200, ,

SPAT

1.3

10.5

1102

9167

N02CC04

ATC

rizatriptan; oral

1.9

10.5

136

739

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

10.3

673

5243

H02

ICPC

Hearing complaint

1.4

10.3

613

4709

H29

ICPC

Ear symptom/complaint other

1.4

10.3

458

3354

L15

ICPC

Knee symptom/complaint

1.3

10.3

937

7655

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

10.1

457

3353

R05

ICD-10 Finland

Cough

1.3

10.1

756

6006

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

10.1

759

6037

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

10.1

273

1811

K89

ICPC

Transient cerebral ischaemia

2.6

10.1

211

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

10.0

110

567

K80

ICPC

Cardiac arrhythmia NOS

1.5

10.0

335

2325

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

9.9

2471

22691

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

9.8

620

4803

C10AA01

ATC

simvastatin; oral

1.2

9.8

1663

14616

R00.2

ICD-10 Finland

Palpitations

1.6

9.8

259

1710

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

9.7

896

7321

SPAT1097

SPAT

Recording of ECG

1.4

9.7

543

4129

A10BB01

ATC

glibenclamide; oral

0.3

9.7

779

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

9.7

243

1584

SPAT1153

SPAT

Removal of sutures

1.3

9.7

1164

9829

R06AE07

ATC

cetirizine; oral

1.3

9.6

1405

12131

K30

ICD-10 Finland

Functional dyspepsia

1.4

9.6

384

2755

M79.6

ICD-10 Finland

Pain in limb

1.2

9.6

1527

13315

SPAT1312

SPAT

General health counselling

1.3

9.5

1015

8442

G04CA02

ATC

tamsulosin; oral

1.3

9.5

714

5670

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

9.5

218

1391

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

9.4

799

6452

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

9.4

302

2077

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

100.3

9.4

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.8

9.4

156

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

9.3

1861

16617

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.2

970

8055

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

9.1

106

558

N05AH04

ATC

quetiapine; oral

1.4

9.1

412

3026

A10BB12

ATC

glimepiride; oral

0.5

9.1

1579

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

9.1

771

6227

M03BX02

ATC

tizanidine; oral

1.2

9.0

2021

18244

130

Kela drug reimbursment

Malignant tumour

0.6

9.0

153

2495

A02BC03

ATC

lansoprazole; oral

1.3

9.0

1021

8552

M79.1

ICD-10 Finland

Myalgia

1.4

8.9

457

3423

J01CA04

ATC

amoxicillin; systemic

1.3

8.9

2758

25769

D02

ICPC

Abdominal pain epigastric

1.6

8.9

213

1375

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

8.8

814

6646

N01

ICPC

Headache

1.5

8.7

273

1869

G30.0

ICD-10 Finland

Alzheimer disease with early onset

50.1

8.7

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.7

8.6

320

4431

I95.1

ICD-10 Finland

Orthostatic hypotension

1.8

8.6

131

752

SPAT1310

SPAT

Counselling related to known health issue

1.3

8.5

1045

8819

C10AX09

ATC

ezetimibe; oral

1.3

8.5

658

5243

N81.6

ICD-10 Finland

Rectocele

1.5

8.5

269

1847

SFA10

NOMESCO Finland

One-surface restoration

1.2

8.5

1729

15414

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

8.4

656

5233

R01AD12

ATC

fluticasone furoate; nasal

1.3

8.4

865

7152

M01AX05

ATC

glucosamine; oral

1.3

8.3

804

6592

Z00.0

ICD-10 Finland

General medical examination

1.3

8.3

629

4995

N27

ICPC

Fear of neurological disease other

2.2

8.3

302

S82

ICPC

Naevus/mole

1.4

8.2

474

3616

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

8.2

165

1020

J01DB01

ATC

cefalexin; oral

1.3

8.2

2851

26826

SPAT1050

SPAT

Extensive neurological examination

2.2

8.2

323

H13

ICPC

Plugged feeling ear

1.3

8.2

730

5924

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

8.2

275

1911

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

8.2

1291

11195

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

8.1

306

2173

J01FA10

ATC

azithromycin; systemic

1.2

8.1

1749

15656

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

8.0

286

2009

TDA90, ,

SPAT

1.5

8.0

270

1877

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

6.3

8.0

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.3

8.0

268

SFA20

NOMESCO Finland

Two-surface restoration

1.2

8.0

1802

16191

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

8.0

1402

12285

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

7.9

246

1682

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.1

7.9

348

UJF32

NOMESCO Finland

Coloscopy

1.3

7.8

964

8125

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.8

1388

12165

H93.1

ICD-10 Finland

Tinnitus

1.5

7.8

233

1580

F05.1

ICD-10 Finland

Delirium superimposed on dementia

10.8

7.8

XKD00

NOMESCO Finland

Uroflowmetry

1.3

7.8

489

3781

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

7.7

979

8277

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.2

7.7

285

J01AA02

ATC

doxycycline; systemic

1.2

7.7

2765

25990

R41.1

ICD-10 Finland

Anterograde amnesia

18.4

7.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

7.5

430

3275

P06

ICPC

Sleep disturbance

1.4

7.5

365

2710

Z01.2

ICD-10 Finland

Dental examination

1.2

7.5

1436

12667

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

7.5

679

5515

SPAT1216

SPAT

Assessment of functional ability

1.3

7.5

524

4114

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

7.5

2057

18792

SPAT1360

SPAT

Extensive global examination

1.5

7.4

212

1425

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

80.3

7.4

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

7.4

385

2893

G43

ICD-10 Finland

Migraine

2.0

7.3

365

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

7.3

209

1405

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

7.3

963

8175

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.5

7.3

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

7.2

346

2565

C05AA08

ATC

fluocortolone; rectal, topical

1.3

7.2

445

3433

R4110, ,

SPAT

1.3

7.2

509

4003

SPAT1260

SPAT

Consultation of another employee

1.3

7.2

572

4570

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.9

7.2

111

M54.5

ICD-10 Finland

Low back pain

1.2

7.1

1172

10175

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

7.0

399

3037

DAX08

NOMESCO Finland

Fitting of hearing aid

1.5

7.0

232

1610

F02

ICPC

Red eye

1.6

6.9

142

884

SPAT1043

SPAT

Audiometry

1.4

6.9

384

2911

R31

ICD-10 Finland

Unspecified haematuria

1.4

6.9

330

2442

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.9

1763

15939

N05AX08

ATC

risperidone; systemic

1.6

6.9

161

1034

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

6.9

1188

R05

ICPC

Cough

1.2

6.9

827

6940

P03

ICPC

Feeling depressed

1.5

6.8

204

1385

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.8

937

7976

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

6.8

172

1127

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

6.8

1284

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

6.8

659

5395

R07.3

ICD-10 Finland

Other chest pain

1.4

6.7

350

2628

XF404

NOMESCO Finland

Ambulatory ECG

1.4

6.7

297

2171

N29

ICPC

Neurological sympt/complt other

2.1

6.7

302

C07AA05

ATC

propranolol; systemic

1.3

6.7

570

4591

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

6.6

212

1459

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

6.6

1729

15643

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

6.6

116

D06

ICPC

Abdominal pain localized other

1.4

6.6

277

2007

S18

ICPC

Laceration/cut

1.2

6.6

1718

15541

X58

ICD-10 Finland

Exposure to other specified factors

1.3

6.5

404

3116

A10AE05

ATC

insulin detemir; parenteral

0.5

6.5

1017

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.5

409

3161

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.7

6.5

129

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

6.5

325

2428

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

6.5

142

901

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.4

6.4

306

2265

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.2

6.4

360

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.3

6.4

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

6.4

369

2816

A29

ICPC

General symptom/complaint other

1.3

6.4

453

3562

G04CB02

ATC

dutasteride; oral

1.5

6.4

222

1556

D01

ICPC

Abdominal pain/cramps general

1.3

6.3

367

2807

Y06

ICPC

Prostate symptom/complaint

1.8

6.2

532

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.2

1131

9884

M25.5

ICD-10 Finland

Pain in joint

1.2

6.2

1053

9140

R51.81

ICD-10 Finland

Facial pain NOS

1.9

6.2

402

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.1

6.2

264

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.5

6.2

1079

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

6.2

514

4126

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

6.2

250

1801

G04BD12

ATC

mirabegron; oral

1.3

6.1

453

3580

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

6.1

120

741

U02

ICPC

Urinary frequency/urgency

1.3

6.1

531

4287

J01EA01

ATC

trimethoprim; systemic

1.2

6.1

863

7359

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

6.1

1229

10844

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

2.3

6.1

182

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.2

6.0

271

M01AH05

ATC

etoricoxib; oral

1.2

6.0

2060

19020

M01AC06

ATC

meloxicam; systemic, rectal

1.2

6.0

1247

11025

L03

ICPC

Low back symptom/complaint

1.2

6.0

953

8217

H81.3

ICD-10 Finland

Other peripheral vertigo

1.7

6.0

100

591

L17

ICPC

Foot/toe symptom/complaint

1.2

6.0

1065

9282

A10AA02, ,

ATC

0.3

6.0

491

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Neurology
13 [38004458]

4.1e-01

6.3e-01

1.4e+00

8.1e+00

3.0e+00

1.8e+00

9.0e-01

cases:14.13%

controls:9.86%

cases:7.01%

controls:3.85%

cases:2.69%

controls:0.70%

cases:57.32%

controls:0.04%

cases:12.33%

controls:0.72%

cases:20.46%

controls:4.10%

cases:21.91%

controls:10.26%

530

3701

3222

33827

263

1444

3488

36084

101

262

3650

37266

2150

1601

37513

462

268

3285

37206

755

1501

2936

35149

710

3232

2531

28258

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

1.7e-01

3.3e-01

1.2e+00

7.0e+00

2.2e+00

4.4e-01

3.5e-01

cases:7.57%

controls:6.47%

cases:4.13%

controls:3.00%

cases:1.28%

controls:0.37%

cases:15.30%

controls:0.02%

cases:3.42%

controls:0.39%

cases:4.85%

controls:3.18%

cases:15.30%

controls:11.28%

284

2428

3468

35100

155

1125

3596

36403

140

3703

37388

574

3177

37522

128

147

3619

37327

179

1166

3512

35484

496

3551

2745

27939

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]

7.8e-01

1.2e+00

3.1e+00

1.0e+50

3.6e+00

1.8e+00

8.3e-01

cases:1.65%

controls:0.76%

cases:0.61%

controls:0.19%

cases:0.35%

controls:0.02%

cases:0.48%

controls:0.00%

cases:0.67%

controls:0.02%

cases:1.22%

controls:0.20%

cases:1.67%

controls:0.74%

287

3690

37241

3728

37455

3738

37522

3733

37528

3722

37467

3646

36575

232

3187

31258

Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]

6.2e-01

1.4e+00

2.4e+00

—

3.0e+00

2.3e+00

1.5e+00

cases:1.15%

controls:0.62%

cases:0.85%

controls:0.21%

cases:0.51%

controls:0.05%

—

cases:0.83%

controls:0.04%

cases:2.79%

controls:0.28%

cases:4.04%

controls:0.97%

232

3709

37296

3719

37449

3732

37510

—

3716

37458

103

104

3588

36546

131

304

3110

31186

Emergency Room Visit
ER [9203]

1.8e-01

2.7e-01

9.2e-01

7.7e+00

1.2e+00

3.3e-01

3.9e-01

cases:35.82%

controls:31.80%

cases:14.08%

controls:11.09%

cases:3.55%

controls:1.44%

cases:58.65%

controls:0.06%

cases:4.56%

controls:1.44%

cases:14.93%

controls:11.20%

cases:40.02%

controls:31.03%

1344

11934

2408

25594

528

4162

3223

33366

133

541

3618

36987

2200

1551

37505

171

539

3576

36935

551

4105

3140

32545

1297

9770

1944

21720

Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]

7.6e-01

1.4e+00

3.0e+00

—

3.1e+00

1.4e+00

9.4e-01

cases:1.89%

controls:0.89%

cases:1.25%

controls:0.31%

cases:0.77%

controls:0.04%

—

cases:0.51%

controls:0.02%

cases:1.30%

controls:0.32%

cases:3.09%

controls:1.23%

335

3681

37193

118

3704

37410

3722

37514

—

3728

37465

119

3643

36531

100

388

3141

31102

Other amnesia
R41.3 [45539342]

1.4e+00

3.2e+00

—

1.0e+50

—

3.2e+00

1.9e+00

cases:0.61%

controls:0.15%

cases:1.36%

controls:0.06%

—

cases:4.83%

controls:0.00%

—

cases:1.11%

controls:0.05%

cases:1.60%

controls:0.24%

3729

37473

3700

37507

—

181

3570

37528

—

3650

36633

3189

31415

Emergency Medicine
93 [38004510]

1.3e-01

2.2e-01

9.9e-01

6.7e+00

9.0e-01

4.0e-01

3.0e-01

cases:12.79%

controls:11.40%

cases:7.33%

controls:5.97%

cases:2.29%

controls:0.86%

cases:27.75%

controls:0.05%

cases:2.16%

controls:0.89%

cases:9.37%

controls:6.51%

cases:24.81%

controls:19.70%

480

4279

3272

33249

275

2242

3476

35286

323

3665

37205

1041

2710

37511

334

3666

37140

346

2387

3345

34263

804

6203

2437

25287

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

1.6e-02

1.6e-01

8.0e-01

6.1e+00

1.5e+00

2.5e-01

2.1e-01

cases:10.61%

controls:10.46%

cases:6.00%

controls:5.15%

cases:1.55%

controls:0.70%

cases:15.70%

controls:0.04%

cases:3.07%

controls:0.68%

cases:6.69%

controls:5.30%

cases:19.93%

controls:16.74%

398

3926

3354

33602

225

1931

3526

35597

262

3693

37266

589

3162

37513

115

254

3632

37220

247

1943

3444

34707

646

5271

2595

26219

Inpatient Hospital
21 [8717]

3.4e-02

7.1e-02

5.3e-02

6.6e+00

1.2e+00

2.7e-01

2.6e-01

cases:32.38%

controls:31.64%

cases:11.25%

controls:10.56%

cases:1.55%

controls:1.47%

cases:26.37%

controls:0.05%

cases:4.78%

controls:1.54%

cases:12.60%

controls:9.87%

cases:30.92%

controls:25.65%

1215

11874

2537

25654

422

3963

3329

33565

551

3693

36977

989

2762

37510

179

577

3568

36897

465

3619

3226

33031

1002

8076

2239

23414

Transient global amnesia
G45.4 [45566883]

2.4e+00

—

1.0e+50

—

5.8e+00

cases:0.27%

controls:0.02%

—

cases:0.77%

controls:0.00%

cases:99.73%

controls:0.00%

cases:11.61%

controls:0.00%

—

cases:6.79%

controls:0.02%

3742

37519

—

3722

37528

3741

37528

435

3312

37474

—

220

3021

31483

Carotid artery syndrome (hemispheric)
G45.1 [45576586]

7.6e-01

1.1e+00

2.5e+00

1.0e+50

2.5e+00

1.5e+00

7.6e-01

cases:0.75%

controls:0.35%

cases:0.32%

controls:0.11%

cases:0.16%

controls:0.01%

cases:0.51%

controls:0.00%

cases:0.16%

controls:0.01%

cases:0.49%

controls:0.11%

cases:0.89%

controls:0.42%

132

3724

37396

3739

37487

3745

37523

3732

37528

3741

37469

3673

36609

132

3212

31358

Thorax X-ray examination
GD1AA [2001303617]

1.1e-01

1.3e-01

7.3e-01

6.1e+00

7.0e-01

2.5e-01

3.9e-01

cases:9.17%

controls:8.29%

cases:3.71%

controls:3.27%

cases:0.80%

controls:0.39%

cases:6.66%

controls:0.02%

cases:0.93%

controls:0.47%

cases:4.17%

controls:3.27%

cases:14.75%

controls:10.49%

344

3110

3408

34418

139

1226

3612

36302

145

3721

37383

250

3501

37522

175

3712

37299

154

1198

3537

35452

478

3303

2763

28187

Memory disturbance
P20 [2002000816]

3.8e-01

1.0e+00

2.1e+00

—

2.1e+00

1.7e+00

9.4e-01

cases:1.25%

controls:0.86%

cases:1.01%

controls:0.38%

cases:0.35%

controls:0.04%

—

cases:0.56%

controls:0.07%

cases:2.30%

controls:0.44%

cases:4.44%

controls:1.78%

322

3705

37206

141

3713

37387

3738

37512

—

3726

37449

161

3606

36489

144

559

3097

30931

Headache
R51.80 [2000503603]

5.4e-01

8.8e-01

2.0e+00

—

2.6e+00

9.6e-01

6.8e-01

cases:2.59%

controls:1.53%

cases:1.12%

controls:0.47%

cases:0.29%

controls:0.04%

—

cases:0.56%

controls:0.04%

cases:1.22%

controls:0.47%

cases:3.33%

controls:1.72%

574

3655

36954

176

3709

37352

3740

37513

—

3726

37458

173

3646

36477

108

541

3133

30949

Internal Medicine
11 [38004456]

6.1e-02

1.6e-02

5.1e-01

5.8e+00

8.1e-01

1.5e-01

1.9e-01

cases:24.84%

controls:23.73%

cases:9.54%

controls:9.41%

cases:2.51%

controls:1.53%

cases:17.25%

controls:0.06%

cases:3.34%

controls:1.52%

cases:10.67%

controls:9.36%

cases:26.57%

controls:23.04%

932

8904

2820

28624

358

3531

3393

33997

573

3657

36955

647

3104

37504

125

569

3622

36905

394

3432

3297

33218

861

7254

2380

24236

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

1.3e-02

-1.5e-02

4.6e-01

5.3e+00

1.1e+00

1.4e-01

2.0e-01

cases:24.87%

controls:24.62%

cases:16.61%

controls:16.81%

cases:4.93%

controls:3.17%

cases:29.65%

controls:0.21%

cases:9.23%

controls:3.37%

cases:19.51%

controls:17.44%

cases:43.60%

controls:38.79%

933

9241

2819

28287

623

6309

3128

31219

185

1191

3566

36337

1112

2639

37450

346

1264

3401

36210

720

6391

2971

30259

1413

12216

1828

19274

Outpatient Hospital
22 [8756]

7.9e-02

4.1e-02

4.8e-04

5.1e+00

1.3e+00

3.2e-01

3.1e-01

cases:27.75%

controls:26.20%

cases:8.24%

controls:7.93%

cases:0.96%

controls:0.96%

cases:6.45%

controls:0.04%

cases:3.68%

controls:1.02%

cases:9.56%

controls:7.16%

cases:26.32%

controls:20.74%

1041

9832

2711

27696

309

2977

3442

34551

360

3715

37168

242

3509

37512

138

382

3609

37092

353

2623

3338

34027

853

6531

2388

24959

Emergency Room and Inpatient Visit
ERIP [262]

-3.8e-02

-5.7e-02

2.6e-01

5.9e+00

1.1e+00

1.1e-01

1.0e-01

cases:3.36%

controls:3.49%

cases:1.84%

controls:1.95%

cases:0.37%

controls:0.29%

cases:5.76%

controls:0.02%

cases:0.80%

controls:0.27%

cases:2.52%

controls:2.27%

cases:8.76%

controls:7.96%

126

1308

3626

36220

730

3682

36798

108

3737

37420

216

3535

37522

102

3717

37372

832

3598

35818

284

2507

2957

28983

INR in Blood by Coagulation assay
34714-6 [3032080]

3.1e-02

7.8e-02

4.5e-01

5.3e+00

6.2e-01

3.1e-01

3.2e-01

cases:8.98%

controls:8.73%

cases:5.47%

controls:5.08%

cases:2.75%

controls:1.77%

cases:15.28%

controls:0.09%

cases:3.42%

controls:1.87%

cases:7.02%

controls:5.22%

cases:17.90%

controls:13.62%

337

3276

3415

34252

205

1905

3546

35623

103

664

3648

36864

573

3178

37493

128

701

3619

36773

259

1914

3432

34736

580

4289

2661

27201

Office Visit
OMOP4822458 [581477]

-7.7e-03

1.8e-01

2.2e-01

4.4e+00

2.1e+00

5.0e-01

1.8e-01

cases:8.45%

controls:8.51%

cases:2.88%

controls:2.43%

cases:0.43%

controls:0.34%

cases:1.63%

controls:0.02%

cases:2.67%

controls:0.34%

cases:3.85%

controls:2.36%

cases:8.86%

controls:7.48%

317

3193

3435

34335

108

911

3643

36617

129

3735

37399

3690

37520

100

129

3647

37345

142

865

3549

35785

287

2356

2954

29134

Pure hypercholesterolaemia
E78.01 [2000501514]

1.3e-01

1.5e-01

1.6e-01

5.0e+00

1.1e+00

4.0e-01

2.7e-01

cases:3.81%

controls:3.35%

cases:1.97%

controls:1.71%

cases:0.32%

controls:0.27%

cases:2.32%

controls:0.02%

cases:0.85%

controls:0.27%

cases:2.98%

controls:2.01%

cases:8.11%

controls:6.32%

143

1258

3609

36270

642

3677

36886

102

3739

37426

3664

37522

102

3715

37372

110

737

3581

35913

263

1991

2978

29499

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

-6.7e-03

8.6e-03

3.3e-01

5.2e+00

1.0e+00

1.1e-01

9.7e-02

cases:28.84%

controls:28.98%

cases:23.78%

controls:23.63%

cases:6.03%

controls:4.39%

cases:29.67%

controls:0.23%

cases:11.24%

controls:4.41%

cases:27.09%

controls:25.04%

cases:50.63%

controls:48.20%

1082

10874

2670

26654

892

8866

2859

28662

226

1646

3525

35882

1113

2638

37443

421

1654

3326

35820

1000

9177

2691

27473

1641

15177

1600

16313

donepezil; oral
N06DA02 [21604795]

2.9e+00

—

1.0e+50

3.6e+00

cases:0.24%

controls:0.01%

—

cases:0.68%

controls:0.00%

cases:1.73%

controls:0.05%

3743

37523

—

3666

36650

3185

31475

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

6.5e-03

1.3e-02

3.4e-01

5.2e+00

1.0e+00

1.0e-01

9.8e-02

cases:29.32%

controls:29.18%

cases:24.15%

controls:23.91%

cases:6.13%

controls:4.46%

cases:29.17%

controls:0.24%

cases:11.40%

controls:4.53%

cases:27.42%

controls:25.39%

cases:50.97%

controls:48.51%

1100

10952

2652

26576

906

8973

2845

28555

230

1673

3521

35855

1094

2657

37439

427

1696

3320

35778

1012

9306

2679

27344

1652

15277

1589

16213

CBC panel - Blood by Automated count
58410-2 [40761511]

4.1e-02

5.1e-02

2.9e-01

5.0e+00

8.5e-01

1.5e-01

1.6e-01

cases:28.54%

controls:27.72%

cases:20.45%

controls:19.63%

cases:4.77%

controls:3.61%

cases:20.98%

controls:0.18%

cases:7.98%

controls:3.56%

cases:22.84%

controls:20.23%

cases:45.97%

controls:42.06%

1071

10403

2681

27125

767

7365

2984

30163

179

1353

3572

36175

787

2964

37461

299

1333

3448

36141

843

7416

2848

29234

1490

13245

1751

18245

Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]

3.4e-01

4.7e-01

1.2e+00

1.0e+50

3.9e+00

1.5e+00

1.0e+00

cases:1.04%

controls:0.74%

cases:0.43%

controls:0.27%

cases:0.13%

controls:0.04%

cases:1.36%

controls:0.00%

cases:0.64%

controls:0.01%

cases:1.16%

controls:0.25%

cases:2.25%

controls:0.82%

279

3713

37249

100

3735

37428

3746

37513

3700

37528

3723

37469

3648

36558

259

3168

31231

General Practice
1 [38004446]

-5.9e-02

8.6e-03

4.4e-01

5.5e+00

9.2e-01

1.1e-01

7.8e-02

cases:11.25%

controls:11.85%

cases:4.88%

controls:4.84%

cases:1.07%

controls:0.69%

cases:5.33%

controls:0.02%

cases:1.71%

controls:0.69%

cases:5.80%

controls:5.21%

cases:17.31%

controls:16.22%

422

4448

3330

33080

183

1816

3568

35712

258

3711

37270

200

3551

37519

259

3683

37215

214

1910

3477

34740

561

5107

2680

26383

Migraine with aura [classical migraine]
G43.1 [45562086]

6.7e-01

8.4e-01

—

1.0e+50

2.4e+00

1.2e+00

cases:1.04%

controls:0.53%

cases:0.53%

controls:0.23%

—

cases:0.48%

controls:0.00%

cases:0.21%

controls:0.02%

cases:0.57%

controls:0.18%

cases:1.67%

controls:0.49%

200

3713

37328

3731

37441

—

3733

37528

3739

37467

3670

36585

154

3187

31336

dipyridamole; oral, parenteral
B01AC07 [21600992]

4.8e-01

6.5e-01

1.0e+00

1.0e+50

2.0e+00

1.4e+00

1.2e+00

cases:1.07%

controls:0.66%

cases:0.85%

controls:0.45%

cases:0.43%

controls:0.15%

cases:0.13%

controls:0.00%

cases:0.99%

controls:0.14%

cases:1.82%

controls:0.44%

cases:2.10%

controls:0.63%

249

3712

37279

167

3719

37361

3735

37470

3746

37528

3710

37423

161

3624

36489

199

3173

31291

Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]

3.6e-01

7.2e-01

2.0e+00

—

2.3e+00

7.9e-01

4.7e-01

cases:1.97%

controls:1.38%

cases:0.96%

controls:0.47%

cases:0.32%

controls:0.05%

—

cases:0.45%

controls:0.05%

cases:1.11%

controls:0.51%

cases:3.05%

controls:1.94%

518

3678

37010

176

3715

37352

3739

37511

—

3730

37457

186

3650

36464

610

3142

30880

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

6.8e-03

3.0e-02

2.5e-01

5.0e+00

8.3e-01

9.0e-02

9.8e-02

cases:31.37%

controls:31.22%

cases:27.46%

controls:26.87%

cases:7.17%

controls:5.68%

cases:29.54%

controls:0.29%

cases:11.98%

controls:5.60%

cases:30.67%

controls:28.80%

cases:53.63%

controls:51.17%

1177

11718

2575

25810

1030

10082

2721

27446

269

2131

3482

35397

1108

107

2643

37421

449

2099

3298

35375

1132

10555

2559

26095

1738

16115

1503

15375

Essential (primary) hypertension
I10 [45591453]

-1.2e-01

3.2e-02

2.2e-01

4.7e+00

8.8e-01

2.8e-01

1.4e-01

cases:18.28%

controls:20.13%

cases:10.48%

controls:10.18%

cases:2.11%

controls:1.69%

cases:6.64%

controls:0.06%

cases:4.11%

controls:1.75%

cases:13.84%

controls:10.87%

cases:31.81%

controls:28.78%

686

7554

3066

29974

393

3819

3358

33709

636

3672

36892

249

3502

37504

154

654

3593

36820

511

3984

3180

32666

1031

9064

2210

22426

Erythrocytes [#/volume] in Urine
30391-7 [3002582]

-3.4e-02

-1.5e-01

5.2e-01

5.0e+00

9.1e-01

2.6e-01

1.2e-01

cases:4.77%

controls:4.93%

cases:2.53%

controls:2.92%

cases:0.69%

controls:0.41%

cases:2.32%

controls:0.02%

cases:1.04%

controls:0.42%

cases:3.74%

controls:2.92%

cases:9.87%

controls:8.83%

179

1849

3573

35679

1095

3656

36433

155

3725

37373

3664

37522

158

3708

37316

138

1069

3553

35581

320

2779

2921

28711

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

5.3e-02

2.9e-02

1.1e-01

4.8e+00

5.7e-01

2.3e-01

2.6e-01

cases:13.35%

controls:12.75%

cases:7.06%

controls:6.87%

cases:1.15%

controls:1.03%

cases:5.07%

controls:0.05%

cases:2.00%

controls:1.14%

cases:8.86%

controls:7.16%

cases:24.81%

controls:20.22%

501

4784

3251

32744

265

2580

3486

34948

386

3708

37142

190

3561

37511

429

3672

37045

327

2624

3364

34026

804

6368

2437

25122

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

-2.6e-02

1.0e-01

1.4e-01

4.4e+00

8.8e-01

3.2e-01

2.5e-01

cases:7.65%

controls:7.83%

cases:4.69%

controls:4.25%

cases:0.80%

controls:0.69%

cases:2.03%

controls:0.03%

cases:1.63%

controls:0.68%

cases:6.18%

controls:4.58%

cases:15.37%

controls:12.40%

287

2940

3465

34588

176

1594

3575

35934

260

3721

37268

3675

37518

255

3686

37219

228

1677

3463

34973

498

3906

2743

27584

Casts [#/volume] in Urine by Automated count
51483-6 [3030467]

-8.3e-02

-1.6e-01

6.2e-01

4.9e+00

8.8e-01

1.4e-01

cases:3.97%

controls:4.30%

cases:2.16%

controls:2.52%

cases:0.64%

controls:0.35%

cases:2.08%

controls:0.02%

cases:0.85%

controls:0.36%

cases:2.90%

controls:2.52%

cases:8.33%

controls:7.29%

149

1614

3603

35914

945

3670

36583

130

3727

37398

3673

37522

134

3715

37340

107

923

3584

35727

270

2296

2971

29194

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

8.0e-03

7.6e-02

2.7e-01

4.2e+00

9.8e-01

3.2e-01

1.9e-01

cases:8.69%

controls:8.63%

cases:5.20%

controls:4.84%

cases:1.04%

controls:0.79%

cases:2.35%

controls:0.03%

cases:2.05%

controls:0.78%

cases:7.23%

controls:5.38%

cases:17.31%

controls:14.80%

326

3237

3426

34291

195

1815

3556

35713

298

3712

37230

3663

37515

294

3670

37180

267

1971

3424

34679

561

4661

2680

26829

Bacteria [Presence] in Urine
87829-8 [36304419]

-6.1e-02

-1.8e-01

4.5e-01

4.8e+00

9.1e-01

1.5e-01

cases:3.94%

controls:4.18%

cases:2.00%

controls:2.40%

cases:0.51%

controls:0.32%

cases:1.89%

controls:0.02%

cases:0.85%

controls:0.34%

cases:2.68%

controls:2.32%

cases:7.81%

controls:6.81%

148

1569

3604

35959

899

3676

36629

121

3732

37407

3680

37522

129

3715

37345

851

3592

35799

253

2146

2988

29344

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

-4.6e-02

-2.6e-02

2.6e-01

4.7e+00

8.3e-01

7.3e-02

1.5e-01

cases:20.50%

controls:21.26%

cases:18.21%

controls:18.60%

cases:5.01%

controls:3.92%

cases:18.98%

controls:0.21%

cases:8.33%

controls:3.80%

cases:21.19%

controls:20.00%

cases:39.65%

controls:36.15%

769

7979

2983

29549

683

6980

3068

30548

188

1470

3563

36058

712

3039

37450

312

1424

3435

36050

782

7329

2909

29321

1285

11384

1956

20106

Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]

1.5e-01

1.6e-01

1.9e+00

—

2.7e+00

7.2e-01

3.9e-01

cases:5.57%

controls:4.84%

cases:2.43%

controls:2.07%

cases:1.28%

controls:0.19%

—

cases:2.88%

controls:0.20%

cases:4.20%

controls:2.10%

cases:10.98%

controls:7.70%

209

1815

3543

35713

778

3660

36750

3703

37455

—

108

3639

37398

155

768

3536

35882

356

2425

2885

29065

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

2.9e-02

2.0e-02

2.0e-01

4.9e+00

8.2e-01

1.1e-01

8.2e-02

cases:33.42%

controls:32.79%

cases:29.14%

controls:28.73%

cases:7.54%

controls:6.28%

cases:30.13%

controls:0.34%

cases:12.97%

controls:6.17%

cases:33.13%

controls:30.74%

cases:55.14%

controls:53.09%

1254

12304

2498

25224

1093

10781

2658

26747

283

2358

3468

35170

1130

126

2621

37402

486

2314

3261

35160

1223

11268

2468

25382

1787

16719

1454

14771

Platelets [#/volume] in Blood
26515-7 [3007461]

3.1e-02

2.0e-02

2.0e-01

4.9e+00

8.2e-01

1.1e-01

8.5e-02

cases:33.40%

controls:32.71%

cases:29.09%

controls:28.67%

cases:7.54%

controls:6.27%

cases:30.10%

controls:0.34%

cases:12.94%

controls:6.16%

cases:33.08%

controls:30.69%

cases:55.11%

controls:53.00%

1253

12276

2499

25252

1091

10760

2660

26768

283

2354

3468

35174

1129

126

2622

37402

485

2310

3262

35164

1221

11249

2470

25401

1786

16689

1455

14801

MCH [Entitic mass]
28539-5 [3035941]

2.9e-02

1.7e-02

1.9e-01

4.9e+00

8.2e-01

1.1e-01

8.1e-02

cases:33.37%

controls:32.74%

cases:29.03%

controls:28.69%

cases:7.52%

controls:6.27%

cases:30.10%

controls:0.34%

cases:12.92%

controls:6.15%

cases:33.11%

controls:30.69%

cases:55.08%

controls:53.05%

1252

12285

2500

25243

1089

10765

2662

26763

282

2353

3469

35175

1129

126

2622

37402

484

2305

3263

35169

1222

11248

2469

25402

1785

16707

1456

14783

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

2.9e-02

1.9e-02

2.0e-01

4.9e+00

8.2e-01

1.1e-01

8.3e-02

cases:33.42%

controls:32.77%

cases:29.11%

controls:28.72%

cases:7.54%

controls:6.28%

cases:30.10%

controls:0.34%

cases:12.94%

controls:6.17%

cases:33.13%

controls:30.73%

cases:55.14%

controls:53.08%

1254

12298

2498

25230

1092

10777

2659

26751

283

2355

3468

35173

1129

126

2622

37402

485

2312

3262

35162

1223

11261

2468

25389

1787

16716

1454

14774

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

2.9e-02

1.8e-02

2.0e-01

4.9e+00

8.1e-01

1.1e-01

7.9e-02

cases:33.42%

controls:32.78%

cases:29.11%

controls:28.74%

cases:7.54%

controls:6.28%

cases:30.10%

controls:0.34%

cases:12.94%

controls:6.17%

cases:33.13%

controls:30.75%

cases:55.08%

controls:53.10%

1254

12300

2498

25228

1092

10785

2659

26743

283

2357

3468

35171

1129

126

2622

37402

485

2314

3262

35160

1223

11270

2468

25380

1785

16722

1456

14768

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

2.6e-02

1.6e-02

2.0e-01

4.9e+00

8.1e-01

1.1e-01

8.2e-02

cases:33.40%

controls:32.81%

cases:29.11%

controls:28.79%

cases:7.57%

controls:6.30%

cases:30.13%

controls:0.34%

cases:12.94%

controls:6.19%

cases:33.16%

controls:30.81%

cases:55.17%

controls:53.14%

1253

12313

2499

25215

1092

10804

2659

26724

284

2364

3467

35164

1130

126

2621

37402

485

2319

3262

35155

1224

11291

2467

25359

1788

16733

1453

14757

Leukocytes [#/volume] in Blood
26464-8 [3010813]

3.0e-02

2.1e-02

1.9e-01

4.9e+00

8.1e-01

1.1e-01

8.5e-02

cases:33.48%

controls:32.80%

cases:29.17%

controls:28.73%

cases:7.54%

controls:6.29%

cases:30.13%

controls:0.34%

cases:12.92%

controls:6.18%

cases:33.19%

controls:30.77%

cases:55.23%

controls:53.13%

1256

12311

2496

25217

1094

10781

2657

26747

283

2362

3468

35166

1130

126

2621

37402

484

2317

3263

35157

1225

11276

2466

25374

1790

16730

1451

14760

EKG study
11524-6 [3013512]

2.4e-02

-1.1e-01

4.7e-01

5.5e+00

5.5e-01

1.7e-01

1.9e-01

cases:6.56%

controls:6.41%

cases:3.39%

controls:3.75%

cases:0.75%

controls:0.47%

cases:3.63%

controls:0.02%

cases:0.91%

controls:0.53%

cases:4.63%

controls:3.92%

cases:13.55%

controls:11.46%

246

2406

3506

35122

127

1407

3624

36121

175

3723

37353

136

3615

37522

197

3713

37277

171

1437

3520

35213

439

3608

2802

27882

Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]

2.3e-02

-2.2e-01

3.5e-01

4.8e+00

8.9e-01

2.3e-01

1.6e-01

cases:6.10%

controls:5.97%

cases:2.67%

controls:3.29%

cases:0.61%

controls:0.43%

cases:2.43%

controls:0.02%

cases:1.09%

controls:0.45%

cases:4.01%

controls:3.23%

cases:11.29%

controls:9.76%

229

2241

3523

35287

100

1234

3651

36294

163

3728

37365

3660

37520

170

3706

37304

148

1182

3543

35468

366

3074

2875

28416

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

7.9e-03

-6.5e-02

1.3e-01

4.8e+00

7.4e-01

9.0e-03

-2.9e-02

cases:20.04%

controls:19.92%

cases:16.18%

controls:17.08%

cases:4.29%

controls:3.79%

cases:18.72%

controls:0.19%

cases:7.61%

controls:3.77%

cases:18.56%

controls:18.42%

cases:33.42%

controls:34.06%

752

7474

3000

30054

607

6409

3144

31119

161

1423

3590

36105

702

3049

37457

285

1414

3462

36060

685

6752

3006

29898

1083

10726

2158

20764

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

3.8e-02

-1.8e-02

2.4e-01

4.7e+00

8.5e-01

4.4e-02

-6.2e-02

cases:24.39%

controls:23.70%

cases:19.11%

controls:19.40%

cases:5.12%

controls:4.09%

cases:19.78%

controls:0.23%

cases:9.15%

controls:4.12%

cases:21.57%

controls:20.83%

cases:38.07%

controls:39.56%

915

8894

2837

28634

717

7279

3034

30249

192

1535

3559

35993

742

3009

37443

343

1544

3404

35930

796

7633

2895

29017

1234

12456

2007

19034

Outpatient Visit
OP [9202]

2.4e-01

1.9e-01

2.4e-01

3.3e+00

5.2e-01

5.3e-01

4.9e-01

cases:76.52%

controls:72.04%

cases:56.01%

controls:51.29%

cases:13.38%

controls:10.85%

cases:12.42%

controls:0.53%

cases:16.92%

controls:10.76%

cases:64.45%

controls:51.50%

cases:87.69%

controls:81.41%

2871

27034

881

10494

2101

19249

1650

18279

502

4073

3249

33455

466

198

3285

37330

634

4031

3113

33443

2379

18876

1312

17774

2842

25637

399

5853

Supplier / Service Provider
OMOP5117446 [33004]

-7.1e-01

-7.7e-01

-9.1e-01

1.7e+00

2.3e+00

2.0e+00

2.6e+00

cases:14.37%

controls:25.40%

cases:3.68%

controls:7.62%

cases:0.35%

controls:0.86%

cases:0.16%

controls:0.03%

cases:0.75%

controls:0.07%

cases:3.90%

controls:0.55%

cases:16.51%

controls:1.40%

539

9531

3213

27997

138

2861

3613

34667

323

3738

37205

3745

37517

3719

37446

144

203

3547

36447

535

441

2706

31049

aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]

9.5e-02

3.6e-01

2.3e+00

—

2.0e+00

7.4e-01

4.0e-01

cases:2.35%

controls:2.14%

cases:1.25%

controls:0.88%

cases:0.96%

controls:0.10%

—

cases:0.77%

controls:0.10%

cases:1.76%

controls:0.85%

cases:4.78%

controls:3.25%

802

3664

36726

329

3704

37199

3715

37491

—

3718

37435

310

3626

36340

155

1023

3086

30467

acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]

8.2e-02

3.0e-01

-3.0e-01

2.5e+00

1.3e+00

8.6e-01

8.3e-01

cases:1.33%

controls:1.23%

cases:1.36%

controls:1.01%

cases:0.24%

controls:0.32%

cases:0.19%

controls:0.02%

cases:1.25%

controls:0.35%

cases:2.49%

controls:1.07%

cases:3.52%

controls:1.57%

461

3702

37067

379

3700

37149

121

3742

37407

3744

37522

133

3700

37341

393

3599

36257

114

495

3127

30995

platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]

8.2e-02

3.0e-01

-3.0e-01

2.5e+00

1.3e+00

8.6e-01

8.3e-01

cases:1.33%

controls:1.23%

cases:1.36%

controls:1.01%

cases:0.24%

controls:0.32%

cases:0.19%

controls:0.02%

cases:1.25%

controls:0.35%

cases:2.49%

controls:1.07%

cases:3.52%

controls:1.57%

461

3702

37067

379

3700

37149

121

3742

37407

3744

37522

133

3700

37341

393

3599

36257

114

495

3127

30995

Syncope and collapse
R55 [45568141]

1.5e-01

8.0e-01

1.4e+00

1.0e+50

2.9e+00

1.1e+00

5.3e-01

cases:1.44%

controls:1.24%

cases:0.80%

controls:0.36%

cases:0.19%

controls:0.05%

cases:0.43%

controls:0.00%

cases:0.29%

controls:0.02%

cases:1.06%

controls:0.35%

cases:2.44%

controls:1.45%

467

3698

37061

136

3721

37392

3744

37511

3735

37528

3736

37468

128

3652

36522

458

3162

31032

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

2.4e-02

-6.2e-02

1.2e-01

3.8e+00

1.3e+00

1.1e-01

2.0e-01

cases:12.58%

controls:12.32%

cases:5.63%

controls:5.96%

cases:0.88%

controls:0.78%

cases:1.31%

controls:0.03%

cases:2.43%

controls:0.68%

cases:6.64%

controls:5.96%

cases:20.55%

controls:17.52%

472

4624

3280

32904

211

2238

3540

35290

293

3718

37235

3702

37517

256

3656

37218

245

2185

3446

34465

666

5516

2575

25974

Leukocytes [#/volume] in Urine
30405-5 [3018095]

-3.8e-02

-7.1e-02

4.3e-01

4.5e+00

7.5e-01

1.9e-01

8.1e-02

cases:5.33%

controls:5.52%

cases:3.17%

controls:3.40%

cases:0.75%

controls:0.48%

cases:2.37%

controls:0.03%

cases:1.12%

controls:0.53%

cases:4.23%

controls:3.52%

cases:11.14%

controls:10.37%

200

2073

3552

35455

119

1275

3632

36253

182

3723

37346

3662

37518

199

3705

37275

156

1290

3535

35360

361

3264

2880

28226

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

4.2e-02

2.7e-02

-2.9e-02

4.6e+00

4.4e-01

1.3e-01

1.9e-01

cases:14.23%

controls:13.72%

cases:7.73%

controls:7.54%

cases:1.09%

controls:1.12%

cases:3.31%

controls:0.03%

cases:1.81%

controls:1.17%

cases:8.72%

controls:7.73%

cases:24.96%

controls:21.54%

534

5150

3218

32378

290

2829

3461

34699

422

3710

37106

124

3627

37515

439

3679

37035

322

2832

3369

33818

809

6783

2432

24707

Laboratory Visit
OMOP4822461 [32036]

2.0e-02

3.7e-02

1.5e-01

4.3e+00

7.0e-01

1.5e-01

6.0e-02

cases:36.35%

controls:35.89%

cases:35.78%

controls:34.93%

cases:12.61%

controls:11.06%

cases:31.48%

controls:0.63%

cases:20.12%

controls:11.11%

cases:40.94%

controls:37.48%

cases:58.22%

controls:56.76%

1364

13469

2388

24059

1342

13109

2409

24419

473

4149

3278

33379

1181

236

2570

37292

754

4164

2993

33310

1511

13735

2180

22915

1887

17875

1354

13615

pH of Serum or Plasma
2753-2 [3018418]

1.3e-02

1.3e-01

-3.0e-02

3.8e+00

9.6e-01

3.8e-01

1.9e-01

cases:4.93%

controls:4.87%

cases:3.12%

controls:2.74%

cases:0.43%

controls:0.44%

cases:0.69%

controls:0.02%

cases:1.20%

controls:0.46%

cases:4.33%

controls:3.00%

cases:9.84%

controls:8.31%

185

1827

3567

35701

117

1030

3634

36498

165

3735

37363

3725

37522

173

3702

37301

160

1099

3531

35551

319

2617

2922

28873

Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]

1.5e-01

-1.4e-02

-8.3e-02

4.8e+00

2.9e-01

2.6e-01

7.0e-02

cases:8.32%

controls:7.23%

cases:4.03%

controls:4.08%

cases:0.59%

controls:0.64%

cases:1.92%

controls:0.02%

cases:0.83%

controls:0.62%

cases:5.58%

controls:4.34%

cases:14.44%

controls:13.59%

312

2713

3440

34815

151

1531

3600

35997

239

3729

37289

3679

37522

232

3716

37242

206

1592

3485

35058

468

4281

2773

27209

Cerebral infarction, unspecified
I63.9 [45596216]

1.1e-01

-2.6e-02

1.7e+00

—

2.4e+00

9.0e-01

1.8e-01

cases:1.31%

controls:1.17%

cases:0.51%

controls:0.52%

cases:0.40%

controls:0.07%

—

cases:0.67%

controls:0.06%

cases:1.30%

controls:0.53%

cases:2.04%

controls:1.71%

440

3703

37088

195

3732

37333

3736

37500

—

3722

37451

195

3643

36455

540

3175

30950

Memory test
SPAT1053 [2001700154]

4.7e-01

6.1e-01

1.1e+00

—

1.9e+00

1.2e+00

8.5e-01

cases:2.19%

controls:1.38%

cases:0.99%

controls:0.54%

cases:0.16%

controls:0.05%

—

cases:0.35%

controls:0.05%

cases:1.65%

controls:0.52%

cases:4.75%

controls:2.08%

519

3670

37009

203

3714

37325

3745

37508

—

3734

37454

190

3630

36460

154

656

3087

30834

12 lead EKG panel
34534-8 [3044889]

7.0e-02

1.1e-01

2.9e-03

3.7e+00

9.6e-01

1.9e-01

1.5e-01

cases:17.00%

controls:16.04%

cases:9.89%

controls:8.98%

cases:1.12%

controls:1.12%

cases:1.33%

controls:0.03%

cases:2.72%

controls:1.06%

cases:10.43%

controls:8.78%

cases:28.17%

controls:25.23%

638

6018

3114

31510

371

3370

3380

34158

419

3709

37109

3701

37515

102

399

3645

37075

385

3218

3306

33432

913

7946

2328

23544

Partial epileptic seizure with cloudiness and automatism
G40.21 [2000502140]

—

2.5e+00

2.4e+00

—

cases:0.16%

controls:0.01%

cases:0.43%

controls:0.04%

—

3685

36645

3227

31478

Disorientation, unspecified
R41.0 [45558469]

6.0e-01

1.8e+00

—

1.0e+50

1.7e+00

1.4e+00

cases:0.21%

controls:0.12%

cases:0.29%

controls:0.05%

—

cases:0.29%

controls:0.00%

cases:0.41%

controls:0.07%

cases:0.83%

controls:0.21%

3744

37484

3740

37509

—

3736

37474

3676

36624

3214

31423

Neck artery ultrasound examination with Doppler method
PA6DE [2001308705]

4.9e-01

1.3e-01

—

1.0e+50

3.1e+00

1.1e+00

7.0e-01

cases:0.75%

controls:0.46%

cases:0.13%

controls:0.12%

—

cases:0.85%

controls:0.00%

cases:0.29%

controls:0.01%

cases:0.41%

controls:0.14%

cases:1.02%

controls:0.51%

172

3724

37356

3746

37484

—

3719

37528

3736

37469

3676

36598

160

3208

31330

Normoblasts [#/volume] in Blood
715-3 [3021589]

-1.3e-02

-7.6e-02

-7.2e-02

4.3e+00

5.4e-01

9.2e-02

1.1e-01

cases:7.41%

controls:7.50%

cases:5.79%

controls:6.21%

cases:1.25%

controls:1.35%

cases:4.69%

controls:0.07%

cases:2.22%

controls:1.30%

cases:7.21%

controls:6.62%

cases:14.32%

controls:13.06%

278

2815

3474

34713

217

2331

3534

35197

505

3704

37023

176

3575

37503

488

3664

36986

266

2425

3425

34225

464

4113

2777

27377

Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]

1.7e-01

1.4e-01

—

1.0e+50

2.9e+00

1.2e+00

7.6e-01

cases:0.88%

controls:0.75%

cases:0.24%

controls:0.21%

—

cases:1.07%

controls:0.00%

cases:0.29%

controls:0.02%

cases:0.70%

controls:0.22%

cases:1.70%

controls:0.80%

280

3719

37248

3742

37450

—

3711

37528

3736

37468

3665

36568

252

3186

31238

Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]

5.5e-02

4.7e-02

2.5e-01

3.0e+00

1.5e+00

1.6e-01

1.5e-01

cases:25.48%

controls:24.45%

cases:15.12%

controls:14.53%

cases:2.00%

controls:1.56%

cases:0.67%

controls:0.03%

cases:6.75%

controls:1.53%

cases:16.82%

controls:14.65%

cases:40.60%

controls:37.04%

956

9175

2796

28353

567

5452

3184

32076

585

3676

36943

3726

37515

253

574

3494

36900

621

5369

3070

31281

1316

11663

1925

19827

acetylsalicylic acid; oral
B01AC06 [21600991]

-4.9e-02

8.8e-02

-4.7e-01

2.3e+00

1.3e+00

6.1e-01

4.3e-01

cases:2.80%

controls:2.93%

cases:2.11%

controls:1.93%

cases:0.35%

controls:0.55%

cases:0.19%

controls:0.02%

cases:2.14%

controls:0.59%

cases:3.66%

controls:2.01%

cases:6.20%

controls:4.12%

105

1101

3647

36427

725

3672

36803

208

3738

37320

3744

37521

221

3667

37253

135

738

3556

35912

201

1296

3040

30194

Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]

5.2e-02

1.4e-01

2.2e-01

3.0e+00

1.3e+00

2.0e-01

1.9e-01

cases:23.56%

controls:22.63%

cases:16.16%

controls:14.29%

cases:2.24%

controls:1.80%

cases:0.56%

controls:0.03%

cases:6.57%

controls:1.95%

cases:17.99%

controls:15.18%

cases:41.04%

controls:36.60%

884

8494

2868

29034

606

5362

3145

32166

675

3667

36853

3730

37517

246

729

3501

36745

664

5565

3027

31085

1330

11524

1911

19966

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

5.4e-02

-6.6e-02

8.7e-02

4.3e+00

2.0e-01

2.9e-01

2.4e-01

cases:7.60%

controls:7.22%

cases:2.93%

controls:3.13%

cases:0.45%

controls:0.42%

cases:1.39%

controls:0.02%

cases:0.45%

controls:0.37%

cases:3.58%

controls:2.70%

cases:12.40%

controls:10.00%

285

2711

3467

34817

110

1173

3641

36355

156

3734

37372

3699

37521

140

3730

37334

132

989

3559

35661

402

3148

2839

28342

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]

—

-1.0e+50

—

2.6e+00

1.9e+00

—

cases:0.00%

controls:0.04%

—

cases:0.57%

controls:0.04%

cases:0.86%

controls:0.13%

—

3751

37514

—

3670

36635

3213

31449

Osmolality of Urine
2695-5 [3026782]

-1.2e-01

-3.0e-01

2.1e-02

4.5e+00

4.7e-01

1.8e-01

1.7e-01

cases:3.12%

controls:3.49%

cases:1.25%

controls:1.69%

cases:0.27%

controls:0.26%

cases:1.23%

controls:0.01%

cases:0.40%

controls:0.25%

cases:1.87%

controls:1.57%

cases:5.74%

controls:4.87%

117

1309

3635

36219

633

3704

36895

3741

37430

3705

37523

3732

37380

576

3622

36074

186

1535

3055

29955

Bacteria identified in Urine by Culture
630-4 [3026008]

-6.8e-02

-1.6e-01

1.7e-01

4.5e+00

3.7e-01

2.5e-01

1.2e-02

cases:4.42%

controls:4.72%

cases:2.21%

controls:2.58%

cases:0.43%

controls:0.36%

cases:1.17%

controls:0.01%

cases:0.56%

controls:0.39%

cases:3.58%

controls:2.80%

cases:9.19%

controls:9.09%

166

1772

3586

35756

970

3668

36558

135

3735

37393

3707

37523

146

3726

37328

132

1027

3559

35623

298

2863

2943

28627

Ketones [Presence] in Urine by Test strip
2514-8 [3035350]

1.3e-01

-3.5e-02

-3.0e-03

4.5e+00

4.0e-01

1.9e-01

3.6e-02

cases:9.36%

controls:8.32%

cases:4.96%

controls:5.12%

cases:0.77%

controls:0.78%

cases:2.29%

controls:0.03%

cases:1.17%

controls:0.79%

cases:6.80%

controls:5.68%

cases:17.90%

controls:17.37%

351

3121

3401

34407

186

1923

3565

35605

291

3722

37237

3665

37518

297

3703

37177

251

2080

3440

34570

580

5469

2661

26021

Lactate [Moles/volume] in Venous blood
2519-7 [3008037]

-5.8e-02

3.1e-01

2.3e+00

—

2.1e+00

-1.3e-01

-7.9e-01

cases:0.27%

controls:0.28%

cases:0.21%

controls:0.16%

cases:0.16%

controls:0.02%

—

cases:0.16%

controls:0.02%

cases:0.19%

controls:0.22%

cases:0.46%

controls:1.01%

106

3742

37422

3743

37469

3745

37522

—

3741

37467

3684

36571

319

3226

31171

Glucose [Presence] in Urine by Test strip
25428-4 [3009261]

1.3e-01

-3.0e-02

1.1e-02

4.5e+00

3.7e-01

2.1e-01

2.7e-02

cases:9.65%

controls:8.57%

cases:5.07%

controls:5.21%

cases:0.80%

controls:0.79%

cases:2.24%

controls:0.03%

cases:1.15%

controls:0.80%

cases:6.96%

controls:5.73%

cases:17.86%

controls:17.48%

362

3216

3390

34312

190

1955

3561

35573

297

3721

37231

3667

37518

298

3704

37176

257

2099

3434

34551

579

5504

2662

25986

Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]

1.2e-01

-2.8e-02

1.4e-02

4.4e+00

4.1e-01

2.1e-01

2.8e-02

cases:9.04%

controls:8.12%

cases:4.93%

controls:5.06%

cases:0.77%

controls:0.76%

cases:2.19%

controls:0.03%

cases:1.17%

controls:0.78%

cases:6.75%

controls:5.56%

cases:17.43%

controls:17.03%

339

3047

3413

34481

185

1900

3566

35628

286

3722

37242

3669

37518

293

3703

37181

249

2037

3442

34613

565

5364

2676

26126

Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
72260-3 [43055225]

-1.0e+50

—

2.3e+00

2.1e+00

cases:0.00%

controls:0.02%

—

cases:0.16%

controls:0.02%

cases:0.37%

controls:0.04%

3752

37519

—

3685

36644

3229

31476

Epilepsy and comparable convulsive disorders
111 [2001600111]

1.8e-01

—

1.0e+50

2.7e+00

1.7e+00

cases:0.24%

controls:0.20%

—

cases:0.29%

controls:0.00%

cases:1.11%

controls:0.07%

cases:1.27%

controls:0.24%

3743

37453

—

3736

37474

3650

36623

3200

31413

Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]

5.8e-02

5.9e-02

1.9e-01

2.6e+00

1.4e+00

1.6e-01

1.3e-01

cases:26.60%

controls:25.49%

cases:17.62%

controls:16.78%

cases:2.35%

controls:1.95%

cases:0.72%

controls:0.05%

cases:7.47%

controls:1.89%

cases:19.99%

controls:17.53%

cases:45.17%

controls:41.87%

998

9565

2754

27963

661

6296

3090

31232

732

3663

36796

3724

37508

280

708

3467

36766

738

6424

2953

30226

1464

13184

1777

18306

flecainide; oral, parenteral
C01BC04 [21600266]

6.3e-01

8.8e-01

8.2e-01

—

9.9e-01

9.6e-01

8.6e-01

cases:1.25%

controls:0.67%

cases:1.15%

controls:0.48%

cases:0.40%

controls:0.18%

—

cases:0.48%

controls:0.18%

cases:1.27%

controls:0.49%

cases:1.73%

controls:0.74%

252

3705

37276

180

3708

37348

3736

37462

—

3729

37407

181

3644

36469

232

3185

31258

memantine; oral
N06DX01 [21604799]

—

4.3e+00

—

cases:1.39%

controls:0.02%

—

3196

31484

Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]

5.3e-02

5.1e-02

1.9e-01

2.6e+00

1.4e+00

1.5e-01

1.4e-01

cases:27.00%

controls:25.98%

cases:18.05%

controls:17.30%

cases:2.43%

controls:2.02%

cases:0.72%

controls:0.06%

cases:7.53%

controls:1.91%

cases:20.54%

controls:18.17%

cases:46.31%

controls:42.80%

1013

9748

2739

27780

677

6494

3074

31034

757

3660

36771

3724

37507

282

715

3465

36759

758

6660

2933

29990

1501

13478

1740

18012

Tension-type headache
G44.2 [45581495]

4.2e-01

5.9e-01

—

2.5e+00

7.8e-01

5.7e-01

cases:2.21%

controls:1.46%

cases:0.75%

controls:0.42%

—

cases:0.45%

controls:0.04%

cases:0.87%

controls:0.40%

cases:2.44%

controls:1.40%

549

3669

36979

156

3723

37372

—

3730

37460

146

3659

36504

440

3162

31050

sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]

4.1e-01

5.2e-01

1.1e+00

—

1.0e+00

6.1e-01

4.8e-01

cases:2.32%

controls:1.56%

cases:1.41%

controls:0.85%

cases:0.59%

controls:0.19%

—

cases:0.61%

controls:0.22%

cases:1.52%

controls:0.83%

cases:1.94%

controls:1.21%

584

3665

36944

318

3698

37210

3729

37456

—

3724

37390

303

3635

36347

380

3178

31110

Lipid panel - Serum or Plasma
100898-6 [1761868]

3.5e-02

-1.5e-03

1.8e-01

3.0e+00

1.1e+00

-3.0e-02

8.2e-02

cases:6.80%

controls:6.58%

cases:4.13%

controls:4.14%

cases:0.53%

controls:0.45%

cases:0.27%

controls:0.01%

cases:1.33%

controls:0.43%

cases:4.44%

controls:4.57%

cases:12.90%

controls:12.00%

255

2469

3497

35059

155

1553

3596

35975

168

3731

37360

3741

37523

160

3697

37314

164

1675

3527

34975

418

3779

2823

27711

pH of Urine
2756-5 [3015736]

1.3e-01

1.3e-02

-1.8e-02

4.1e+00

2.8e-01

1.7e-01

-4.4e-02

cases:7.44%

controls:6.61%

cases:3.92%

controls:3.87%

cases:0.56%

controls:0.57%

cases:1.47%

controls:0.02%

cases:0.77%

controls:0.58%

cases:4.96%

controls:4.20%

cases:12.90%

controls:13.39%

279

2481

3473

35047

147

1453

3604

36075

214

3730

37314

3696

37519

219

3718

37255

183

1540

3508

35110

418

4218

2823

27272

Unspecified dementia
F03 [45566772]

—

1.0e+50

—

2.0e+00

2.1e+00

—

cases:0.13%

controls:0.00%

—

cases:0.22%

controls:0.03%

cases:0.80%

controls:0.10%

—

3746

37528

—

3683

36639

3215

31460

Case Management Agency
251B00000X [38004193]

-3.8e-03

3.6e-02

1.9e-01

3.6e+00

3.5e-01

9.1e-02

cases:60.42%

controls:60.51%

cases:54.44%

controls:53.54%

cases:24.23%

controls:20.98%

cases:30.50%

controls:1.24%

cases:27.76%

controls:21.32%

cases:59.23%

controls:57.02%

cases:79.05%

controls:77.51%

2267

22709

1485

14819

2042

20094

1709

17434

909

7873

2842

29655

1144

467

2607

37061

1040

7988

2707

29486

2186

20896

1505

15754

2562

24407

679

7083

Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]

1.4e-01

1.7e-01

9.0e-02

4.0e+00

5.5e-01

2.6e-01

-2.6e-02

cases:4.10%

controls:3.59%

cases:2.75%

controls:2.33%

cases:0.37%

controls:0.34%

cases:0.91%

controls:0.02%

cases:0.64%

controls:0.37%

cases:3.31%

controls:2.56%

cases:7.81%

controls:8.00%

154

1349

3598

36179

103

873

3648

36655

128

3737

37400

3717

37522

139

3723

37335

122

939

3569

35711

253

2518

2988

28972

Cardiology
6 [38004451]

1.3e-01

2.2e-01

2.7e-01

2.7e+00

6.2e-01

3.7e-01

2.8e-01

cases:12.37%

controls:11.05%

cases:6.29%

controls:5.13%

cases:1.09%

controls:0.84%

cases:0.56%

controls:0.04%

cases:1.52%

controls:0.82%

cases:7.37%

controls:5.21%

cases:17.71%

controls:14.01%

464

4146

3288

33382

236

1927

3515

35601

315

3710

37213

3730

37514

309

3690

37165

272

1909

3419

34741

574

4411

2667

27079

rivastigmine; oral, transdermal
N06DA03 [21604796]

—

1.0e+50

3.9e+00

—

cases:0.27%

controls:0.00%

cases:0.96%

controls:0.02%

—

3681

36650

3210

31484

Alzheimer disease with late onset
G30.1 [45552521]

—

3.9e+00

—

cases:1.08%

controls:0.02%

—

3206

31483

Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]

9.7e-02

1.5e-01

2.0e-01

2.4e+00

1.0e+00

2.1e-01

2.3e-01

cases:18.18%

controls:16.78%

cases:11.30%

controls:9.88%

cases:1.52%

controls:1.25%

cases:0.21%

controls:0.02%

cases:3.74%

controls:1.39%

cases:12.35%

controls:10.27%

cases:32.06%

controls:27.32%

682

6297

3070

31231

424

3708

3327

33820

468

3694

37060

3743

37521

140

521

3607

36953

456

3764

3235

32886

1039

8603

2202

22887

Sleep apnoea
G47.3 [45562094]

2.0e-01

1.7e-01

-6.6e-02

2.9e+00

2.2e-01

4.1e-01

4.2e-01

cases:5.76%

controls:4.76%

cases:3.63%

controls:3.06%

cases:0.51%

controls:0.54%

cases:0.51%

controls:0.03%

cases:0.80%

controls:0.65%

cases:4.47%

controls:3.03%

cases:8.92%

controls:6.02%

216

1786

3536

35742

136

1150

3615

36378

203

3732

37325

3732

37518

242

3717

37232

165

1109

3526

35541

289

1895

2952

29595

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

3.2e-02

-1.1e-02

1.5e-01

3.1e+00

6.8e-01

1.0e-01

1.2e-01

cases:29.88%

controls:29.22%

cases:23.30%

controls:23.49%

cases:4.83%

controls:4.19%

cases:3.65%

controls:0.17%

cases:7.93%

controls:4.18%

cases:26.96%

controls:24.99%

cases:51.06%

controls:48.19%

1121

10966

2631

26562

874

8817

2877

28711

181

1573

3570

35955

137

3614

37464

297

1568

3450

35906

995

9159

2696

27491

1655

15175

1586

16315

Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]

3.3e-02

2.5e-02

1.8e-01

2.4e+00

1.3e+00

1.0e-01

9.8e-02

cases:27.85%

controls:27.20%

cases:19.94%

controls:19.55%

cases:2.77%

controls:2.32%

cases:0.77%

controls:0.07%

cases:7.98%

controls:2.20%

cases:22.68%

controls:20.89%

cases:48.20%

controls:45.75%

1045

10207

2707

27321

748

7335

3003

30193

104

871

3647

36657

3722

37502

299

825

3448

36649

837

7658

2854

28992

1562

14408

1679

17082

Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]

9.2e-02

6.0e-03

1.7e-01

2.3e+00

1.2e+00

1.7e-01

2.5e-01

cases:17.64%

controls:16.35%

cases:9.06%

controls:9.01%

cases:1.39%

controls:1.17%

cases:0.43%

controls:0.04%

cases:3.76%

controls:1.21%

cases:10.43%

controls:8.97%

cases:29.62%

controls:24.68%

662

6135

3090

31393

340

3383

3411

34145

438

3699

37090

3735

37512

141

454

3606

37020

385

3286

3306

33364

960

7771

2281

23719

Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]

-2.7e-02

-1.4e-01

3.4e-01

3.6e+00

5.8e-01

-8.5e-02

1.7e-01

cases:4.21%

controls:4.32%

cases:2.05%

controls:2.36%

cases:0.48%

controls:0.34%

cases:0.67%

controls:0.02%

cases:0.61%

controls:0.34%

cases:2.52%

controls:2.74%

cases:10.86%

controls:9.34%

158

1621

3594

35907

884

3674

36644

128

3733

37400

3726

37521

129

3724

37345

1003

3598

35647

352

2940

2889

28550

Atherosclerotic heart disease
I25.1 [45596196]

-1.4e-01

-2.2e-01

2.6e-01

3.6e+00

8.6e-02

-1.1e-01

3.1e-02

cases:4.13%

controls:4.72%

cases:1.97%

controls:2.45%

cases:0.61%

controls:0.47%

cases:0.85%

controls:0.02%

cases:0.45%

controls:0.42%

cases:2.44%

controls:2.72%

cases:7.19%

controls:6.98%

155

1771

3597

35757

921

3677

36607

178

3728

37350

3719

37519

156

3730

37318

998

3601

35652

233

2199

3008

29291

Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]

—

1.0e+50

—

2.5e+00

1.0e+00

—

cases:0.16%

controls:0.00%

—

cases:0.16%

controls:0.01%

cases:0.46%

controls:0.17%

—

3745

37528

—

3685

36645

3226

31438

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]

3.8e-01

—

2.1e+00

1.4e+00

cases:0.16%

controls:0.11%

—

cases:0.33%

controls:0.04%

cases:0.74%

controls:0.19%

3746

37487

—

3679

36636

3217

31430

Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 [3011166]

—

1.0e+50

—

2.3e+00

1.2e+00

—

cases:0.13%

controls:0.00%

—

cases:0.16%

controls:0.02%

cases:0.40%

controls:0.12%

—

3746

37528

—

3685

36644

3228

31451

Protein [Presence] in Urine by Test strip
20454-5 [3014051]

6.7e-02

-1.3e-01

1.3e-01

3.5e+00

1.2e-01

-2.2e-02

-1.4e-01

cases:3.76%

controls:3.52%

cases:1.87%

controls:2.12%

cases:0.35%

controls:0.30%

cases:0.51%

controls:0.02%

cases:0.35%

controls:0.31%

cases:2.47%

controls:2.52%

cases:7.07%

controls:8.02%

141

1322

3611

36206

794

3681

36734

114

3738

37414

3732

37522

115

3734

37359

923

3600

35727

229

2525

3012

28965

Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]

-2.3e-01

3.3e-01

1.7e+00

—

1.8e+00

9.4e-02

-1.3e-01

cases:0.69%

controls:0.87%

cases:0.59%

controls:0.42%

cases:0.27%

controls:0.05%

—

cases:0.35%

controls:0.06%

cases:0.62%

controls:0.57%

cases:1.97%

controls:2.25%

327

3726

37201

159

3729

37369

3741

37509

—

3734

37452

208

3668

36442

709

3177

30781

Cerebral aneurysm, nonruptured
I67.1 [45538401]

3.0e-01

3.6e-01

-1.0e+50

1.0e+50

—

2.0e+00

1.4e+00

cases:0.37%

controls:0.28%

cases:0.16%

controls:0.11%

cases:0.00%

controls:0.02%

cases:0.19%

controls:0.00%

—

cases:0.70%

controls:0.10%

cases:0.89%

controls:0.22%

104

3738

37424

3745

37486

3751

37522

3744

37528

—

3665

36614

3212

31421

Short blood count panel - Blood
55429-5 [40758558]

-1.6e-01

-2.0e-01

-7.4e-01

3.4e+00

4.7e-01

-6.5e-02

7.2e-02

cases:4.05%

controls:4.74%

cases:2.27%

controls:2.75%

cases:0.29%

controls:0.61%

cases:0.77%

controls:0.03%

cases:0.96%

controls:0.60%

cases:2.63%

controls:2.80%

cases:7.25%

controls:6.78%

152

1780

3600

35748

1032

3666

36496

230

3740

37298

3722

37518

225

3711

37249

1026

3594

35624

235

2135

3006

29355

Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]

—

1.0e+50

—

2.3e+00

1.1e+00

—

cases:0.16%

controls:0.00%

—

cases:0.16%

controls:0.02%

cases:0.46%

controls:0.16%

—

3745

37528

—

3685

36644

3226

31440

Medical doctor
Z2221 [2001311556]

-8.5e-02

8.1e-02

-3.7e-01

3.0e+00

3.6e-01

1.8e-01

3.7e-01

cases:4.61%

controls:5.00%

cases:1.71%

controls:1.57%

cases:0.16%

controls:0.23%

cases:0.27%

controls:0.01%

cases:0.29%

controls:0.21%

cases:1.73%

controls:1.46%

cases:4.91%

controls:3.46%

173

1877

3579

35651

591

3687

36937

3745

37441

3741

37523

3736

37397

534

3627

36116

159

1088

3082

30402

Atrial fibrillation and flutter
I48 [45596206]

-2.6e-02

1.2e-01

1.1e-01

3.1e+00

4.9e-01

8.3e-02

2.2e-01

cases:5.38%

controls:5.52%

cases:3.55%

controls:3.14%

cases:0.77%

controls:0.69%

cases:0.96%

controls:0.04%

cases:1.15%

controls:0.70%

cases:3.82%

controls:3.53%

cases:9.50%

controls:7.75%

202

2070

3550

35458

133

1180

3618

36348

259

3722

37269

3715

37512

264

3704

37210

141

1292

3550

35358

308

2439

2933

29051

Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]

5.9e-02

3.6e-02

1.2e-01

2.3e+00

1.0e+00

4.2e-02

1.1e-01

cases:27.05%

controls:25.90%

cases:17.30%

controls:16.79%

cases:2.27%

controls:2.02%

cases:0.43%

controls:0.04%

cases:5.42%

controls:2.00%

cases:18.61%

controls:17.98%

cases:45.08%

controls:42.26%

1015

9719

2737

27809

649

6301

3102

31227

758

3666

36770

3735

37512

203

748

3544

36726

687

6590

3004

30060

1461

13309

1780

18181

Pharmacy visit
OMOP4822462 [581458]

7.1e-01

5.1e-01

6.2e-02

2.5e-01

3.6e-01

6.3e-01

1.1e+00

cases:97.97%

controls:95.96%

cases:93.52%

controls:89.68%

cases:54.44%

controls:52.91%

cases:3.49%

controls:2.75%

cases:61.36%

controls:52.49%

cases:94.61%

controls:90.37%

cases:99.11%

controls:97.29%

3676

36013

1515

3508

33656

243

3872

2042

19855

1709

17673

131

1031

3620

36497

2299

19669

1448

17805

3492

33122

199

3528

3212

30637

853

CT angiography of head and neck vasculature
PA7AD [2001300233]

-9.5e-02

7.5e-01

2.5e+00

1.0e+50

—

7.5e-01

cases:0.16%

controls:0.18%

cases:0.21%

controls:0.10%

cases:0.16%

controls:0.01%

cases:1.36%

controls:0.00%

—

cases:0.93%

controls:0.44%

3746

37462

3743

37490

3745

37523

3700

37528

—

138

3211

31352

galantamine; oral
N06DA04 [21604797]

—

1.0e+50

3.2e+00

—

cases:0.16%

controls:0.00%

cases:0.40%

controls:0.02%

—

3685

36650

3228

31485

Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]

1.3e-01

-1.1e-01

1.3e+00

1.0e+50

2.7e+00

6.9e-01

4.7e-01

cases:1.04%

controls:0.91%

cases:0.29%

controls:0.33%

cases:0.13%

controls:0.03%

cases:0.16%

controls:0.00%

cases:0.37%

controls:0.02%

cases:0.62%

controls:0.31%

cases:1.94%

controls:1.23%

342

3713

37186

123

3740

37405

3746

37515

3745

37528

3733

37465

115

3668

36535

386

3178

31104

Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]

3.1e-01

-2.0e-01

1.3e+00

1.0e+50

2.7e+00

5.9e-01

4.7e-01

cases:1.41%

controls:1.04%

cases:0.29%

controls:0.36%

cases:0.13%

controls:0.04%

cases:0.16%

controls:0.00%

cases:0.45%

controls:0.03%

cases:0.65%

controls:0.36%

cases:2.10%

controls:1.32%

389

3699

37139

135

3740

37393

3746

37514

3745

37528

3730

37463

132

3667

36518

415

3173

31075

Epilepsy
G40 [45595935]

3.9e-02

—

2.1e+00

1.1e+00

cases:0.21%

controls:0.21%

—

cases:0.51%

controls:0.07%

cases:0.74%

controls:0.24%

3744

37451

—

3672

36626

3217

31415

Administrative procedure
-62 [2002000133]

1.0e+00

1.4e+00

—

2.2e+00

8.0e-01

cases:0.40%

controls:0.15%

cases:0.21%

controls:0.05%

—

cases:0.19%

controls:0.02%

cases:0.25%

controls:0.11%

3737

37473

3743

37508

—

3684

36642

3233

31455

Sampling
SPAT1263 [2001700364]

6.4e-02

-1.5e-02

-4.0e-01

2.9e+00

-2.2e-01

-6.6e-02

2.1e-01

cases:8.45%

controls:7.97%

cases:3.28%

controls:3.33%

cases:0.40%

controls:0.59%

cases:0.35%

controls:0.02%

cases:0.48%

controls:0.60%

cases:3.28%

controls:3.50%

cases:12.37%

controls:10.25%

317

2990

3435

34538

123

1248

3628

36280

223

3736

37305

3738

37521

225

3729

37249

121

1281

3570

35369

401

3229

2840

28261

General psychiatric examination, not elsewhere classified
Z00.4 [45605094]

5.7e-02

4.8e-01

—

1.9e+00

1.2e+00

5.7e-01

cases:0.59%

controls:0.55%

cases:0.27%

controls:0.17%

—

cases:0.24%

controls:0.03%

cases:0.54%

controls:0.17%

cases:0.99%

controls:0.56%

208

3730

37320

3741

37466

—

3738

37461

3671

36587

176

3209

31314

testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]

6.5e-01

7.4e-01

7.9e-01

—

1.1e+00

8.2e-01

8.8e-01

cases:1.25%

controls:0.66%

cases:0.85%

controls:0.41%

cases:0.29%

controls:0.13%

—

cases:0.35%

controls:0.11%

cases:1.00%

controls:0.44%

cases:1.39%

controls:0.58%

248

3705

37280

154

3719

37374

3740

37478

—

3734

37432

163

3654

36487

183

3196

31307

Neuropsychological investigation
XA800 [2001300412]

2.6e-01

9.2e-01

—

2.0e+00

1.0e+00

cases:0.45%

controls:0.35%

cases:0.19%

controls:0.07%

—

cases:0.70%

controls:0.09%

cases:0.68%

controls:0.24%

131

3735

37397

3744

37500

—

3665

36616

3219

31413

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
F00.20*G30.8 [2000501580]

—

3.0e+00

—

cases:0.46%

controls:0.02%

—

3226

31483

Mild depressive episode without somatic syndrome
F32.00 [2000501978]

5.2e-01

1.5e+00

—

1.5e+00

5.8e-01

cases:0.45%

controls:0.27%

cases:0.24%

controls:0.05%

—

cases:0.30%

controls:0.07%

cases:0.40%

controls:0.23%

101

3735

37427

3742

37508

—

3680

36626

3228

31419

Headache
N01 [2002000720]

1.6e-01

7.2e-01

—

1.0e+50

2.5e+00

6.2e-01

5.1e-01

cases:1.01%

controls:0.86%

cases:0.53%

controls:0.26%

—

cases:0.21%

controls:0.00%

cases:0.29%

controls:0.02%

cases:0.43%

controls:0.23%

cases:1.67%

controls:1.01%

324

3714

37204

3731

37430

—

3743

37528

3736

37465

3675

36564

317

3187

31173

Gas panel - Venous blood
24339-4 [3000991]

-1.5e-01

2.5e-01

—

3.0e+00

9.2e-01

3.6e-01

1.2e-01

cases:0.77%

controls:0.90%

cases:0.64%

controls:0.50%

—

cases:0.27%

controls:0.01%

cases:0.19%

controls:0.07%

cases:0.79%

controls:0.55%

cases:2.04%

controls:1.81%

337

3723

37191

188

3727

37340

—

3741

37523

3740

37446

202

3662

36448

571

3175

30919

Dizziness and giddiness
R42 [45568132]

4.4e-01

3.2e-01

8.7e-01

—

1.5e+00

5.6e-01

4.3e-01

cases:4.53%

controls:2.96%

cases:1.41%

controls:1.03%

cases:0.27%

controls:0.11%

—

cases:0.51%

controls:0.11%

cases:1.90%

controls:1.09%

cases:6.29%

controls:4.19%

170

1112

3582

36416

385

3698

37143

3741

37486

—

3728

37433

400

3621

36250

204

1321

3037

30169

Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]

-5.1e-02

-1.4e-01

6.0e-02

1.8e+00

1.1e+00

-2.8e-02

6.4e-02

cases:21.80%

controls:22.68%

cases:14.69%

controls:16.58%

cases:2.29%

controls:2.16%

cases:0.53%

controls:0.09%

cases:6.03%

controls:2.07%

cases:17.34%

controls:17.75%

cases:41.10%

controls:39.55%

818

8511

2934

29017

551

6221

3200

31307

811

3665

36717

3731

37496

226

777

3521

36697

640

6506

3051

30144

1332

12454

1909

19036

Chest pain, unspecified
R07.4 [45558450]

3.7e-01

5.2e-01

4.6e-01

—

1.1e+00

4.8e-01

5.0e-01

cases:6.58%

controls:4.66%

cases:2.51%

controls:1.51%

cases:0.32%

controls:0.20%

—

cases:0.51%

controls:0.18%

cases:2.33%

controls:1.45%

cases:9.19%

controls:5.76%

247

1748

3505

35780

565

3657

36963

3739

37452

—

3728

37408

532

3605

36118

298

1814

2943

29676

Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]

-6.8e-02

-2.5e-01

-8.6e-01

2.9e+00

1.7e-01

8.1e-02

-8.3e-02

cases:5.46%

controls:5.83%

cases:2.27%

controls:2.88%

cases:0.16%

controls:0.38%

cases:0.35%

controls:0.02%

cases:0.51%

controls:0.43%

cases:3.01%

controls:2.78%

cases:8.30%

controls:8.95%

205

2187

3547

35341

1081

3666

36447

141

3745

37387

3738

37521

160

3728

37314

111

1019

3580

35631

269

2819

2972

28671

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]

—

1.5e+00

1.4e+00

—

cases:0.49%

controls:0.11%

cases:0.83%

controls:0.20%

—

3673

36609

3214

31428

Standard cardiac ultrasound examination
FM1AE [2001303278]

1.1e-02

9.3e-03

—

2.9e+00

7.4e-02

2.4e-01

-3.8e-02

cases:3.36%

controls:3.32%

cases:1.23%

controls:1.22%

—

cases:0.24%

controls:0.01%

cases:0.19%

controls:0.17%

cases:1.54%

controls:1.22%

cases:3.52%

controls:3.65%

126

1247

3626

36281

456

3705

37072

—

3742

37523

3740

37409

447

3634

36203

114

1149

3127

30341

Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]

-2.4e-01

—

1.5e+00

1.3e+00

cases:0.16%

controls:0.20%

—

cases:0.62%

controls:0.14%

cases:1.11%

controls:0.30%

3746

37452

—

3668

36600

3205

31396

Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]

1.1e-01

2.3e-01

1.1e+00

—

1.6e+00

2.2e-01

1.6e-01

cases:3.28%

controls:2.94%

cases:1.89%

controls:1.51%

cases:0.72%

controls:0.23%

—

cases:0.96%

controls:0.19%

cases:2.03%

controls:1.63%

cases:5.99%

controls:5.14%

123

1102

3629

36426

566

3680

36962

3724

37440

—

3711

37401

598

3616

36052

194

1619

3047

29871

Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]

-2.8e-01

2.3e-01

1.3e+00

—

1.4e+00

1.7e-01

-1.8e-01

cases:0.80%

controls:1.06%

cases:0.77%

controls:0.62%

cases:0.32%

controls:0.09%

—

cases:0.35%

controls:0.09%

cases:0.87%

controls:0.73%

cases:2.16%

controls:2.58%

397

3722

37131

231

3722

37297

3739

37495

—

3734

37441

269

3659

36381

812

3171

30678

Lumbar puncture
TAB00 [2001300538]

1.1e-01

—

1.0e+50

—

1.7e+00

9.2e-01

cases:0.32%

controls:0.29%

—

cases:0.35%

controls:0.00%

—

cases:0.35%

controls:0.06%

cases:0.62%

controls:0.25%

108

3740

37420

—

3738

37528

—

3678

36627

3221

31412

Dislocation of the jaw joint UNS
K07.69 [2000502798]

1.1e+00

2.6e+00

—

-1.0e+50

4.8e-01

cases:0.19%

controls:0.06%

cases:0.19%

controls:0.01%

—

cases:0.00%

controls:0.05%

cases:0.15%

controls:0.10%

3745

37505

3744

37523

—

3691

36633

3236

31460

Malignant neoplasm of prostate
C61 [45547509]

1.2e-01

2.3e-01

1.9e-01

2.6e+00

4.2e-01

2.7e-01

2.6e-01

cases:1.68%

controls:1.49%

cases:1.52%

controls:1.21%

cases:0.37%

controls:0.31%

cases:0.29%

controls:0.02%

cases:0.48%

controls:0.32%

cases:1.49%

controls:1.14%

cases:2.68%

controls:2.08%

559

3689

36969

453

3694

37075

116

3737

37412

3740

37520

119

3729

37355

418

3636

36232

655

3154

30835

Urinary frequency/urgency
U02 [2002001138]

1.2e-02

2.9e-01

—

1.6e+00

6.5e-01

3.9e-01

cases:1.89%

controls:1.87%

cases:0.99%

controls:0.74%

—

cases:0.24%

controls:0.05%

cases:1.35%

controls:0.71%

cases:3.95%

controls:2.71%

702

3681

36826

279

3714

37249

—

3738

37455

262

3641

36388

128

853

3113

30637

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]

7.9e-02

-3.9e-02

-3.2e-01

2.6e+00

3.3e-01

-3.6e-02

-9.2e-02

cases:1.39%

controls:1.28%

cases:0.80%

controls:0.83%

cases:0.19%

controls:0.26%

cases:0.35%

controls:0.03%

cases:0.29%

controls:0.21%

cases:0.84%

controls:0.87%

cases:1.30%

controls:1.42%

481

3700

37047

312

3721

37216

3744

37432

3738

37518

3736

37395

319

3660

36331

447

3199

31043

Telehealth
OMOP5556618 [722455]

2.8e-02

8.4e-03

2.2e-01

1.5e+00

6.2e-01

1.9e-01

cases:23.35%

controls:22.85%

cases:10.64%

controls:10.56%

cases:2.32%

controls:1.87%

cases:0.48%

controls:0.10%

cases:3.23%

controls:1.76%

cases:12.22%

controls:10.33%

cases:27.86%

controls:24.16%

876

8576

2876

28952

399

3962

3352

33566

701

3664

36827

3733

37489

121

659

3626

36815

451

3786

3240

32864

903

7609

2338

23881

Orthopedic Surgery
20 [38004465]

2.3e-01

2.0e-01

2.8e-01

1.7e+00

2.5e-01

2.3e-01

3.2e-01

cases:19.48%

controls:16.14%

cases:7.60%

controls:6.30%

cases:1.33%

controls:1.01%

cases:0.21%

controls:0.04%

cases:1.33%

controls:1.04%

cases:7.83%

controls:6.35%

cases:23.48%

controls:18.25%

731

6056

3021

31472

285

2364

3466

35164

378

3701

37150

3743

37514

391

3697

37083

289

2328

3402

34322

761

5748

2480

25742

Neurosurgery
14 [38004459]

1.4e-01

3.0e-01

1.0e+00

2.1e+00

1.1e+00

8.8e-01

5.8e-01

cases:2.96%

controls:2.58%

cases:1.28%

controls:0.95%

cases:0.35%

controls:0.13%

cases:0.13%

controls:0.02%

cases:0.43%

controls:0.15%

cases:2.25%

controls:0.95%

cases:4.41%

controls:2.52%

111

969

3641

36559

358

3703

37170

3738

37480

3746

37522

3731

37418

347

3608

36303

143

795

3098

30695

SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]

1.8e-01

-1.6e-01

2.5e+00

2.4e-01

1.5e-01

1.8e-01

cases:8.64%

controls:7.29%

cases:4.13%

controls:3.47%

cases:0.40%

controls:0.47%

cases:0.29%

controls:0.02%

cases:0.56%

controls:0.44%

cases:4.01%

controls:3.46%

cases:13.14%

controls:11.26%

324

2737

3428

34791

155

1302

3596

36226

176

3736

37352

3740

37519

165

3726

37309

148

1267

3543

35383

426

3545

2815

27945

clopidogrel; oral
B01AC04 [21600989]

8.0e-02

2.9e-01

1.1e-01

—

1.4e+00

6.2e-01

4.6e-01

cases:3.28%

controls:3.03%

cases:2.61%

controls:1.98%

cases:0.61%

controls:0.55%

—

cases:2.03%

controls:0.50%

cases:3.77%

controls:2.05%

cases:6.45%

controls:4.15%

123

1138

3629

36390

742

3653

36786

206

3728

37322

—

189

3671

37285

139

753

3552

35897

209

1308

3032

30182

Glucose [Moles/volume] in Venous blood
39480-9 [3038515]

2.1e-04

2.8e-01

2.5e+00

1.0e+50

—

-2.2e-01

-7.7e-01

cases:0.27%

controls:0.27%

cases:0.19%

controls:0.14%

cases:0.16%

controls:0.01%

cases:0.83%

controls:0.00%

—

cases:0.16%

controls:0.20%

cases:0.43%

controls:0.93%

100

3742

37428

3744

37475

3745

37523

3720

37528

—

3685

36576

293

3227

31197

Thrombin time
3243-3 [3036489]

1.4e-01

1.4e+00

1.0e+50

2.5e+00

3.9e-01

2.9e-01

cases:0.61%

controls:0.54%

cases:0.24%

controls:0.21%

cases:0.13%

controls:0.03%

cases:0.75%

controls:0.00%

cases:0.16%

controls:0.01%

cases:0.27%

controls:0.18%

cases:0.80%

controls:0.60%

201

3729

37327

3742

37450

3746

37516

3723

37528

3741

37469

3681

36583

189

3215

31301

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

3.7e-02

-2.3e-02

-2.1e-02

2.3e+00

9.4e-02

5.5e-02

1.6e-01

cases:17.51%

controls:16.98%

cases:10.88%

controls:11.11%

cases:2.05%

controls:2.09%

cases:0.99%

controls:0.10%

cases:2.32%

controls:2.12%

cases:11.81%

controls:11.25%

cases:29.50%

controls:26.37%

657

6371

3095

31157

408

4168

3343

33360

786

3674

36742

3714

37491

794

3660

36680

436

4122

3255

32528

956

8303

2285

23187

Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]

—

1.0e+50

—

2.5e+00

1.1e+00

—

cases:0.16%

controls:0.00%

—

cases:0.35%

controls:0.03%

cases:0.34%

controls:0.12%

—

3745

37528

—

3678

36639

3230

31453

Senile nuclear cataract
H25.1 [45581628]

-3.5e-03

-3.5e-02

-9.5e-02

2.5e+00

-8.6e-02

3.3e-01

1.5e-02

cases:3.73%

controls:3.74%

cases:1.36%

controls:1.41%

cases:0.21%

controls:0.23%

cases:0.19%

controls:0.02%

cases:0.27%

controls:0.29%

cases:2.14%

controls:1.55%

cases:6.42%

controls:6.33%

140

1405

3612

36123

528

3700

37000

3743

37440

3744

37522

109

3737

37365

568

3612

36082

208

1993

3033

29497

Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]

7.5e-02

4.3e-03

—

2.5e+00

—

1.5e-01

2.1e-01

cases:5.30%

controls:4.94%

cases:1.41%

controls:1.41%

—

cases:0.19%

controls:0.02%

—

cases:1.60%

controls:1.38%

cases:6.45%

controls:5.30%

199

1853

3553

35675

528

3698

37000

—

3744

37522

—

506

3632

36144

209

1670

3032

29820

oxcarbazepine; oral
N03AF02 [21604418]

3.4e-02

-9.5e-02

—

8.1e-01

1.1e+00

1.3e+00

cases:0.40%

controls:0.39%

cases:0.29%

controls:0.32%

—

cases:0.24%

controls:0.11%

cases:1.08%

controls:0.35%

cases:1.60%

controls:0.44%

145

3737

37383

121

3740

37407

—

3738

37434

127

3651

36523

138

3189

31352

Other specified special examinations
Z01.8 [45581003]

3.6e-01

3.0e-02

—

1.3e+00

8.0e-01

2.6e-01

cases:4.10%

controls:2.90%

cases:0.93%

controls:0.91%

—

cases:0.43%

controls:0.12%

cases:1.98%

controls:0.90%

cases:4.44%

controls:3.46%

154

1090

3598

36438

340

3716

37188

—

3731

37430

329

3618

36321

144

1091

3097

30399

levetiracetam; oral, parenteral
N03AX14 [21604436]

2.1e-04

9.2e-02

—

1.1e+00

1.3e+00

1.2e+00

cases:0.24%

controls:0.24%

cases:0.21%

controls:0.19%

—

cases:0.21%

controls:0.07%

cases:0.79%

controls:0.22%

cases:1.27%

controls:0.40%

3743

37438

3743

37455

—

3739

37448

3662

36570

127

3200

31363

Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]

-1.4e-01

—

1.0e+50

—

1.5e+00

9.7e-01

cases:0.21%

controls:0.25%

—

cases:0.24%

controls:0.00%

—

cases:0.27%

controls:0.06%

cases:0.80%

controls:0.30%

3744

37436

—

3742

37528

—

3681

36627

3215

31394

Anaesthesia of skin
R20.0 [45587502]

—

-1.0e+50

—

-1.0e+50

2.4e+00

—

cases:0.00%

controls:0.01%

—

cases:0.00%

controls:0.02%

cases:0.22%

controls:0.02%

—

3751

37523

—

3691

36644

3234

31484

Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]

1.1e-01

2.8e-01

-1.0e+50

—

2.4e+00

1.5e-01

3.5e-01

cases:0.67%

controls:0.60%

cases:0.24%

controls:0.18%

cases:0.00%

controls:0.02%

—

cases:0.27%

controls:0.02%

cases:0.19%

controls:0.16%

cases:0.80%

controls:0.57%

225

3727

37303

3742

37460

3751

37520

—

3737

37465

3684

36590

178

3215

31312

Other and unspecified convulsions
R56.8 [45602033]

2.4e-01

8.6e-01

2.1e+00

—

1.5e+00

8.8e-01

cases:0.45%

controls:0.36%

cases:0.32%

controls:0.14%

cases:0.13%

controls:0.02%

—

cases:0.60%

controls:0.13%

cases:0.83%

controls:0.35%

134

3735

37394

3739

37477

3746

37522

—

3669

36602

109

3214

31381

Concussion
S06.0 [45582805]

3.4e-01

5.0e-01

1.9e+00

—

1.8e-01

5.4e-01

cases:1.20%

controls:0.86%

cases:0.51%

controls:0.31%

cases:0.19%

controls:0.03%

—

cases:0.35%

controls:0.29%

cases:2.13%

controls:1.25%

322

3707

37206

116

3732

37412

3744

37517

—

108

3678

36542

395

3172

31095

Cholesterol non HDL [Moles/volume] in Serum or Plasma
70204-3 [42868678]

6.8e-02

3.3e-01

—

2.3e+00

3.1e-01

2.3e-01

cases:0.53%

controls:0.50%

cases:0.51%

controls:0.37%

—

cases:0.16%

controls:0.02%

cases:0.62%

controls:0.46%

cases:1.82%

controls:1.44%

187

3732

37341

137

3732

37391

—

3741

37468

167

3668

36483

455

3182

31035

Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]

-1.5e-01

—

1.0e+50

—

1.4e+00

9.0e-01

cases:0.24%

controls:0.28%

—

cases:0.29%

controls:0.00%

—

cases:0.30%

controls:0.07%

cases:0.93%

controls:0.38%

105

3743

37423

—

3740

37528

—

3680

36623

119

3211

31371

General Surgery
2 [38004447]

1.3e-01

1.6e-01

5.2e-02

2.3e+00

2.4e-01

1.7e-01

1.1e-01

cases:22.89%

controls:20.72%

cases:7.38%

controls:6.37%

cases:0.91%

controls:0.86%

cases:0.59%

controls:0.06%

cases:1.09%

controls:0.86%

cases:6.94%

controls:5.92%

cases:18.02%

controls:16.42%

859

7775

2893

29753

277

2390

3474

35138

323

3717

37205

3729

37505

324

3706

37150

256

2171

3435

34479

584

5170

2657

26320

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

-2.3e-02

-1.0e-01

-4.5e-02

2.2e+00

-9.9e-02

3.9e-02

1.6e-01

cases:9.12%

controls:9.31%

cases:4.75%

controls:5.22%

cases:1.04%

controls:1.09%

cases:0.69%

controls:0.07%

cases:0.96%

controls:1.06%

cases:5.55%

controls:5.35%

cases:16.85%

controls:14.70%

342

3494

3410

34034

178

1959

3573

35569

408

3712

37120

3725

37500

397

3711

37077

205

1962

3486

34688

546

4629

2695

26861

Cardiac arrhythmia, unspecified
I49.9 [45581778]

3.5e-01

6.4e-01

—

1.7e+00

3.8e-01

4.7e-01

cases:1.97%

controls:1.40%

cases:0.69%

controls:0.37%

—

cases:0.24%

controls:0.04%

cases:0.65%

controls:0.45%

cases:2.84%

controls:1.80%

527

3678

37001

138

3725

37390

—

3738

37458

164

3667

36486

567

3149

30923

tolfenamic acid; oral, rectal
M01AG02 [21603988]

3.9e-01

5.3e-01

—

2.2e+00

4.0e-01

4.3e-01

cases:1.41%

controls:0.96%

cases:0.48%

controls:0.28%

—

cases:0.19%

controls:0.02%

cases:0.35%

controls:0.24%

cases:0.77%

controls:0.50%

361

3699

37167

106

3733

37422

—

3740

37466

3678

36563

158

3216

31332

Epilepsy, unspecified
G40.9 [45562083]

2.2e-01

1.6e-01

—

1.0e+50

1.6e+00

1.1e+00

1.0e+00

cases:0.37%

controls:0.30%

cases:0.24%

controls:0.21%

—

cases:0.16%

controls:0.00%

cases:0.16%

controls:0.03%

cases:0.57%

controls:0.19%

cases:1.14%

controls:0.40%

112

3738

37416

3742

37451

—

3745

37528

3741

37462

3670

36581

127

3204

31363

Excision of lesion of internal nose
DHB10 [2001301688]

2.1e+00

—

-1.0e+50

cases:0.16%

controls:0.02%

—

cases:0.00%

controls:0.02%

3746

37521

—

3241

31484

Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]

-1.5e-01

-2.3e-01

1.8e+00

—

2.1e+00

2.0e-01

-2.9e-01

cases:0.35%

controls:0.40%

cases:0.19%

controls:0.23%

cases:0.13%

controls:0.02%

—

cases:0.16%

controls:0.02%

cases:0.33%

controls:0.27%

cases:0.89%

controls:1.20%

151

3739

37377

3744

37440

3746

37520

—

3741

37467

3679

36552

377

3212

31113

Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]

2.6e-01

-1.5e-01

—

2.1e+00

1.8e-01

3.9e-01

cases:0.48%

controls:0.37%

cases:0.16%

controls:0.19%

—

cases:0.16%

controls:0.02%

cases:0.24%

controls:0.20%

cases:0.96%

controls:0.65%

139

3734

37389

3745

37458

—

3741

37467

3682

36575

205

3210

31285

Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]

—

-1.0e+50

—

2.1e+00

1.6e-01

9.3e-02

—

cases:0.00%

controls:0.03%

—

cases:0.16%

controls:0.02%

cases:0.16%

controls:0.14%

cases:0.43%

controls:0.39%

—

3751

37518

—

3741

37467

3685

36599

124

3227

31366

Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]

-7.9e-01

-6.9e-01

-5.8e-02

2.9e+00

3.4e-02

-5.5e-01

-3.4e-01

cases:0.64%

controls:1.40%

cases:0.40%

controls:0.80%

cases:0.13%

controls:0.14%

cases:0.35%

controls:0.02%

cases:0.16%

controls:0.15%

cases:0.51%

controls:0.89%

cases:1.79%

controls:2.49%

527

3728

37001

299

3736

37229

3746

37475

3738

37521

3741

37416

327

3672

36323

785

3183

30705

Other procedure for haemorrhoids or prolapse of mucosa
JHB96 [2001305144]

—

2.1e+00

—

cases:0.19%

controls:0.02%

—

3235

31483

Malaise and fatigue
R53 [45553741]

1.7e-01

2.0e-01

1.1e+00

—

1.7e+00

3.5e-01

4.0e-01

cases:2.61%

controls:2.21%

cases:1.23%

controls:1.01%

cases:0.29%

controls:0.09%

—

cases:0.45%

controls:0.08%

cases:1.38%

controls:0.98%

cases:5.65%

controls:3.85%

829

3654

36699

378

3705

37150

3740

37493

—

3730

37443

360

3640

36290

183

1213

3058

30277

Sequelae of cerebral infarction
I69.3 [45533476]

-1.6e-02

2.2e-01

—

1.0e+50

1.4e+00

6.7e-01

4.0e-01

cases:0.80%

controls:0.81%

cases:0.56%

controls:0.45%

—

cases:0.51%

controls:0.00%

cases:0.32%

controls:0.08%

cases:0.98%

controls:0.50%

cases:2.28%

controls:1.55%

305

3722

37223

168

3730

37360

—

3732

37528

3735

37444

184

3655

36466

487

3167

31003

Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
33203-1 [3042810]

-1.0e+50

—

2.1e+00

cases:0.00%

controls:0.02%

—

cases:0.14%

controls:0.02%

cases:0.37%

controls:0.05%

3752

37519

—

3686

36644

3229

31475

Tau protein [Mass/volume] in Cerebral spinal fluid
30160-6 [3000242]

-1.0e+50

—

2.1e+00

cases:0.00%

controls:0.02%

—

cases:0.14%

controls:0.02%

cases:0.37%

controls:0.05%

3752

37519

—

3686

36644

3229

31475

Migraine
N89 [2002000789]

—

2.1e+00

—

4.2e-01

—

cases:0.19%

controls:0.02%

—

cases:0.25%

controls:0.16%

—

3744

37519

—

3233

31439

estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]

3.5e-01

3.3e-01

3.7e-01

-1.0e+50

3.4e-01

3.5e-01

3.2e-01

cases:32.86%

controls:25.68%

cases:23.38%

controls:18.02%

cases:6.16%

controls:4.35%

cases:0.00%

controls:0.16%

cases:5.76%

controls:4.19%

cases:23.92%

controls:18.14%

cases:32.40%

controls:25.82%

1233

9638

2519

27890

877

6762

2874

30766

231

1634

3520

35894

3751

37467

216

1571

3531

35903

883

6647

2808

30003

1050

8130

2191

23360

Other minor procedure on skin
TQW99 [2001310150]

2.6e-01

5.3e-01

—

1.4e+00

6.8e-01

cases:0.56%

controls:0.43%

cases:0.24%

controls:0.14%

—

cases:0.38%

controls:0.10%

cases:0.99%

controls:0.50%

162

3731

37366

3742

37475

—

3677

36614

158

3209

31332

Observation for suspected nervous system disorder
Z03.3 [45609903]

3.5e-01

6.5e-01

—

1.4e+00

6.4e-01

cases:0.67%

controls:0.47%

cases:0.32%

controls:0.17%

—

cases:0.65%

controls:0.16%

cases:1.14%

controls:0.60%

176

3727

37352

3739

37465

—

3667

36590

190

3204

31300

Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]

-6.0e-02

-2.5e-01

1.0e+00

—

9.6e-01

8.0e-02

-8.5e-02

cases:1.92%

controls:2.04%

cases:0.96%

controls:1.23%

cases:0.40%

controls:0.14%

—

cases:0.48%

controls:0.18%

cases:1.52%

controls:1.40%

cases:3.89%

controls:4.22%

764

3680

36764

462

3715

37066

3736

37474

—

3729

37405

514

3635

36136

126

1328

3115

30162

Geriatric Medicine
38 [38004478]

1.6e-01

-5.8e-02

-1.0e+50

1.0e+50

—

1.2e+00

7.4e-01

cases:0.32%

controls:0.27%

cases:0.13%

controls:0.14%

cases:0.00%

controls:0.02%

cases:0.19%

controls:0.00%

—

cases:0.54%

controls:0.16%

cases:1.48%

controls:0.71%

102

3740

37426

3746

37475

3751

37519

3744

37528

—

3671

36591

225

3193

31265

Other seropositive rheumatoid arthritis
M05.8 [45538634]

-3.4e-01

-4.3e-01

-4.9e-01

1.9e+00

-2.9e-01

-5.8e-01

-2.2e-01

cases:1.09%

controls:1.53%

cases:0.75%

controls:1.14%

cases:0.19%

controls:0.30%

cases:0.19%

controls:0.03%

cases:0.24%

controls:0.32%

cases:0.65%

controls:1.15%

cases:1.39%

controls:1.72%

575

3711

36953

429

3723

37099

114

3744

37414

3744

37518

120

3738

37354

422

3667

36228

543

3196

30947

finasteride; oral
D11AX10 [21602350]

4.3e-01

4.1e-01

—

4.8e-01

6.0e-01

cases:2.83%

controls:1.85%

cases:2.11%

controls:1.37%

cases:0.59%

controls:0.39%

—

cases:0.61%

controls:0.38%

cases:2.30%

controls:1.44%

cases:4.32%

controls:2.41%

106

695

3646

36833

516

3672

37012

146

3729

37382

—

143

3724

37331

529

3606

36121

140

759

3101

30731

finasteride; oral
G04CB01 [21602675]

4.3e-01

4.1e-01

—

4.8e-01

6.0e-01

cases:2.83%

controls:1.85%

cases:2.11%

controls:1.37%

cases:0.59%

controls:0.39%

—

cases:0.61%

controls:0.38%

cases:2.30%

controls:1.44%

cases:4.32%

controls:2.41%

106

695

3646

36833

516

3672

37012

146

3729

37382

—

143

3724

37331

529

3606

36121

140

759

3101

30731

Gas and Carbon monoxide and Electrolytes panel - Arterial blood
93685-6 [1001509]

—

1.9e+00

7.1e-01

—

cases:0.19%

controls:0.03%

cases:0.15%

controls:0.08%

—

3684

36640

3236

31466

Anxiety disorder, unspecified
F41.9 [45542849]

2.9e-01

2.4e-01

—

1.9e+00

8.8e-01

1.8e-01

cases:0.77%

controls:0.58%

cases:0.35%

controls:0.27%

—

cases:0.24%

controls:0.03%

cases:0.49%

controls:0.20%

cases:0.89%

controls:0.75%

218

3723

37310

102

3738

37426

—

3738

37461

3673

36576

236

3212

31254

Complex partial seizures with only alteration of consciousness
G40.20 [2000502139]

—

1.7e+00

1.9e+00

—

cases:0.19%

controls:0.04%

cases:0.43%

controls:0.07%

—

3684

36637

3227

31469

Benign neoplasm: Skin of other and unspecified parts of face
D23.3 [45595740]

-1.2e-01

1.9e+00

—

8.6e-01

1.8e-02

cases:0.21%

controls:0.24%

cases:0.24%

controls:0.04%

—

cases:0.14%

controls:0.06%

cases:0.34%

controls:0.33%

3744

37438

3742

37514

—

3686

36629

105

3230

31385

Cone beam CT of paranasal sinus
DM1AI [2001301744]

1.4e-01

—

1.9e+00

8.5e-01

cases:0.19%

controls:0.16%

—

cases:0.24%

controls:0.04%

cases:0.43%

controls:0.18%

3745

37467

—

3682

36636

3227

31432

Neck symptom/complaint
L01 [2002000626]

2.4e-01

2.9e-01

6.9e-01

—

1.4e+00

3.4e-01

4.5e-01

cases:2.00%

controls:1.58%

cases:0.83%

controls:0.62%

cases:0.16%

controls:0.08%

—

cases:0.29%

controls:0.07%

cases:0.87%

controls:0.62%

cases:3.52%

controls:2.28%

594

3677

36934

232

3720

37296

3745

37498

—

3736

37447

227

3659

36423

114

718

3127

30772

Simple partial seizures
G40.10 [2000502135]

-1.0e+50

—

1.8e+00

1.2e+00

cases:0.00%

controls:0.05%

cases:0.00%

controls:0.03%

—

cases:0.19%

controls:0.03%

cases:0.22%

controls:0.07%

3752

37511

3751

37518

—

3684

36639

3234

31469

Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]

1.9e-01

1.8e-01

5.0e-01

—

1.0e+00

4.7e-01

3.3e-01

cases:4.08%

controls:3.39%

cases:2.05%

controls:1.72%

cases:0.45%

controls:0.27%

—

cases:0.75%

controls:0.27%

cases:2.44%

controls:1.53%

cases:5.83%

controls:4.27%

153

1273

3599

36255

644

3674

36884

103

3734

37425

—

101

3719

37373

561

3601

36089

189

1344

3052

30146

Palpitations/awareness of heart
K04 [2002000547]

2.6e-01

1.1e+00

—

1.2e-01

7.0e-01

cases:0.64%

controls:0.50%

cases:0.37%

controls:0.12%

—

cases:0.16%

controls:0.14%

cases:1.17%

controls:0.58%

186

3728

37342

3737

37482

—

3685

36597

184

3203

31306

Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]

1.4e-01

—

1.0e+50

—

1.8e+00

5.7e-01

cases:0.24%

controls:0.21%

—

cases:0.29%

controls:0.00%

—

cases:0.30%

controls:0.05%

cases:0.37%

controls:0.21%

3743

37450

—

3740

37528

—

3680

36632

3229

31424

Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]

-1.9e-01

4.6e-01

1.7e+00

—

1.8e+00

3.4e-01

-1.1e-01

cases:0.43%

controls:0.51%

cases:0.40%

controls:0.25%

cases:0.19%

controls:0.03%

—

cases:0.24%

controls:0.04%

cases:0.51%

controls:0.37%

cases:1.45%

controls:1.62%

193

3736

37335

3736

37433

3744

37515

—

3738

37459

135

3672

36515

509

3194

30981

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
351 [2001600312]

-3.4e-02

2.7e-01

-1.0e+50

—

1.8e+00

4.9e-01

1.4e-01

cases:1.31%

controls:1.35%

cases:0.51%

controls:0.39%

cases:0.00%

controls:0.06%

—

cases:0.24%

controls:0.04%

cases:0.87%

controls:0.53%

cases:2.53%

controls:2.21%

507

3703

37021

145

3732

37383

3751

37504

—

3738

37459

195

3659

36455

695

3159

30795

Observation for suspected disease or condition, unspecified
Z03.9 [45552062]

2.7e-01

4.6e-01

7.4e-01

1.0e+50

1.5e+00

4.8e-01

3.2e-01

cases:3.44%

controls:2.64%

cases:1.39%

controls:0.88%

cases:0.24%

controls:0.11%

cases:0.13%

controls:0.00%

cases:0.48%

controls:0.11%

cases:1.52%

controls:0.95%

cases:4.32%

controls:3.19%

129

992

3623

36536

330

3699

37198

3742

37485

3746

37528

3729

37432

347

3635

36303

140

1003

3101

30487

Psychologist
Z2445 [2001311558]

3.6e-01

—

-1.0e+50

—

1.8e+00

1.0e+00

cases:0.37%

controls:0.26%

—

cases:0.00%

controls:0.02%

—

cases:0.27%

controls:0.05%

cases:0.31%

controls:0.11%

3738

37430

—

3751

37522

—

3681

36633

3231

31455

Other faecal abnormalities
R19.5 [45587500]

1.5e-01

1.8e+00

—

1.1e+00

4.2e-01

cases:0.13%

controls:0.11%

cases:0.19%

controls:0.03%

—

cases:0.16%

controls:0.05%

cases:0.25%

controls:0.16%

3747

37485

3744

37516

—

3685

36631

3233

31439

Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]

-4.3e-02

5.7e-01

—

1.8e+00

2.6e-01

6.4e-02

cases:0.48%

controls:0.50%

cases:0.37%

controls:0.21%

—

cases:0.19%

controls:0.03%

cases:0.43%

controls:0.34%

cases:1.54%

controls:1.45%

188

3734

37340

3737

37449

—

3740

37462

123

3675

36527

456

3191

31034

Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]

-8.0e-02

5.5e-01

—

1.8e+00

2.1e-01

3.6e-02

cases:0.48%

controls:0.52%

cases:0.37%

controls:0.22%

—

cases:0.19%

controls:0.03%

cases:0.41%

controls:0.33%

cases:1.54%

controls:1.49%

195

3734

37333

3737

37447

—

3740

37462

121

3676

36529

469

3191

31021

CT of aorta
PD5AD [2001309000]

6.3e-01

1.7e+00

—

1.8e+00

8.1e-01

cases:0.24%

controls:0.13%

cases:0.19%

controls:0.03%

—

cases:0.19%

controls:0.03%

cases:0.56%

controls:0.25%

3743

37480

3744

37515

—

3684

36638

3223

31412

Prothrombin time (PT) actual/Normal
5894-1 [3033658]

-5.7e-02

-7.3e-02

5.6e-01

—

1.5e+00

2.4e-01

2.5e-01

cases:4.16%

controls:4.39%

cases:2.11%

controls:2.26%

cases:0.53%

controls:0.31%

—

cases:1.39%

controls:0.31%

cases:2.52%

controls:2.00%

cases:7.25%

controls:5.74%

156

1648

3596

35880

849

3672

36679

115

3731

37413

—

117

3695

37357

732

3598

35918

235

1806

3006

29684

Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]

-1.5e-01

4.4e-01

1.7e+00

—

1.6e+00

4.1e-01

-1.4e-01

cases:0.48%

controls:0.56%

cases:0.40%

controls:0.26%

cases:0.21%

controls:0.04%

—

cases:0.16%

controls:0.03%

cases:0.51%

controls:0.34%

cases:1.33%

controls:1.52%

210

3734

37318

3736

37431

3743

37514

—

3741

37462

125

3672

36525

480

3198

31010

Palpitations
R00.2 [45558446]

4.3e-01

9.5e-01

—

6.2e-01

7.9e-01

cases:1.12%

controls:0.73%

cases:0.53%

controls:0.21%

—

cases:0.49%

controls:0.26%

cases:1.85%

controls:0.85%

273

3710

37255

3731

37450

—

3673

36554

268

3181

31222

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

1.5e-02

-1.2e-01

-4.6e-01

1.7e+00

3.1e-02

-2.6e-02

1.1e-01

cases:11.09%

controls:10.94%

cases:6.56%

controls:7.34%

cases:1.12%

controls:1.76%

cases:0.51%

controls:0.09%

cases:1.79%

controls:1.73%

cases:7.10%

controls:7.27%

cases:18.08%

controls:16.54%

416

4106

3336

33422

246

2755

3505

34773

662

3709

36866

3732

37494

650

3680

36824

262

2664

3429

33986

586

5210

2655

26280

General medical examination
Z00.0 [45585791]

3.7e-01

5.0e-01

8.3e-01

1.0e+50

1.3e+00

1.2e-01

2.5e-01

cases:3.28%

controls:2.30%

cases:1.15%

controls:0.70%

cases:0.21%

controls:0.09%

cases:0.21%

controls:0.00%

cases:0.32%

controls:0.09%

cases:0.92%

controls:0.82%

cases:3.64%

controls:2.86%

123

862

3629

36666

262

3708

37266

3743

37493

3743

37528

3735

37442

301

3657

36349

118

901

3123

30589

Vertigo/dizziness
N17 [2002000728]

4.6e-01

1.1e-01

8.2e-01

—

1.1e+00

8.2e-01

4.1e-01

cases:1.92%

controls:1.23%

cases:0.53%

controls:0.48%

cases:0.13%

controls:0.06%

—

cases:0.13%

controls:0.04%

cases:0.92%

controls:0.41%

cases:2.96%

controls:1.98%

460

3680

37068

179

3731

37349

3746

37506

—

3742

37458

149

3657

36501

625

3145

30865

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]

-2.3e-01

-2.4e-01

-1.0e+50

—

1.7e+00

1.4e-01

3.5e-02

cases:1.73%

controls:2.17%

cases:0.35%

controls:0.44%

cases:0.00%

controls:0.03%

—

cases:0.21%

controls:0.04%

cases:0.54%

controls:0.47%

cases:1.67%

controls:1.61%

816

3687

36712

165

3738

37363

3751

37515

—

3739

37459

172

3671

36478

507

3187

30983

Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]

-8.3e-02

5.3e-01

1.4e+00

—

1.7e+00

9.9e-02

-8.7e-02

cases:0.59%

controls:0.64%

cases:0.51%

controls:0.30%

cases:0.19%

controls:0.05%

—

cases:0.21%

controls:0.04%

cases:0.46%

controls:0.42%

cases:1.70%

controls:1.85%

239

3730

37289

112

3732

37416

3744

37511

—

3739

37459

153

3674

36497

582

3186

30908

Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]

-8.9e-02

7.0e-02

8.1e-01

—

1.7e+00

1.5e-01

2.6e-01

cases:3.09%

controls:3.37%

cases:1.12%

controls:1.04%

cases:0.24%

controls:0.11%

—

cases:0.51%

controls:0.10%

cases:1.19%

controls:1.03%

cases:4.72%

controls:3.69%

116

1265

3636

36263

392

3709

37136

3742

37488

—

3728

37438

377

3647

36273

153

1162

3088

30328

Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]

-3.4e-01

-7.0e-01

—

1.7e+00

2.8e-01

-1.5e-01

cases:1.28%

controls:1.79%

cases:0.29%

controls:0.59%

—

cases:0.27%

controls:0.05%

cases:0.73%

controls:0.55%

cases:1.64%

controls:1.90%

670

3704

36858

221

3740

37307

—

3737

37455

202

3664

36448

597

3188

30893

Subjective visual disturbances
H53.1 [45557467]

4.7e-01

7.9e-01

—

9.4e-01

7.2e-01

cases:0.91%

controls:0.57%

cases:0.45%

controls:0.21%

—

cases:0.49%

controls:0.19%

cases:1.57%

controls:0.77%

213

3718

37315

3734

37451

—

3673

36580

244

3190

31246

FEV1
20150-9 [3024653]

2.3e-01

3.3e-01

—

6.5e-01

1.0e+00

cases:2.69%

controls:2.15%

cases:0.96%

controls:0.69%

—

cases:1.06%

controls:0.55%

cases:3.73%

controls:1.40%

101

807

3651

36721

259

3715

37269

—

203

3652

36447

121

441

3120

31049

FEV1/FVC
19926-5 [3011505]

2.3e-01

3.3e-01

—

6.5e-01

1.0e+00

cases:2.69%

controls:2.15%

cases:0.96%

controls:0.69%

—

cases:1.06%

controls:0.55%

cases:3.73%

controls:1.40%

101

807

3651

36721

259

3715

37269

—

203

3652

36447

121

441

3120

31049

Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]

2.3e-01

3.3e-01

—

6.5e-01

1.0e+00

cases:2.69%

controls:2.15%

cases:0.96%

controls:0.69%

—

cases:1.06%

controls:0.55%

cases:3.73%

controls:1.40%

101

807

3651

36721

259

3715

37269

—

203

3652

36447

121

441

3120

31049

Transient cerebral ischaemia
K89 [2002000616]

4.8e-01

-1.0e+50

—

1.0e+50

—

1.7e+00

cases:0.13%

controls:0.08%

cases:0.00%

controls:0.04%

—

cases:0.27%

controls:0.00%

—

cases:0.14%

controls:0.02%

cases:0.46%

controls:0.09%

3747

37497

3751

37513

—

3741

37528

—

3686

36641

3226

31462

Titanium [Mass/volume] in Blood
59753-4 [40762814]

—

-1.0e+50

1.6e+00

—

cases:0.00%

controls:0.02%

cases:0.25%

controls:0.05%

—

3691

36643

3233

31475

Orthodontics
143 [44777673]

2.2e-01

—

1.6e+00

cases:0.16%

controls:0.13%

—

cases:0.40%

controls:0.08%

3746

37480

—

3228

31465

Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]

-1.4e-01

-6.8e-02

2.7e-01

—

1.6e+00

2.4e-01

1.4e-02

cases:3.25%

controls:3.71%

cases:1.41%

controls:1.51%

cases:0.21%

controls:0.16%

—

cases:0.67%

controls:0.13%

cases:2.11%

controls:1.67%

cases:6.36%

controls:6.27%

122

1392

3630

36136

567

3698

36961

3743

37467

—

3722

37424

613

3613

36037

206

1975

3035

29515

Amaurosis fugax
G45.3 [45600791]

1.9e-01

1.6e+00

—

1.0e+50

—

9.4e-01

cases:0.19%

controls:0.15%

cases:0.24%

controls:0.05%

—

cases:0.19%

controls:0.00%

—

cases:0.46%

controls:0.18%

3745

37470

3742

37510

—

3744

37528

—

3226

31433

zolpidem; oral
N05CF02 [21604655]

3.7e-01

4.3e-01

3.3e-01

—

2.8e-01

4.2e-01

3.8e-01

cases:5.44%

controls:3.81%

cases:3.68%

controls:2.42%

cases:0.75%

controls:0.54%

—

cases:0.72%

controls:0.54%

cases:3.63%

controls:2.40%

cases:5.80%

controls:4.04%

204

1429

3548

36099

138

907

3613

36621

201

3723

37327

—

204

3720

37270

134

881

3557

35769

188

1273

3053

30217

androstanolone
A14AA01 [21600917]

6.3e-01

6.8e-01

7.8e-01

—

1.2e+00

8.2e-01

7.9e-01

cases:0.77%

controls:0.41%

cases:0.53%

controls:0.27%

cases:0.19%

controls:0.09%

—

cases:0.21%

controls:0.07%

cases:0.65%

controls:0.29%

cases:0.83%

controls:0.38%

155

3723

37373

102

3731

37426

3744

37496

—

3739

37449

105

3667

36545

120

3214

31370

androstanolone
G03BB02 [21602513]

6.1e-01

6.8e-01

6.6e-01

—

9.2e-01

8.3e-01

7.7e-01

cases:0.75%

controls:0.41%

cases:0.51%

controls:0.26%

cases:0.16%

controls:0.08%

—

cases:0.16%

controls:0.06%

cases:0.62%

controls:0.27%

cases:0.74%

controls:0.34%

153

3724

37375

3732

37431

3745

37497

—

3741

37450

100

3668

36550

108

3217

31382

Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
40724-7 [3040363]

—

-1.0e+50

—

1.6e+00

—

cases:0.00%

controls:0.04%

—

cases:0.31%

controls:0.06%

—

3751

37514

—

3231

31470

Psychiatry
26 [38004469]

-3.4e-02

3.0e-02

2.6e-01

2.0e+00

7.7e-01

4.7e-01

3.4e-01

cases:3.89%

controls:4.02%

cases:1.76%

controls:1.71%

cases:0.67%

controls:0.51%

cases:0.13%

controls:0.02%

cases:1.20%

controls:0.56%

cases:2.57%

controls:1.63%

cases:4.47%

controls:3.23%

146

1509

3606

36019

641

3685

36887

193

3726

37335

3746

37521

210

3702

37264

598

3596

36052

145

1016

3096

30474

Vertebro-basilar artery syndrome
G45.0 [45538120]

5.8e-01

1.5e+00

—

1.0e+50

2.3e+00

1.6e+00

7.7e-01

cases:0.48%

controls:0.27%

cases:0.19%

controls:0.04%

—

cases:0.45%

controls:0.00%

cases:0.13%

controls:0.01%

cases:0.35%

controls:0.07%

cases:0.56%

controls:0.26%

101

3734

37427

3744

37512

—

3734

37528

3742

37469

3678

36623

3223

31409

FEV1 percent change
69983-5 [42868472]

1.9e-01

3.0e-01

—

6.5e-01

9.1e-01

cases:2.29%

controls:1.90%

cases:0.80%

controls:0.59%

—

cases:0.87%

controls:0.45%

cases:3.09%

controls:1.26%

712

3666

36816

223

3721

37305

—

166

3659

36484

100

397

3141

31093

Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]

1.9e-01

3.0e-01

—

6.5e-01

9.1e-01

cases:2.29%

controls:1.90%

cases:0.80%

controls:0.59%

—

cases:0.87%

controls:0.45%

cases:3.09%

controls:1.26%

712

3666

36816

223

3721

37305

—

166

3659

36484

100

397

3141

31093

FEV1 --post bronchodilation
20155-8 [3023550]

1.9e-01

3.0e-01

—

6.5e-01

9.1e-01

cases:2.29%

controls:1.90%

cases:0.80%

controls:0.59%

—

cases:0.87%

controls:0.45%

cases:3.09%

controls:1.26%

712

3666

36816

223

3721

37305

—

166

3659

36484

100

397

3141

31093

FEV1/FVC --post bronchodilation
69970-2 [42868459]

1.9e-01

3.0e-01

—

6.5e-01

9.1e-01

cases:2.29%

controls:1.90%

cases:0.80%

controls:0.59%

—

cases:0.87%

controls:0.45%

cases:3.09%

controls:1.26%

712

3666

36816

223

3721

37305

—

166

3659

36484

100

397

3141

31093

FVC percent change Respiratory system
69982-7 [42868471]

1.9e-01

3.0e-01

—

6.5e-01

9.1e-01

cases:2.29%

controls:1.90%

cases:0.80%

controls:0.59%

—

cases:0.87%

controls:0.45%

cases:3.09%

controls:1.26%

712

3666

36816

223

3721

37305

—

166

3659

36484

100

397

3141

31093

Acute prostatitis
N41.0 [45563017]

—

-1.0e+50

—

1.6e+00

—

cases:0.00%

controls:0.02%

—

cases:0.56%

controls:0.12%

—

3751

37521

—

3223

31453

Very extensive CT angiography of aorta
PD5CD [2001309225]

1.6e+00

—

cases:0.24%

controls:0.05%

—

3743

37509

—

Constipation outlet obstruction type
K59.01 [2000502925]

—

1.8e+00

1.6e+00

—

cases:0.16%

controls:0.03%

cases:0.46%

controls:0.10%

—

3685

36640

3226

31459

epinephrine
S01EA01 [21603673]

4.3e-01

4.4e-01

—

8.8e-01

6.7e-01

cases:1.33%

controls:0.87%

cases:0.61%

controls:0.40%

—

cases:0.89%

controls:0.37%

cases:1.60%

controls:0.83%

328

3702

37200

149

3728

37379

—

137

3658

36513

260

3189

31230

epinephrine; parenteral
C01CA24 [21600303]

4.3e-01

4.4e-01

—

8.8e-01

6.7e-01

cases:1.33%

controls:0.87%

cases:0.61%

controls:0.40%

—

cases:0.89%

controls:0.37%

cases:1.60%

controls:0.83%

328

3702

37200

149

3728

37379

—

137

3658

36513

261

3189

31229

Intensity modified radiotherapy
ZX070 [2001311478]

—

-1.0e+50

—

-1.0e+50

1.5e+00

—

cases:0.00%

controls:0.03%

—

cases:0.00%

controls:0.04%

cases:0.37%

controls:0.08%

—

3751

37517

—

3691

36637

3229

31465

Cerebral extensive angiography with X-ray
PA2BC [2001300225]

—

-1.0e+50

—

1.5e+00

—

cases:0.00%

controls:0.03%

—

cases:0.34%

controls:0.07%

—

3751

37516

—

3230

31467

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]

8.0e-02

3.8e-02

1.2e+00

—

9.4e-01

1.6e-01

3.4e-01

cases:3.52%

controls:3.26%

cases:1.39%

controls:1.34%

cases:0.45%

controls:0.14%

—

cases:0.40%

controls:0.16%

cases:1.44%

controls:1.23%

cases:6.63%

controls:4.81%

132

1222

3620

36306

501

3699

37027

3734

37475

—

3732

37415

450

3638

36200

215

1516

3026

29974

Tenodesis, shortening or lengthening of tendon of foot
NHL68 [2001308353]

—

-1.0e+50

—

-1.0e+50

1.5e+00

—

cases:0.00%

controls:0.02%

—

cases:0.00%

controls:0.05%

cases:0.34%

controls:0.08%

—

3751

37519

—

3691

36633

3230

31466

Acromioplastia, arthroscopic
NBG15 [2001307302]

7.1e-01

4.7e-01

—

-1.0e+50

—

7.7e-01

cases:1.20%

controls:0.59%

cases:0.19%

controls:0.12%

—

cases:0.00%

controls:0.01%

—

cases:0.86%

controls:0.40%

223

3707

37305

3744

37484

—

3747

37469

—

126

3213

31364

Posterior colporrpahy with sutures for primary rectocele
LEF03 [2001306706]

7.0e-01

4.5e-01

-1.0e+50

—

-1.0e+50

—

7.8e-01

cases:0.83%

controls:0.41%

cases:0.21%

controls:0.14%

cases:0.00%

controls:0.02%

—

cases:0.00%

controls:0.02%

—

cases:0.77%

controls:0.36%

155

3721

37373

3743

37477

3751

37520

—

3747

37468

—

112

3216

31378

Transient cerebral ischaemic attacks and related syndromes
G45 [45562092]

—

1.4e+00

—

1.5e+00

—

cases:0.13%

controls:0.03%

—

cases:0.37%

controls:0.09%

—

3746

37516

—

3229

31463

lacosamide; oral, parenteral
N03AX18 [21604440]

—

-1.0e+50

—

9.5e-01

1.4e+00

—

cases:0.00%

controls:0.06%

cases:0.00%

controls:0.03%

—

cases:0.16%

controls:0.06%

cases:0.31%

controls:0.07%

—

3751

37507

3751

37518

—

3685

36627

3231

31467

Chondromalacia patellae
M22.4 [45538712]

1.4e+00

—

cases:0.35%

controls:0.08%

—

3739

37497

—

candesartan; oral
C09CA06 [21601829]

2.4e-01

2.0e-01

2.5e-01

1.3e+00

5.8e-01

3.6e-01

2.5e-01

cases:7.57%

controls:6.04%

cases:6.42%

controls:5.31%

cases:1.95%

controls:1.52%

cases:0.16%

controls:0.04%

cases:2.67%

controls:1.52%

cases:7.80%

controls:5.58%

cases:10.40%

controls:8.30%

284

2268

3468

35260

241

1991

3510

35537

571

3678

36957

3745

37512

100

568

3647

36906

288

2045

3403

34605

337

2613

2904

28877

Measurement of expired nitric oxide
444642008 [40480257]

1.6e-01

—

1.4e+00

cases:0.24%

controls:0.21%

—

cases:0.43%

controls:0.10%

3743

37451

—

3227

31457

Health maint/preventive medicine
A98 [2002000231]

7.2e-02

6.5e-02

2.7e-01

1.0e+00

2.2e-01

1.1e-01

1.5e-01

cases:34.78%

controls:33.17%

cases:26.90%

controls:25.64%

cases:5.36%

controls:4.14%

cases:0.45%

controls:0.17%

cases:5.18%

controls:4.18%

cases:29.94%

controls:27.69%

cases:55.32%

controls:51.58%

1305

12448

2447

25080

1009

9622

2742

27906

201

1553

3550

35975

3734

37465

194

1567

3553

35907

1105

10149

2586

26501

1793

16242

1448

15248

Otolaryngology
4 [38004449]

3.3e-01

2.6e-01

3.6e-01

2.1e+00

4.1e-01

3.9e-01

cases:15.09%

controls:11.33%

cases:5.55%

controls:4.32%

cases:0.91%

controls:0.63%

cases:0.13%

controls:0.02%

cases:1.01%

controls:0.68%

cases:6.31%

controls:4.29%

cases:17.68%

controls:12.70%

566

4252

3186

33276

208

1621

3543

35907

237

3717

37291

3746

37522

254

3709

37220

233

1571

3458

35079

573

3998

2668

27492

amitriptyline; oral, parenteral
N06AA09 [21604696]

3.1e-01

2.7e-01

6.5e-02

-1.0e+50

6.6e-01

3.4e-01

4.2e-01

cases:5.65%

controls:4.21%

cases:2.69%

controls:2.07%

cases:0.56%

controls:0.52%

cases:0.00%

controls:0.02%

cases:0.99%

controls:0.51%

cases:3.12%

controls:2.25%

cases:6.63%

controls:4.47%

212

1581

3540

35947

101

777

3650

36751

197

3730

37331

3751

37519

192

3710

37282

115

823

3576

35827

215

1409

3026

30081

Audiology
64 [38004489]

3.2e-01

2.8e-01

7.3e-01

—

6.2e-01

5.8e-01

4.8e-01

cases:3.76%

controls:2.76%

cases:1.57%

controls:1.19%

cases:0.35%

controls:0.17%

—

cases:0.29%

controls:0.16%

cases:2.09%

controls:1.17%

cases:5.99%

controls:3.79%

141

1035

3611

36493

448

3692

37080

3738

37465

—

3736

37415

430

3614

36220

194

1192

3047

30298

Presence of prosthetic heart valve
Z95.2 [45542495]

4.9e-01

7.2e-01

—

1.4e+00

5.4e-01

cases:0.43%

controls:0.26%

cases:0.27%

controls:0.13%

—

cases:0.54%

controls:0.14%

cases:0.71%

controls:0.41%

3736

37430

3741

37479

—

3671

36600

130

3218

31360

pH of Venous blood
2746-6 [3012544]

-2.5e-01

2.8e-01

1.4e+00

—

1.2e+00

9.5e-02

-6.3e-02

cases:0.85%

controls:1.10%

cases:0.83%

controls:0.63%

cases:0.35%

controls:0.09%

—

cases:0.27%

controls:0.08%

cases:0.81%

controls:0.74%

cases:2.44%

controls:2.59%

411

3720

37117

235

3720

37293

3738

37495

—

3737

37443

271

3661

36379

816

3162

30674

Foot and toes extensive X-ray examination
NH3BA [2001308270]

8.0e-03

—

-1.0e+50

—

-1.0e+50

1.4e+00

5.1e-01

cases:0.35%

controls:0.34%

—

cases:0.00%

controls:0.02%

—

cases:0.00%

controls:0.02%

cases:0.30%

controls:0.08%

cases:0.62%

controls:0.37%

129

3739

37399

—

3751

37522

—

3747

37467

3680

36622

117

3221

31373

Supraventricular tachycardia
I47.1 [45567178]

6.0e-01

9.8e-01

—

1.0e+50

—

1.4e+00

4.8e-01

cases:0.83%

controls:0.46%

cases:0.35%

controls:0.13%

—

cases:0.16%

controls:0.00%

—

cases:0.49%

controls:0.13%

cases:0.83%

controls:0.52%

171

3721

37357

3738

37479

—

3745

37528

—

3673

36604

163

3214

31327

acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]

-1.5e-01

-2.3e-01

—

1.4e+00

2.0e-01

3.9e-02

cases:1.52%

controls:1.76%

cases:0.75%

controls:0.94%

—

cases:0.91%

controls:0.23%

cases:1.16%

controls:0.95%

cases:2.72%

controls:2.61%

660

3695

36868

351

3723

37177

—

3713

37386

349

3648

36301

823

3153

30667

Base excess in Venous blood by calculation
1927-3 [3002032]

-2.7e-01

2.3e-01

1.4e+00

—

1.3e+00

1.5e-01

-2.3e-01

cases:0.80%

controls:1.05%

cases:0.77%

controls:0.62%

cases:0.32%

controls:0.08%

—

cases:0.29%

controls:0.08%

cases:0.84%

controls:0.73%

cases:2.04%

controls:2.54%

394

3722

37134

231

3722

37297

3739

37497

—

3736

37443

266

3660

36384

800

3175

30690

Transrectal gold marker implantation in prostate under ultrasound guidance
KE3AT [2001306393]

—

-1.0e+50

1.3e+00

—

cases:0.00%

controls:0.02%

cases:0.49%

controls:0.13%

—

3691

36644

3225

31449

Extensive CT of neck arteries
PA6BD [2001308697]

2.5e-01

1.3e+00

—

6.4e-01

7.0e-01

cases:0.59%

controls:0.46%

cases:0.40%

controls:0.11%

—

cases:0.24%

controls:0.13%

cases:0.68%

controls:0.34%

172

3730

37356

3736

37488

—

3682

36603

107

3219

31383

Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]

6.2e-02

1.4e-01

4.5e-01

—

8.8e-01

2.8e-01

4.3e-01

cases:3.81%

controls:3.59%

cases:2.64%

controls:2.30%

cases:0.48%

controls:0.31%

—

cases:0.56%

controls:0.23%

cases:2.93%

controls:2.22%

cases:6.82%

controls:4.56%

143

1347

3609

36181

863

3652

36665

115

3733

37413

—

3726

37387

108

813

3583

35837

221

1437

3020

30053

Cystocele
N81.1 [45558171]

6.3e-01

7.1e-01

—

9.2e-01

6.5e-01

6.8e-01

cases:1.76%

controls:0.95%

cases:0.67%

controls:0.33%

—

cases:0.13%

controls:0.05%

cases:0.57%

controls:0.30%

cases:1.94%

controls:1.00%

356

3686

37172

124

3726

37404

—

3742

37454

109

3670

36541

314

3178

31176

Primary coxarthrosis, bilateral
M16.0 [45543482]

5.1e-01

2.8e-01

9.2e-01

—

5.5e-01

7.7e-01

3.9e-01

cases:1.60%

controls:0.96%

cases:0.56%

controls:0.42%

cases:0.16%

controls:0.06%

—

cases:0.13%

controls:0.08%

cases:0.81%

controls:0.38%

cases:2.04%

controls:1.39%

362

3692

37166

159

3730

37369

3745

37504

—

3742

37445

138

3661

36512

438

3175

31052

Capsular endoscopy
UJF92 [2001305032]

1.8e-01

—

1.3e+00

cases:0.16%

controls:0.13%

—

cases:0.37%

controls:0.10%

3746

37478

—

3229

31457

mometasone; nasal
R01AD09 [21605051]

3.2e-01

2.9e-01

-4.9e-02

—

5.2e-02

3.6e-01

2.9e-01

cases:11.51%

controls:8.62%

cases:4.59%

controls:3.47%

cases:0.53%

controls:0.56%

—

cases:0.59%

controls:0.56%

cases:4.93%

controls:3.49%

cases:10.80%

controls:8.29%

432

3234

3320

34294

172

1304

3579

36224

210

3731

37318

—

209

3725

37265

182

1279

3509

35371

350

2612

2891

28878

Rectocele
N81.6 [45543893]

6.5e-01

5.5e-01

—

6.3e-01

5.9e-01

cases:1.68%

controls:0.89%

cases:0.61%

controls:0.35%

—

cases:0.49%

controls:0.26%

cases:1.70%

controls:0.95%

333

3689

37195

133

3728

37395

—

3673

36555

298

3186

31192

Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]

-1.8e-01

8.3e-03

2.8e-01

—

1.2e+00

2.7e-01

8.7e-02

cases:1.73%

controls:2.08%

cases:1.39%

controls:1.37%

cases:0.24%

controls:0.18%

—

cases:0.69%

controls:0.20%

cases:2.41%

controls:1.86%

cases:6.76%

controls:6.23%

779

3687

36749

516

3699

37012

3742

37460

—

3721

37398

681

3602

35969

219

1962

3022

29528

Atrial premature depolarization
I49.1 [45552795]

1.4e-01

1.2e+00

—

3.7e-01

4.2e-01

cases:0.40%

controls:0.35%

cases:0.32%

controls:0.10%

—

cases:0.16%

controls:0.11%

cases:0.65%

controls:0.43%

130

3737

37398

3739

37492

—

3685

36609

135

3220

31355

Neoplasm skin benign/unspecified
S79 [2002001043]

—

-1.0e+50

1.2e+00

—

cases:0.00%

controls:0.03%

cases:0.40%

controls:0.12%

—

3691

36639

3228

31452

Audiometric test
21727005 [4071702]

2.8e-01

3.8e-01

—

6.9e-01

5.9e-01

6.0e-01

cases:2.77%

controls:2.10%

cases:0.96%

controls:0.66%

—

cases:0.13%

controls:0.07%

cases:1.14%

controls:0.63%

cases:5.03%

controls:2.81%

104

788

3648

36740

246

3715

37282

—

3742

37449

232

3649

36418

163

886

3078

30604

orphenadrine, combinations
M03BC51 [21604113]

2.3e-01

2.2e-01

1.2e+00

—

1.7e-01

2.4e-01

cases:4.53%

controls:3.63%

cases:1.31%

controls:1.05%

cases:0.35%

controls:0.11%

—

cases:1.08%

controls:0.91%

cases:3.55%

controls:2.82%

170

1362

3582

36166

395

3702

37133

3738

37488

—

335

3651

36315

115

889

3126

30601

Other cardiac arrhythmias
I49 [45543179]

1.2e+00

—

7.6e-01

cases:0.35%

controls:0.11%

—

cases:0.34%

controls:0.16%

3739

37488

—

3230

31440

Fear of neurological disease other
N27 [2002000732]

5.4e-01

—

1.6e+00

1.2e+00

cases:0.16%

controls:0.09%

—

cases:0.16%

controls:0.03%

cases:0.43%

controls:0.13%

3746

37493

—

3685

36638

3227

31448

Trigger finger
M65.3 [45538828]

-1.4e-01

1.2e+00

-1.0e+50

—

7.6e-01

4.4e-01

cases:0.45%

controls:0.52%

cases:0.45%

controls:0.14%

cases:0.00%

controls:0.02%

—

cases:0.38%

controls:0.18%

cases:0.89%

controls:0.58%

195

3735

37333

3734

37475

3751

37521

—

3677

36585

182

3212

31308

General anesthesia, balanced
WX408 [2001310808]

1.2e-01

-2.0e-01

8.8e-01

—

5.6e-01

5.8e-01

cases:4.18%

controls:3.74%

cases:0.83%

controls:1.00%

cases:0.16%

controls:0.07%

—

cases:1.27%

controls:0.73%

cases:4.20%

controls:2.39%

157

1405

3595

36123

377

3720

37151

3745

37503

—

267

3644

36383

136

754

3105

30736

escitalopram; oral
N06AB10 [21604718]

2.2e-01

2.6e-01

4.4e-01

-1.0e+50

4.7e-01

6.6e-01

4.9e-01

cases:3.62%

controls:2.94%

cases:2.05%

controls:1.58%

cases:0.61%

controls:0.39%

cases:0.00%

controls:0.02%

cases:0.67%

controls:0.42%

cases:2.95%

controls:1.56%

cases:4.63%

controls:2.90%

136

1102

3616

36426

594

3674

36934

148

3728

37380

3751

37520

156

3722

37318

109

570

3582

36080

150

913

3091

30577

atorvastatin; oral
C10AA05 [21601860]

1.0e-01

6.7e-02

2.6e-02

1.0e+00

6.6e-01

2.5e-01

2.3e-01

cases:13.51%

controls:12.36%

cases:10.96%

controls:10.32%

cases:2.93%

controls:2.86%

cases:0.29%

controls:0.11%

cases:5.34%

controls:2.82%

cases:13.82%

controls:11.13%

cases:20.92%

controls:17.42%

507

4639

3245

32889

411

3874

3340

33654

110

1073

3641

36455

3740

37488

200

1058

3547

36416

510

4079

3181

32571

678

5484

2563

26006

Contact with and exposure to unspecified communicable disease
Z20.9 [45595489]

4.0e-01

—

1.1e+00

cases:0.27%

controls:0.18%

—

cases:0.40%

controls:0.13%

3742

37461

—

3228

31449

Cephalometry with X-ray
EB1MA [2001301916]

1.1e+00

-1.0e+50

—

1.2e+00

cases:0.35%

controls:0.11%

cases:0.00%

controls:0.02%

—

cases:0.19%

controls:0.05%

3739

37485

3751

37519

—

3235

31473

Shoulder and humerus MRI examination with high intensity magnet
NB1BG [2001307231]

-2.0e-01

—

1.1e+00

cases:0.13%

controls:0.16%

—

cases:0.56%

controls:0.19%

3747

37467

—

3223

31431

Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]

-1.3e-01

-2.3e-02

8.6e-02

—

1.1e+00

1.6e-01

9.6e-02

cases:5.81%

controls:6.58%

cases:3.25%

controls:3.33%

cases:0.43%

controls:0.39%

—

cases:1.09%

controls:0.38%

cases:4.33%

controls:3.73%

cases:13.61%

controls:12.51%

218

2470

3534

35058

122

1248

3629

36280

147

3735

37381

—

142

3706

37332

160

1366

3531

35284

441

3940

2800

27550

Nonorganic insomnia
F51.0 [45552492]

4.7e-01

6.0e-01

—

1.3e+00

2.6e-01

3.3e-01

cases:2.16%

controls:1.36%

cases:1.17%

controls:0.65%

—

cases:0.21%

controls:0.06%

cases:0.87%

controls:0.67%

cases:3.02%

controls:2.18%

512

3671

37016

243

3707

37285

—

3739

37452

245

3659

36405

688

3143

30802

Loudness discomfort Level (LDL)
DFF30 [2001301650]

8.3e-01

—

1.2e+00

1.1e+00

cases:0.37%

controls:0.16%

—

cases:0.19%

controls:0.05%

cases:0.74%

controls:0.26%

3738

37467

—

3684

36630

3217

31409

Fracture: hand/foot bone
L74 [2002000693]

2.2e-01

—

1.1e+00

cases:0.16%

controls:0.13%

—

cases:0.49%

controls:0.17%

3746

37480

—

3225

31436

Laboratory test
15220000 [4034850]

-4.5e-02

-2.6e-02

-4.2e-01

—

1.1e+00

-1.5e-02

-2.6e-01

cases:2.35%

controls:2.45%

cases:1.20%

controls:1.23%

cases:0.13%

controls:0.20%

—

cases:0.56%

controls:0.19%

cases:1.33%

controls:1.35%

cases:3.58%

controls:4.58%

920

3664

36608

462

3706

37066

3746

37452

—

3726

37401

494

3642

36156

116

1443

3125

30047

esomeprazole; oral, parenteral
A02BC05 [21600100]

2.2e-01

2.6e-01

2.7e-03

—

2.2e-01

2.5e-01

3.3e-01

cases:12.07%

controls:9.94%

cases:6.88%

controls:5.41%

cases:1.20%

controls:1.20%

—

cases:1.55%

controls:1.24%

cases:6.83%

controls:5.38%

cases:13.98%

controls:10.47%

453

3729

3299

33799

258

2031

3493

35497

449

3706

37079

—

465

3689

37009

252

1971

3439

34679

453

3296

2788

28194

cinchocaine
C05AD04 [21601621]

6.4e-02

7.3e-01

—

8.6e-01

1.0e+00

cases:0.35%

controls:0.33%

cases:0.16%

controls:0.08%

—

cases:0.14%

controls:0.06%

cases:0.59%

controls:0.21%

122

3739

37406

3745

37499

—

3686

36629

3222

31425

Other disorders of vitreous body
H43.8 [45533329]

5.3e-01

4.1e-02

—

-2.7e-02

5.1e-01

cases:2.00%

controls:1.18%

cases:0.40%

controls:0.38%

—

cases:0.41%

controls:0.42%

cases:2.53%

controls:1.53%

444

3677

37084

144

3736

37384

—

153

3676

36497

481

3159

31009

Allergy/allergic reaction NOS
A92 [2002000225]

-2.6e-01

—

1.0e+00

cases:0.13%

controls:0.17%

—

cases:0.43%

controls:0.15%

3747

37463

—

3227

31442

Chronic hypertension
205 [2001600203]

-2.7e-02

-1.0e-01

—

1.0e+00

2.0e-01

cases:1.95%

controls:2.00%

cases:0.35%

controls:0.38%

—

cases:0.84%

controls:0.30%

cases:1.39%

controls:1.14%

750

3679

36778

144

3738

37384

—

109

3660

36541

359

3196

31131

clindamycin; vaginal
G01AA10 [21602372]

4.1e-01

5.1e-01

8.0e-01

—

2.1e-02

6.3e-01

cases:2.40%

controls:1.61%

cases:0.83%

controls:0.50%

cases:0.16%

controls:0.07%

—

cases:0.49%

controls:0.48%

cases:2.81%

controls:1.51%

603

3662

36925

187

3720

37341

3745

37501

—

175

3673

36475

475

3150

31015

Ambulatory ECG
XF404 [2001303370]

2.9e-01

6.1e-01

—

1.0e+00

3.2e-01

cases:1.52%

controls:1.14%

cases:0.51%

controls:0.28%

—

cases:0.81%

controls:0.29%

cases:1.30%

controls:0.94%

429

3695

37099

104

3732

37424

—

106

3661

36544

296

3199

31194

More than one and less than three hours
ZXE10 [2001311401]

6.7e-02

-1.2e-01

—

6.5e-01

3.9e-01

cases:6.69%

controls:6.29%

cases:1.49%

controls:1.68%

—

cases:2.25%

controls:1.19%

cases:6.79%

controls:4.70%

251

2359

3501

35169

629

3695

36899

—

436

3608

36214

220

1479

3021

30011

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1888

11914

2.18

115.97

2.4

2.2

149.01

188.25

u/l

2.80

1824

11209

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2073

14319

2.00

91.56

4.2

26.18

89.83

ng/l

1.48

1612

10972

(3013826) Glucose [Moles/volume] in Serum or Plasma

2695

21484

1.90

65.97

4.6

5.2

6.38

6.77

mmol/l

30.39

2591

20483

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1001

5958

1.93

62.78

1.8

2.0

28.86

29.70

4.20

976

5788

(3032080) INR in Blood by Coagulation assay

2335

17998

1.79

61.48

16.3

17.0

1.26

1.29

inr

1.93

2019

14950

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3546

32163

2.86

50.07

17.8

18.5

22.22

25.39

mg/l

7.25

2982

26860

(3019550) Sodium [Moles/volume] in Serum or Plasma

3638

33677

3.62

45.31

22.1

22.5

140.00

139.62

mmol/l

18.14

3614

33040

(3023103) Potassium [Moles/volume] in Serum or Plasma

3634

33729

3.44

42.79

22.3

22.7

3.97

3.99

mmol/l

3.83

3604

33044

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3378

30420

2.11

41.11

6.4

5.8

1.99

2.01

mu/l

0.36

3122

27748

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3647

34258

3.29

35.28

24.9

25.1

78.49

79.13

umol/l

0.64

3629

33836

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3475

32004

2.16

33.89

6.1

5.8

5.80

6.03

mmol/l

40.49

3210

29012

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2936

25747

1.64

33.47

4.7

4.8

10.98

14.04

mm/h

32.01

2748

23933

(3035941) MCH [Entitic mass]

3653

34472

3.24

32.55

28.2

28.3

30.41

30.40

0.12

3637

34044

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3525

32717

2.27

32.53

7.1

6.6

2.63

mmol/l

0.13

3274

30028

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3653

34474

3.24

32.50

28.2

28.3

91.34

91.68

5.13

3637

34046

(3026361) Erythrocytes [#/volume] in Blood

3653

34475

3.24

32.48

28.3

28.4

4.49

4.41

e12/l

20.37

3609

33552

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3653

34475

3.24

32.48

28.7

28.9

40.43

39.78

11.37

3637

34035

(3010813) Leukocytes [#/volume] in Blood

3653

34476

3.24

32.46

28.3

28.4

6.47

6.74

e9/l

13.33

3611

33554

(3000963) Hemoglobin [Mass/volume] in Blood

3653

34481

3.23

32.35

28.5

28.6

135.51

132.97

g/l

24.99

3637

34075

(3007461) Platelets [#/volume] in Blood

3652

34472

3.21

32.23

28.4

239.82

248.01

e9/l

13.43

3616

33689

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3426

31497

2.01

31.87

6.7

7.2

38.92

39.95

mmol/mol

10.47

3196

29111

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3473

32113

2.09

31.33

6.1

5.6

4.54

4.59

mmol/l

1.93

3234

29563

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3605

33940

2.58

29.45

13.3

13.8

24.72

25.04

u/l

0.46

3499

32844

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3446

31895

1.98

29.12

6.0

5.5

1.48

1.50

mmol/l

1.15

3189

29129

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2914

25803

1.58

28.73

5.1

4.7

14.89

15.04

pmol/l

2.96

2669

23388

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3331

30556

1.80

28.17

5.0

4.6

1.26

1.29

mmol/l

1.65

3059

27534

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

542

3363

1.71

26.99

2.5

2.4

5.66

7.05

ug/l

1.41

483

2970

(3031040) Bacteria [#/volume] in Urine by Automated count

2655

23222

1.49

25.95

5.7

5.2

1528.23

1626.18

e6/l

0.03

320

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3390

31588

1.76

22.73

17.4

18.7

74.57

74.77

ml/min/173m2

0.29

3234

29579

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1651

13544

1.39

20.90

4.6

4.4

3.24

0.42

estimate

0.75

342

3234

(3013512) EKG study

1660

13745

1.37

19.32

4.0

1.00

0.68

—

(3035350) Ketones [Presence] in Urine by Test strip

2151

18644

1.36

18.27

4.6

4.3

0.00

3.37

estimate

2.72

434

4101

(3019150) Specific gravity of Urine by Refractometry

1047

8098

1.41

18.13

5.2

4.5

1.02

1.20

kg/l

0.50

733

5481

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1914

16362

1.35

17.43

2.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2156

18812

1.34

16.86

4.6

4.4

0.00

0.01

estimate

2.00

415

3836

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2977

27348

1.43

16.79

7.9

9.0

78.15

81.45

u/l

3.65

2814

25926

(3021601) Nitrite [Presence] in Urine by Test strip

2117

18432

1.34

16.74

4.6

4.3

0.00

estimate

0.50

425

3952

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2224

19520

1.34

16.58

6.6

7.6

1.22

1.21

mmol/l

1.91

1936

16794

(3029937) Albumin [Presence] in Urine by Test strip

1290

10527

1.34

15.45

5.0

4.5

0.00

estimate

0.08

404

3645

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1880

16342

1.30

13.82

2.4

2.5

81.07

80.53

nmol/l

0.37

1656

14532

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1917

16773

1.29

13.12

2.2

101.05

96.48

pmol/l

3.37

968

8418

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2001

17653

1.29

12.63

5.9

6.8

1.21

mmol/l

0.32

1830

16269

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

940

7521

1.33

12.30

4.4

4.2

141.60

470.29

ng/l

1.81

771

6329

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

131

668

2.00

12.19

1.1

1.2

3.63

3.81

mmol/l

1.36

122

630

(3015736) pH of Urine

1704

14774

1.28

12.17

4.1

3.8

6.32

6.27

0.97

964

7915

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

600

4516

1.39

11.54

8.5

7.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

980

7950

1.31

11.51

5.4

4.9

21.94

22.05

0.09

514

4188

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2290

20684

1.27

11.36

3.2

3.4

45.92

54.48

u/l

3.87

2133

19060

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

126

657

1.95

11.03

1.3

1.4

1714.73

1198.25

e6/l

0.22

106

507

(3044889) 12 lead EKG panel

2653

24464

1.29

10.84

4.8

4.6

0.50

1712.53

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1179

9874

1.28

10.73

6.6

6.1

2.55

3.15

ug/l

1.48

1070

8897

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1380

11809

1.27

10.47

2.7

65.06

60.88

u/l

0.96

1275

10884

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2753

25548

1.29

10.46

24.2

24.5

332.32

331.09

g/l

11.69

2748

25410

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

122

645

1.92

10.28

1.2

1.4

13.33

40.16

e6/l

1.10

462

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

903

7356

1.30

10.07

1.3

1.75

1.43

u/ml

0.22

226

1872

(3017446) Testosterone [Moles/volume] in Serum or Plasma

310

2119

1.50

9.96

2.4

2.3

13.54

12.80

nmol/l

0.82

285

1875

(3044290) Cell count panel - Cerebral spinal fluid

116

611

1.93

9.90

1.2

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1295

11061

1.26

9.81

1.7

21.49

20.77

nmol/l

0.88

1083

9146

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

111

3.26

9.70

2.3

2.2

51.20

51.57

umol/l

0.03

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

326

2282

1.47

9.31

2.4

2.5

26.93

22.59

au/ml

0.35

182

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1530

13397

1.24

9.10

3.7

3.5

—

1.51

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

149

2.84

8.94

1.0

337.72

227.89

ng/l

1.52

105

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

149

2.84

8.94

1.0

50.53

29.26

ng/l

1.52

102

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

299

2087

1.47

8.67

1.3

44.84

56.10

au/ml

0.38

144

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

147

2.81

8.58

1.0

840.26

891.76

ng/l

0.32

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1681

14933

1.23

8.54

1.9

2.0

1.30

1.33

mmol/l

0.74

1374

12220

(3019309) Folate [Moles/volume] in Red Blood Cells

779

6350

1.29

8.46

1.8

1.7

1156.14

1192.81

nmol/l

0.53

575

4739

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

925

7728

1.26

8.18

1.7

1.23

1.41

mg/l

0.61

702

6119

(3000850) Epithelial cells [#/volume] in Urine

1019

8632

1.25

7.94

2.8

5.89

5.54

e6/l

0.08

945

7857

(40768804) Tissue Pathology biopsy report

1640

14627

1.22

7.74

2.3

—

(3045414) Leukocytes [Presence] in Urine

487

3769

1.34

7.69

2.2

0.00

0.01

estimate

0.78

744

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1861

16858

1.21

7.32

2.7

2.9

—

estimate

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1077

9262

1.23

7.17

3.6

3.8

0.24

0.35

estimate

0.20

330

3112

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2145

19747

1.20

6.92

5.9

7.0

11.64

11.70

umol/l

0.10

2031

18858

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1680

15140

1.20

6.80

2.9

3.1

121.66

143.52

ug/l

3.82

1539

13925

(3026008) Bacteria identified in Urine by Culture

1379

12265

1.20

6.30

3.6

3.5

—

(3017732) Neutrophils [#/volume] in Blood

564

4579

1.27

6.18

2.7

3.3

4.48

4.59

e9/l

0.10

477

3879

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1450

12971

1.19

6.18

3.2

3.3

930.17

1469.17

ng/l

12.90

1259

11357

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

900

7699

1.22

6.16

1.7

23119512.34

30964265.08

pmol/l

0.18

731

6246

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

708

5908

1.24

6.13

3.7

3.5

0.72

0.80

ug/l

1.10

512

4142

(3019225) pH of Specimen

479

3831

1.29

5.92

4.0

4.5

7.37

7.36

0.35

343

2687

(3030981) Hyaline casts [#/volume] in Urine by Automated count

408

3200

1.31

5.84

2.6

2.4

0.36

0.48

e6/l

0.84

393

3067

(3015377) Calcium [Moles/volume] in Serum or Plasma

1478

13291

1.18

5.84

3.0

3.7

2.35

2.36

mmol/l

1.59

1325

11928

(3024561) Albumin [Mass/volume] in Serum or Plasma

1864

17108

1.18

5.73

4.5

5.2

35.81

35.05

g/l

8.38

1734

15985

(3018418) pH of Serum or Plasma

1339

11957

1.19

5.70

4.1

4.4

7.40

1.78

1001

8638

(3002582) Erythrocytes [#/volume] in Urine

1369

12277

1.18

5.49

3.7

3.5

154.90

61.45

e6/l

0.77

1097

9413

(40768797) Stomach Pathology biopsy report

638

5332

1.24

5.40

1.2

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

521

1.71

5.30

2.0

1.9

197.02

206.22

pmol/l

0.38

485

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2747

26122

1.19

5.28

21.5

23.2

13.63

13.83

14.37

2732

25754

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

195

1392

1.42

5.11

1.9

2.1

155.08

550.14

ug/l

5.36

189

1326

(36660697) Celiac disease serology panel - Serum

335

2614

1.31

4.99

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1014

8952

1.18

4.77

4.9

4.1

0.00

0.64

—

102

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

315

1.85

4.71

1.1

—

4.70

—

(3048689) Calprotectin [Mass/mass] in Stool

497

4114

1.24

4.58

2.0

2.2

155.23

149.42

ug/g

0.10

379

3241

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

203

1496

1.38

4.46

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

264

1.91

4.44

1.1

—

(3018095) Leukocytes [#/volume] in Urine

1501

13729

1.16

4.41

4.3

4.2

127.23

114.65

e6/l

0.11

1135

9770

(3004119) Hemoglobin [Mass/volume] in Venous blood

316

2492

1.29

4.38

2.7

3.1

132.84

127.46

g/l

4.42

311

2419

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

894

7860

1.18

4.37

2.8

3.2

2.45

2.47

mmol/l

4.67

815

7033

(3012441) Differential panel - Pleural fluid

454

0.37

4.35

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

521

1.63

4.31

1.3

1.4

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

140

2.22

4.17

1.1

1.3

—

73.46

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

109

0.00

4.17

0.0

12.9

—

0.65

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

120

814

1.49

4.17

1.2

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

1961

18333

1.15

4.12

5.5

6.4

1.82

1.89

e9/l

0.91

1729

15825

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

376

3053

1.26

4.12

2.6

2.8

63.20

60.89

ml/min/173m2

0.77

162

1362

(3013650) Neutrophils [#/volume] in Blood by Automated count

2158

20322

1.15

4.04

8.0

10.2

3.92

4.14

e9/l

4.96

1893

17472

(4034850) Laboratory test

150

1071

1.42

4.00

10.9

11.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

473

3958

1.22

3.93

1.4

1.3

—

(3006315) Basophils [#/volume] in Blood

1930

18063

1.14

3.90

5.4

6.4

0.04

e9/l

1.43

1679

15200

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

553

4706

1.21

3.88

5.7

5.4

32.75

33.38

0.67

374

2957

(3025941) Bacteria identified in Stool by Culture

218

1663

1.33

3.87

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

269

2115

1.29

3.84

2.3

2.7

0.63

0.62

0.50

269

2102

(3013115) Eosinophils [#/volume] in Blood

1980

18577

1.14

3.82

5.5

6.6

0.19

e9/l

1.02

1741

15921

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.54

3.79

1.2

1.1

0.70

0.74

umol/24h

0.15

(3045788) Cell count panel - Pleural fluid

453

0.42

3.79

1.5

—

(3045424) Erythrocytes [Presence] in Urine

245

1913

1.30

3.69

2.3

2.2

0.00

0.44

estimate

0.50

575

(3001604) Monocytes [#/volume] in Blood

1919

17996

1.14

3.67

5.4

6.4

0.56

0.60

e9/l

11.56

1666

15129

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

335

1.71

3.64

1.2

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1174

10667

1.15

3.62

3.5

3.4

0.17

0.48

e6/l

21.06

914

7904

(1761868) Lipid panel - Serum or Plasma

1189

10813

1.15

3.62

3.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

105

716

1.48

3.60

1.2

1.1

6.94

9.21

eliau/ml

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

177

1.99

3.58

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

268

2128

1.28

3.56

2.4

2.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

729

6418

1.17

3.44

1.4

1.3

28.80

36.12

iu/ml

1.12

217

1982

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

2.00

3.43

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

139

1009

1.39

3.42

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

196

1.90

3.33

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

311

2535

1.25

3.33

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

109

764

1.44

3.28

1.1

5.83

4.15

0.31

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

149

1980

0.74

3.19

1.8

1.7

1.41

1.56

g/l

1.21

119

1720

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

683

6036

1.16

3.05

1.3

9.40

13.24

u/ml

0.86

260

2180

(3003327) Ova and parasites identified in Stool by Light microscopy

142

1057

1.36

3.04

1.6

1.7

—

(40768806) Pleura Pathology biopsy report

462

0.49

2.97

1.6

—

(36304419) Bacteria [Presence] in Urine

1098

10046

1.13

2.95

3.4

0.00

281.72

estimate

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

206

1628

1.28

2.89

1.3

—

(40762814) Titanium [Mass/volume] in Blood

2.51

2.87

2.3

2.5

2.52

4.32

ug/l

—

(3025577) Chromium [Mass/volume] in Blood

252

1.71

2.84

2.3

2.05

2.28

ug/l

0.23

212

(3005322) IgE [Units/volume] in Serum or Plasma

248

2011

1.25

2.82

1.3

121.32

198.88

u/ml

2.77

239

1849

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

768

0.62

2.80

3.9

18.74

38.99

u/ml

2.54

749

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.08

2.77

1.1

1.2

1.64

1.79

umol/24h

0.33

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

231

1864

1.25

2.75

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

475

0.52

2.75

1.3

1.4

67555.06

73202.95

e6/l

0.07

259

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

897

0.65

2.74

2.1

2.3

176.38

87.10

ug/min

0.55

517

(3010838) Calcium [Moles/time] in 24 hour Urine

691

1.41

2.73

1.8

1.9

5.33

4.62

mmol/24h

1.27

597

(4024509) Urine culture

238

1933

1.25

2.68

2.1

—

(3014051) Protein [Presence] in Urine by Test strip

1043

9574

1.12

2.61

3.1

3.3

0.01

0.05

1.54

294

(4035726) Immunohistochemistry procedure

314

3703

0.83

2.47

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

137

1.90

2.45

1.2

1.4

164.44

159.34

pmol/l

0.08

137

(3007164) IgA [Mass/volume] in Serum or Plasma

720

6488

1.14

2.42

1.4

1.5

2.26

2.56

g/l

3.91

400

3754

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.09

2.42

1.1

1.3

—

13.61

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

425

1.49

2.39

2.1

2.4

1.20

mmol/l

0.11

418

(40758558) Short blood count panel - Blood

1191

11068

1.11

2.36

5.6

6.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

476

1.46

2.35

1.1

12.49

25.78

au/ml

1.16

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

125

1.93

2.35

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

147

1147

1.29

2.34

3.6

6.1

1.27

1.29

mmol/l

0.06

126

1012

(3022145) Colonoscopy Study observation

490

4327

1.15

2.23

1.3

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

635

1.38

2.19

1.3

1.4

41.42

36.32

iu/l

0.63

535

(3041354) Potassium [Moles/volume] in Venous blood

434

1.46

2.18

2.1

2.4

4.01

4.07

mmol/l

0.59

427

(3035285) Chloride [Moles/volume] in Venous blood

434

1.46

2.18

2.1

2.4

107.35

105.31

mmol/l

5.29

427

(4027681) Cerebrospinal fluid IgG ratio and IgG index

137

1.83

2.13

1.3

1.2

0.50

0.53

ratio

0.30

(3036489) Thrombin time

160

1280

1.26

2.12

1.9

20.32

21.34

1.61

138

1146

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

157

1254

1.26

2.11

1.5

1.6

22.94

24.52

u/ml

0.07

207

(3049717) Cytology report of Urine Cyto stain

184

1501

1.24

2.06

2.5

2.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

157

1258

1.26

2.06

1.6

1.4

288.62

265.58

ug/g

0.85

104

778

(3023410) Appearance of Cerebral spinal fluid

285

1.55

2.05

1.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

340

0.53

2.02

1.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1101

0.74

1.99

1.5

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

524

0.63

1.96

2.6

2.1

3.30

863.67

u/ml

0.92

514

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

246

2897

0.84

1.95

1.5

1.8

1.48

1.53

0.52

209

2455

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

125

1579

0.78

1.94

2.8

2.4

10.25

10.27

g/l

0.02

103

1413

(3019832) Treponema pallidum Ab [Presence] in Serum

128

1010

1.28

1.92

1.4

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.12

1.92

1.3

1.30

151.81

mg/l

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

489

1.40

1.91

1.3

—

nmol/l

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

219

1838

1.20

1.88

3.5

5.0

1.50

1.56

0.73

213

1744

(3008152) Bicarbonate [Moles/volume] in Arterial blood

293

2526

1.17

1.86

5.9

6.9

24.57

24.63

mmol/l

0.12

284

2419

(3026782) Osmolality of Urine

790

7269

1.11

1.85

2.9

3.1

529.05

514.01

mosm/kgh2o

1.22

702

6339

(3007930) Methemoglobin/Hemoglobin.total in Blood

203

1695

1.21

1.84

3.6

5.2

0.88

0.87

0.24

196

1605

(40768443) Skin Pathology biopsy report

213

1790

1.20

1.81

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

435

1.41

1.81

1.6

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

385

1.43

1.81

1.6

1.7

—

(40768441) Liver Pathology biopsy report

275

0.51

1.81

1.4

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

375

0.58

1.77

1.2

1.3

1.32

1.57

nmol/l

0.91

335

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1222

0.77

1.74

3.2

2.4

0.00

g/l

-0.00

1156

(3009214) Lutropin [Units/volume] in Serum or Plasma

501

1.36

1.69

1.5

1.3

9.43

12.74

u/l

1.58

400

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

531

5848

0.89

1.66

2.4

2.7

23.32

21.58

1.97

480

5451

(3021387) Prolactin [Units/volume] in Serum or Plasma

495

1.36

1.64

2.5

1.7

252.40

303.59

mu/l

0.77

454

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

918

0.75

1.63

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

518

4691

1.12

1.63

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

168

2011

0.83

1.63

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

360

1.42

1.63

1.2

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

732

6754

1.10

1.63

3.2

3.1

1.03

1.61

e6/l

0.69

434

3689

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

113

1409

0.80

1.62

3.4

3.2

8.27

4.36

ratio

0.36

804

(3017143) Hepatitis C virus Ab [Presence] in Serum

261

3007

0.86

1.62

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

129

1584

0.81

1.61

3.5

3.4

38.84

58.79

mg/l

1.02

112

1361

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

711

6554

1.10

1.61

1.9

—

(3044007) Cell count panel - Peritoneal fluid

133

0.38

1.61

1.2

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

697

1.30

1.61

1.5

—

(4281824) Cell count and differential, peritoneal fluid

486

0.66

1.61

1.1

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1843

0.82

1.59

2.6

2.4

4.19

4.22

g/l

0.19

133

1692

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1843

0.82

1.59

2.6

2.4

7.26

7.53

g/l

1.32

132

1692

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

214

1.55

1.59

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

375

3335

1.14

1.59

3.3

3.1

139.90

212.78

ng/l

4.07

355

3062

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

834

0.74

1.59

1.4

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1271

12037

1.08

1.58

2.3

2.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1841

0.82

1.58

2.6

2.4

3.29

3.72

g/l

6.28

133

1692

(3028707) Methadone [Presence] in Urine by Screen method

144

1.67

1.57

2.7

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

130

1588

0.81

1.56

3.5

3.4

48.43

91.53

mg/l

0.65

112

1366

(3020779) Urea [Moles/volume] in Serum or Plasma

331

3735

0.88

1.55

6.2

7.0

8.94

10.62

mmol/l

5.42

322

3580

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

217

2524

0.85

1.53

7.4

9.0

24.61

24.35

mmol/l

0.67

211

2482

(3015171) Extractable nuclear Ab [Units/volume] in Serum

164

1370

1.21

1.53

1.3

1.2

0.82

1.39

u/ml

0.47

125

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

1.52

0.0

1.2

—

8.95

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

442

1.36

1.52

1.1

1.3

—

(3006504) Eosinophils/Leukocytes in Blood

1733

16634

1.08

1.51

5.5

6.6

2.90

2.85

0.46

1612

15498

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

217

1.53

1.51

1.3

1.2

—

(3022621) pH of Urine by Test strip

321

2837

1.14

1.50

2.7

2.9

6.11

6.05

0.50

228

1978

(3035933) Granulocytes/Leukocytes in Blood

769

0.74

1.50

3.0

3.5

55.61

58.35

0.87

769

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

134

1624

0.82

1.50

3.1

3.4

980.03

3523.00

u/ml

0.78

109

1385

(3001893) Eosinophils/Leukocytes in Pleural fluid

128

0.39

1.49

1.4

1.5

0.40

3.11

—

109

(3004789) Transferrin [Mass/volume] in Serum or Plasma

576

6276

0.90

1.49

2.4

2.7

2.34

2.29

g/l

1.34

521

5801

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

487

1.34

1.48

1.8

2.3

41.27

22.30

mg/l

1.07

179

(3012501) Base excess in Blood by calculation

801

0.74

1.48

4.1

4.6

2.30

2.84

mmol/l

1.04

573

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

338

3005

1.14

1.46

1.5

—

(3022096) Basophils/Leukocytes in Blood

1731

16637

1.08

1.44

5.6

6.7

0.69

0.68

0.36

1603

15493

(3000494) Fungus identified in Specimen by Culture

485

4411

1.11

1.43

1.4

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.73

1.43

1.0

1.4

—

(3019069) Monocytes/Leukocytes in Blood

1735

16682

1.07

1.42

5.6

6.7

8.96

9.08

1.05

1612

15536

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

349

3898

0.88

1.41

2.2

0.21

0.20

g/l

0.70

317

3656

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

426

4701

0.89

1.40

4.1

4.3

10.29

25.43

ug/l

2.47

357

3864

(1002224) Polysomnography panel

138

1146

1.21

1.39

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

390

1.36

1.37

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

150

1.60

1.37

3.8

4.8

80.64

59.31

mg/l

0.69

106

(3018010) Neutrophils/Leukocytes in Blood

1720

16548

1.07

1.37

5.5

6.5

56.80

57.72

2.58

1631

15744

(3012544) pH of Venous blood

454

4126

1.11

1.37

3.3

3.7

7.39

7.38

2.20

266

2338

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

231

1.48

1.36

1.4

1.5

0.20

nmol/l

0.01

156

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

301

3385

0.88

1.36

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

132

1096

1.21

1.34

4.3

4.2

3.86

3.88

mmol/l

0.34

132

1088

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

1.34

0.0

1.0

—

11.64

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

143

1197

1.20

1.34

1.2

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

116

1406

0.82

1.33

3.6

3.0

0.36

0.35

iu/ml

0.27

792

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

179

1532

1.18

1.31

1.9

1.8

3.28

3.47

mmol/l

1.41

121

1116

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

233

1.46

1.31

2.1

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

539

4955

1.10

1.31

1.9

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

232

0.56

1.30

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

520

0.71

1.29

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

722

1.25

1.27

1.3

1.2

240.00

383.33

titre

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

1.27

1.3

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

1.27

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

194

1.50

1.26

1.4

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

362

1.36

1.26

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1080

0.80

1.26

2.4

2.8

1.57

1.70

mg/l

0.79

968

(3033658) Prothrombin time (PT) actual/Normal

1000

9458

1.08

1.26

3.8

4.2

89.54

88.10

1.05

985

9249

(3002030) Lymphocytes/Leukocytes in Blood

1753

16911

1.07

1.26

5.6

6.7

27.72

26.97

2.01

1652

15926

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

254

0.59

1.25

1.5

1.6

—

(3014271) Vancomycin [Susceptibility]

188

1.49

1.21

3.4

2.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.80

1.21

1.1

1.5

1.17

1.18

mmol/l

0.09

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

109

1312

0.83

1.19

3.1

2.4

0.00

g/l

0.49

1156

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

298

0.64

1.17

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

496

5375

0.91

1.17

5.0

5.8

1.01

1.04

mmol/l

1.95

463

5003

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

141

1.56

1.17

1.0

1.1

395.33

369.77

ng/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

115

959

1.21

1.16

1.6

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.05

1.15

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.15

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

148

1727

0.85

1.15

2.6

2.4

2.65

2.97

g/l

4.73

127

1578

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

1.15

0.0

1.6

—

52.93

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

115

960

1.20

1.15

1.2

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

499

4604

1.10

1.14

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

439

1.30

1.14

3.1

5.4

6.91

7.30

mmol/l

0.45

373

(44786800) Granulocytes/Leukocytes in Body fluid

0.00

1.14

0.0

1.4

—

13.71

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.69

1.13

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

510

1.28

1.13

1.2

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1150

0.82

1.12

1.4

1.6

0.24

0.34

mg/l

1.38

499

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

159

1.51

1.11

1.1

1.52

1.19

u/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

327

3607

0.90

1.10

1.5

—

(44813793) Dust mix specific IgE antibody measurement

209

1.44

1.10

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

187

2135

0.87

1.10

3.9

4.5

29.43

93.45

u/ml

5.75

179

2058

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

155

1335

1.17

1.09

1.7

1.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.0

—

(3002032) Base excess in Venous blood by calculation

430

3950

1.10

1.09

3.2

3.7

1.94

1.90

mmol/l

0.09

389

3486

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

246

2191

1.13

1.09

2.2

2.1

3.27

3.42

ratio

1.18

188

1780

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

355

1.33

1.08

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

128

1.57

1.08

1.7

1.5

79.08

106.50

umol/l

0.38

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

243

0.62

1.08

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

547

0.75

1.08

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

211

1.43

1.06

6.8

6.7

3.45

106.16

ug/l

0.64

127

(3005570) Glucose [Moles/volume] in Urine

348

1.33

1.05

1.8

2.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

212

1.42

1.03

2.7

1.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.96

1.03

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

1.03

1.0

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

276

0.65

1.03

1.3

1.2

—

84.29

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

150

0.53

1.03

1.3

1.5

71.50

66.30

—

124

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

139

1612

0.86

1.02

2.7

2.4

1.31

0.98

g/l

0.34

111

1394

(3029075) Extractable nuclear Ab panel - Serum

215

0.60

1.02

1.0

1.1

—

(3008898) HLA-B27 [Presence]

100

836

1.20

1.01

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

466

1.27

1.00

1.8

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

585

0.77

1.00

1.8

1.6

0.57

0.84

g/l

1.69

448

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

274

0.66

1.00

1.4

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

730

0.79

1.00

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

730

0.79

1.00

1.3

—

(4212803) Bone marrow aspirate examination

2.00

1.00

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.84

0.98

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

539

1.25

0.98

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

972

9264

1.07

0.98

2.2

2.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.81

0.98

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

504

0.75

0.98

1.3

315.73

193.84

miu/ml

0.66

185

(3022948) Iron [Moles/volume] in Serum or Plasma

628

6677

0.93

0.96

2.4

2.7

13.21

12.27

umol/l

2.52

567

6224

(3029634) Reagin Ab [Titer] in Serum by VDRL

337

1.31

0.95

1.7

1.8

—

3.80

—

(3002256) Pathology report gross observation

552

5163

1.08

0.95

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

328

0.70

0.93

1.5

1.6

—

(3021589) Normoblasts [#/volume] in Blood

1607

15577

1.06

0.91

11.4

12.6

0.00

e9/l

2.46

1361

12628

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

151

1.46

0.90

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

241

2174

1.12

0.90

2.7

3.7

1.68

2.07

mmol/l

1.10

188

1649

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

462

0.76

0.89

1.1

244.59

70.76

iu/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

278

0.68

0.89

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

870

0.82

0.88

1.6

—

(4198724) Urine methamphetamine measurement

1.86

0.87

2.4

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

118

1363

0.86

2.9

2.4

0.03

0.04

g/l

0.06

100

1232

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1041

0.84

0.86

2.3

3.43

3.63

g/l

0.66

994

(1616796) Gas panel - Central venous blood

900

0.83

0.86

3.5

4.2

—

(3042936) Bacteria identified in Isolate by Culture

506

5397

0.93

0.85

1.9

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

201

2235

0.89

0.83

2.2

1.9

1.41

1.36

g/l

0.09

181

2037

(40765096) Chromosome analysis panel by Banding

137

0.58

0.83

1.0

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

343

3711

0.92

0.83

2.4

2.7

66.13

66.25

g/l

0.10

304

3404

(3009343) pH of Capillary blood

276

2522

1.10

0.82

2.8

3.8

7.42

0.19

233

2088

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

114

0.53

0.82

1.2

1.3

—

176.48

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.74

0.82

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

163

1446

1.13

0.82

1.8

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

283

2592

1.10

0.81

2.9

3.8

5.08

5.15

kpa

0.90

269

2499

(3025468) Yersinia sp identified in Specimen by Organism specific culture

481

1.23

0.81

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

400

1.25

0.81

1.1

2.34

3.08

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

122

1.48

0.80

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.78

0.0

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

295

1.29

0.78

1.1

1.2

40.60

62.42

u/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.56

0.78

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.51

0.77

1.6

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

517

0.79

0.77

1.5

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

503

1.22

0.76

1.2

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

558

1.20

0.76

1.2

1.52

1.56

g/l

0.55

558

(3014133) Dog dander IgE Ab [Units/volume] in Serum

244

1.31

0.75

1.0

1.1

2.18

1.91

u/ml

0.08

119

(3032057) Clostridioides difficile [Presence] in Stool

1.60

0.74

1.8

1.9

—

(3037756) Immunofixation for Serum or Plasma

949

0.85

0.74

1.9

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

505

1.21

0.74

1.2

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

280

1.29

0.74

1.5

1.6

—

1373.33

—

(21494434) Karyotype in Bone marrow

380

0.76

0.73

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

133

1.43

0.73

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

263

1.30

0.73

1.7

2.0

38.64

38.85

0.03

258

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

2.00

0.72

1.4

1.1

—

29.50

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

107

0.56

0.72

1.5

1.4

21.48

25.73

g/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

220

1.32

0.71

2.3

1.6

19.53

178.56

u/l

—

(3004616) Nuclear Ab [Presence] in Serum

462

1.22

0.71

1.1

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

435

1.22

0.70

1.2

1.3

74.72

47.90

u/ml

—

(3023520) Reticulocytes [#/volume] in Blood

353

3782

0.93

0.70

2.6

69.72

69.82

e9/l

0.02

280

2747

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

193

0.67

0.69

1.4

1.1

—

(21494755) Public health laboratory ask at order entry panel

163

1466

1.12

0.69

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

169

0.65

0.69

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.53

0.69

1.2

90.71

86.49

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.85

0.68

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.85

0.68

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

483

1.20

0.68

1.3

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

102

1.47

0.67

1.1

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

982

0.86

0.67

1.1

1.2

104.00

101.73

titre

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.54

0.67

1.0

1.3

110.80

110.84

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

191

0.68

0.66

1.8

1.6

44.40

39.98

g/l

3.26

191

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

339

1.24

0.66

1.2

42.80

71.00

u/ml

—

(3044009) aPTT.lupus sensitive (LA screen)

1.79

0.66

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

314

2923

1.08

0.66

1.5

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.59

0.65

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

486

1.20

0.64

1.3

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

450

4763

0.94

0.64

2.4

2.5

1.71

1.83

2.00

403

4249

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.48

0.64

1.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

457

4832

0.94

0.63

4.4

245.03

246.63

u/l

0.10

434

4586

(3042631) Mycobacterium sp identified in Specimen

579

0.83

0.63

2.0

3.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.50

0.63

1.3

1.4

94.14

83.33

—

(3044941) Cell count panel - Synovial fluid

730

1.15

0.62

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

208

1.30

0.62

1.6

78.44

83.96

umol/l

0.70

208

(3022313) Gas panel - Capillary blood

194

1775

1.10

0.61

2.7

3.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.61

1.0

1.1

—

(3023368) Bacteria identified in Blood by Culture

1107

10727

1.05

0.61

3.9

4.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1002

9689

1.05

0.61

2.6

2.9

338.67

347.92

umol/l

2.28

872

8396

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

141

0.64

0.60

3.1

2.6

0.58

0.61

mmol/l

—

141

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.3

—

347.62

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

236

1.27

0.59

1.0

1.1

1.35

2.03

u/ml

0.29

106

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

228

2106

1.09

0.59

3.3

4.33

4.41

pmol/l

0.54

201

1853

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

308

1.24

0.59

5.9

5.4

256.30

79.01

u/ml

0.51

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

865

1.14

0.59

1.3

1.2

1.92

6.71

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.44

0.59

1.0

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1174

11403

1.04

0.58

3.1

3.3

35.95

35.85

u/l

0.01

1098

10698

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.9

—

21.94

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.58

0.0

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

115

1028

1.12

0.57

1.6

13034.39

11452.85

e6/l

0.21

710

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

211

1.28

0.57

1.2

1.1

7.94

11.36

iu/ml

—

(3017569) Oxygen content in Arterial blood

240

0.75

0.55

2.1

2.3

15.15

15.87

0.46

240

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

523

1.17

0.55

1.4

1.3

0.19

nmol/l

0.03

417

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

239

1.26

0.55

1.5

1.3

4.04

1.59

u/ml

0.44

143

(40768795) Lymph node Pathology biopsy report

417

0.81

0.55

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

622

0.85

0.54

1.2

—

(3020650) Glucose [Presence] in Urine

116

1.38

0.54

3.4

1.9

0.00

0.08

estimate

1.08

116

(3027135) IgG subclass 1 [Mass/volume] in Serum

361

0.80

0.53

2.2

1.3

5.88

7.15

g/l

1.53

261

(3024139) IgG subclass 3 [Mass/volume] in Serum

361

0.80

0.53

2.2

1.3

0.56

0.43

g/l

0.25

263

(3028192) IgG subclass 2 [Mass/volume] in Serum

361

0.80

0.53

2.2

1.3

2.66

2.90

g/l

0.45

262

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

632

0.85

0.53

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.48

0.53

1.0

1.4

—

(3003694) ABO and Rh group [Type] in Blood

933

9037

1.04

0.53

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

433

1.18

0.52

1.2

1.1

123.70

117.00

0.68

380

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.62

0.52

1.0

1.3

0.28

0.30

g/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

468

0.83

0.51

2.1

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

100

1.40

0.51

2.0

1.5

8.37

9.70

ug/l

0.62

100

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.50

0.51

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1011

0.89

0.51

4.4

3.3

0.78

0.83

nmol/l

0.73

823

(3003181) Sodium [Moles/volume] in Urine

873

0.88

0.51

1.4

65.69

59.61

mmol/l

0.54

709

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

324

1.21

0.50

1.2

1.1

1.97

2.57

eliau/ml

0.18

102

(3024869) Neuronal Ab [Presence] in Serum

1.39

0.50

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

713

0.87

0.50

1.4

1.6

—

(3045142) Bone marrow Pathology biopsy report

488

0.84

0.50

1.1

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

435

1.17

0.50

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

491

1.16

0.50

1.2

0.64

0.62

ratio

0.13

(1761482) Bacteria [#/volume] in Urine by Culture

104

934

1.12

0.50

3.7

4.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

118

1.36

0.50

1.0

1.1

95.36

91.56

0.28

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

454

1.17

0.50

1.2

5.43

5.56

u/ml

0.02

199

(1001926) Buprenorphine [Presence] in Urine by Screen method

243

1.24

0.49

2.4

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

145

1.31

0.48

1.1

1.6

1.96

1.94

umol/l

0.04

130

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.49

0.47

1.3

1.4

—

(40768793) Breast Pathology biopsy report

1057

0.90

0.47

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

272

1.22

0.47

1.2

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

244

0.78

0.47

1.5

1.7

—

(3036603) Volume of Urine

299

0.80

0.46

1.6

1.5

2019.54

1827.49

0.47

293

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

101

913

1.11

0.45

1.6

1.7

4.01

4.64

mg/l

0.25

698

(3010503) CD19 cells [#/volume] in Blood

210

1.24

0.45

2.2

2.1

85.31

133.23

e6/l

0.97

201

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

998

0.90

0.43

1.4

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

106

963

1.10

0.43

2.1

2.4

133.24

126.56

g/l

2.32

731

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

146

1347

1.09

0.43

2.8

4.0

24.95

24.97

mmol/l

0.02

129

1241

(3002079) Sodium [Moles/time] in 24 hour Urine

157

1.28

0.43

1.2

1.3

126.40

158.77

mmol/24h

2.20

157

(3022689) Creatine [Moles/volume] in Urine

128

0.70

0.43

1.2

1.4

7.56

7.19

mmol/l

—

128

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

104

1.35

0.43

1.2

1.5

10.93

11.76

mm/h

0.17

104

(3050794) Legionella sp Ab [Presence] in Serum

1.61

0.43

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

102

926

1.10

0.42

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

322

1.18

0.42

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

322

1.18

0.42

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

322

1.18

0.42

1.4

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

221

1.22

0.42

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

378

1.17

0.42

1.2

1.4

121162.29

117082.95

e6/l

0.02

250

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

267

1.20

0.42

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

1.43

0.41

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

444

1.15

0.41

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

388

1.16

0.41

3.0

4.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

224

2380

0.94

0.41

6.9

9.5

16.37

15.80

2.73

216

2300

(3020491) Glucose [Moles/volume] in Blood

240

1.21

0.41

1.2

2.4

6.71

6.85

mmol/l

0.16

157

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

2.69

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

108

986

1.10

0.41

1.5

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1004

0.90

0.41

1.7

1.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

337

0.83

0.41

1.5

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.40

0.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

271

0.81

0.40

1.1

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.40

0.0

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.40

0.0

1.8

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.39

0.0

1.0

—

(4195642) Thrombophilia screening test

419

1.15

0.38

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.38

0.38

1.0

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

631

6113

1.04

0.38

3.5

3.3

2.41

2.54

e6/l

0.14

327

3033

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

376

0.85

0.37

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

152

1.25

0.37

1.2

1.4

5.31

8.89

umol/l

1.32

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

134

1.27

0.36

1.2

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

134

1.27

0.36

1.2

1.1

143.26

227.27

iu/ml

1.04

134

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

442

4255

1.04

0.36

2.8

2.7

8.82

8.76

umol/l

0.02

392

3736

(3014765) Yersinia sp identified in Stool by Organism specific culture

102

936

1.09

0.36

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

744

0.90

0.35

1.3

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

125

0.72

0.35

2.3

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

157

1473

1.07

0.33

1.8

1.7

9.27

7.33

iu/ml

0.24

362

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

529

1.12

0.33

1.6

1.3

293.54

350.48

pmol/l

0.47

448

(3025130) Human papilloma virus identified in Specimen

350

0.86

0.33

1.6

1.8

—

(3012565) Volume of 24 hour Urine

188

0.80

0.33

2.2

2.4

1961.80

1861.57

0.13

164

(3036071) Salmonella sp Ab [Titer] in Serum

0.70

0.33

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.69

0.33

2.5

3.33

73.73

ug/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

102

942

1.09

0.33

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

397

1.14

0.33

1.4

1.6

—

(3002619) Bacteria identified in Specimen by Culture

0.67

0.33

2.2

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

770

0.91

0.32

1.2

27.35

48.29

u/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

454

0.88

0.31

1.2

1.6

53.93

28.03

ng/l

0.44

454

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1027

0.92

0.31

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

305

1.15

0.30

1.5

1.9

1.29

1.49

u/field

0.11

152

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

283

0.85

0.30

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

283

0.85

0.30

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

147

1.23

0.30

2.1

2.0

34.83

31.00

0.43

147

(3024891) Influenza virus A+B Ag [Presence] in Specimen

693

0.91

0.30

1.1

1.2

—

(3033099) Centromere Ab [Titer] in Serum

1.31

0.30

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

163

1541

1.06

0.29

2.4

1.8

40.84

39.38

u/l

0.39

151

1345

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

288

1.15

0.29

1.7

91.36

107.68

ng/l

0.62

288

(3012516) Albumin [Mass/volume] in Urine

1318

13381

0.98

0.28

3.0

3.5

33.06

44.82

mg/l

1.28

761

8325

(3004716) Salmonella sp identified in Stool by Organism specific culture

137

1290

1.06

0.28

1.4

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.29

0.28

1.8

2.4

1.72

2.30

ratio

0.69

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.27

0.27

9.3

7.1

9.64

10.50

—

(40768800) Prostate Pathology biopsy report

729

1.09

0.27

1.3

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

117

1097

1.07

0.27

1.5

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

751

0.92

0.27

3.4

3.7

31.12

27.56

mg/l

0.31

514

(3020911) Cortisol [Moles/time] in 24 hour Urine

120

0.75

0.27

1.1

1.5

75.44

360.26

nmol/24h

—

120

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

169

1.18

0.25

1.5

1.6

5.00

2.04

u/field

0.67

109

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

197

1.17

0.25

2.2

2.5

35.31

38.89

0.32

110

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

108

1014

1.07

0.25

1.2

1.3

3.18

2.58

u/ml

0.17

105

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.22

0.25

1.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

377

3657

1.03

0.24

5.2

7.3

1.25

1.32

mmol/l

1.07

368

3591

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

276

0.87

0.24

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

137

1299

1.06

0.24

3.1

3.0

314.56

381.29

mg/l

0.33

548

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

716

1.08

0.23

1.2

1.3

15.23

36.94

u/l

4.21

615

(3044242) Glucose [Moles/volume] in Arterial blood

233

0.86

0.23

1.8

2.1

7.29

8.05

mmol/l

0.57

233

(3036481) Cortisol [Moles/volume] in Serum or Plasma

346

3354

1.03

0.23

2.4

368.27

381.78

nmol/l

0.62

320

3097

(3000330) Specific gravity of Urine by Test strip

207

1986

1.04

0.23

3.4

3.6

1.02

ratio

0.33

193

1797

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

744

0.93

0.23

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

413

4018

1.03

0.23

6.2

8.2

122.10

119.60

g/l

1.86

404

3928

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

190

1.16

0.23

2.3

3.1

1.91

1.23

0.76

190

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

141

1482

0.95

0.23

2.8

2.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

949

0.94

0.23

2.5

2.3

161.69

206.89

6.89

905

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

181

1.16

0.22

1.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

181

1.16

0.22

1.3

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

181

1.16

0.22

1.3

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

181

1.16

0.22

1.3

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.77

0.22

1.3

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.25

0.22

1.0

1.1

103.58

77.20

ug/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

153

1.18

0.22

1.1

56.04

17.76

u/ml

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

332

3221

1.03

0.22

3.6

4.1

1.23

mmol/l

0.58

278

2796

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

116

1.21

0.22

2.0

1.8

12.51

62.72

u/l

1.63

110

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

134

1275

1.05

0.21

1.2

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

372

1.10

0.21

1.5

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

210

1.14

0.21

1.2

7.65

9.67

mmol/l

2.27

195

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

163

1.17

0.21

2.6

2.2

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

17.45

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.8

—

2.92

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

523

0.92

0.21

2.4

2.2

0.85

1.14

g/24h

0.57

300

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.02

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.5

—

(3011985) Renin [Units/volume] in Plasma

575

1.08

0.21

1.6

1.4

36.28

65.70

mu/l

1.11

510

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.54

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.21

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.25

0.20

7.6

7.9

4.75

5.42

kpa

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.20

0.0

1.1

—

5.05

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.25

0.20

1.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

136

1.18

0.20

1.4

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

136

1.18

0.20

1.4

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.20

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

144

0.83

0.19

1.5

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

174

1.15

0.19

1.6

1.2

141.40

139.22

nmol/l

0.06

174

(3027923) C peptide [Moles/volume] in Serum or Plasma

197

0.86

0.19

1.4

1.3

0.95

1.15

nmol/l

0.45

140

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.18

0.19

2.7

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

312

0.90

0.19

1.1

0.76

1.10

u/ml

—

129

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

180

1733

1.04

0.19

1.8

1.9

3.04

2.23

ug/l

0.32

155

1549

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

982

0.95

0.19

3.2

3.4

94.61

840.71

u/ml

1.95

894

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

395

1.09

0.18

1.2

1.1

1.19

1.29

u/ml

0.07

221

(3042733) HLA Ab [Presence] in Serum

1.24

0.18

8.0

4.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

766

0.94

0.18

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1342

13561

0.98

0.18

3.5

4.2

5.47

8.50

mg/mmol

2.46

737

8191

(3043410) Blood group antigens tested for on Red Blood Cells

100

1.20

0.18

1.9

—

(3016228) CD19 cells/cells in Blood

147

1.16

0.18

2.2

1.9

5.35

7.87

0.68

142

(3006462) Nitrate [Presence] in Urine

166

1.15

0.18

3.7

4.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

138

1.16

0.17

1.4

1.7

—

(3039000) Anion gap in Blood by calculation

815

1.06

0.17

4.6

7.0

11.54

11.11

mmol/l

0.59

726

(3018572) Chloride [Moles/volume] in Blood

815

1.06

0.17

4.6

7.0

104.78

105.06

mmol/l

0.26

727

(40759836) Histone Ab [Presence] in Serum by Immunoblot

289

0.90

0.17

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

268

0.89

0.17

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

351

0.91

0.17

1.7

1.6

14.63

20.82

u/ml

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

299

0.90

0.17

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.11

0.17

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

272

1.10

0.17

2.5

3.0

36.10

30.51

mg/l

0.22

204

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

129

1.16

0.17

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

198

2045

0.97

0.17

1.3

1.2

116.78

137.07

u/ml

0.41

739

(3048929) Epstein Barr virus Ab [Presence] in Serum

699

1.06

0.17

1.2

—

(4268621) Lupus anticoagulant assay

340

1.09

0.16

2.3

2.2

—

(40768446) Kidney Pathology biopsy report

120

1.17

0.16

1.1

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

158

1.14

0.16

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

1014

1.05

0.16

1.3

6.20

6.05

u/ml

0.02

167

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

101

1056

0.96

0.15

1.6

1.5

1.22

0.16

iu/ml

0.62

200

(3024263) Appearance of Synovial fluid

197

1.12

0.15

1.5

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

507

1.07

0.15

1.2

290.55

290.72

u/ml

0.00

294

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.10

0.15

2.6

1.6

—

(3006270) Folate [Moles/volume] in Blood

265

0.91

0.15

1.0

1.2

358.12

354.73

nmol/l

0.02

217

(40761536) Microorganisms panel - Urine sediment

275

2816

0.97

0.14

4.6

4.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

995

9845

1.01

0.14

2.4

2.96

2.94

mg/l

0.05

870

8502

(3047189) Immunofixation for 24 hour Urine

212

0.90

0.14

1.7

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.19

0.14

1.1

1.3

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

0.83

0.13

1.4

15.25

23.61

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

122

1.15

0.13

2.5

1.9

1.52

1.79

ratio

0.40

117

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.82

0.13

1.3

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

449

0.93

0.13

1.2

1.6

67.92

59.25

0.84

283

(3002523) Influenza virus A Ag [Presence] in Specimen

344

1.08

0.13

1.1

—

(4062490) Immunoglobulin typing, IgG

356

0.93

0.13

2.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

598

1.05

0.13

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

693

0.95

0.12

1.2

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

407

4002

1.02

0.12

3.1

3.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

262

0.92

0.12

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

297

1.08

0.12

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

346

1.07

0.12

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

189

0.90

0.12

1.2

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

116

0.86

0.12

10.0

6.4

26.25

24.75

mmol/l

—

103

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

331

3251

1.02

0.11

3.3

3.8

85.19

94.85

ng/l

1.14

280

2750

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

168

0.89

0.11

1.1

1.5

29.07

29.62

umol/l

0.07

156

(3044927) Protein electrophoresis panel - Urine

425

1.06

0.11

1.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

209

0.91

0.11

2.7

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

209

0.91

0.11

2.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

486

0.95

0.11

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

486

0.95

0.11

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

486

0.95

0.11

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

486

0.95

0.11

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

111

1075

1.03

0.11

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

882

0.96

0.11

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

167

0.90

0.10

1.4

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

164

1681

0.97

0.10

2.0

1.5

23.95

18.65

iu/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

464

0.95

0.10

2.0

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.14

0.10

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

467

1.05

0.09

1.2

1.40

3.65

u/ml

2.09

154

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

330

0.94

0.09

1.2

—

(3003129) Base excess in Capillary blood by calculation

483

0.95

0.09

2.4

0.44

0.52

mmol/l

0.04

470

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

554

0.96

0.09

2.0

17.09

25.02

ug/l

2.19

544

(3000034) Microalbumin [Mass/volume] in Urine

340

0.94

0.09

2.1

2.9

7.84

28.09

mg/l

2.60

247

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.04

0.09

1.0

1.1

6.15

6.41

u/ml

—

(3034426) Prothrombin time (PT)

1.13

0.09

1.3

30.00

28.61

0.35

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.13

0.09

1.5

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

483

4777

1.01

0.08

1.3

466.80

552.12

titre

0.60

100

1111

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.05

0.08

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

351

1.05

0.08

1.1

1.2

6.80

7.67

mmol/l

1.31

297

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

365

3604

1.01

0.08

2.4

2.5

41.86

41.20

u/l

0.05

319

3022

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

430

1.05

0.08

3.5

3.9

—

(3000764) Benzodiazepines [Presence] in Urine

332

1.05

0.08

2.2

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.06

0.08

1.4

1.8

9.87

8.74

mg/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.82

0.07

1.2

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.07

0.07

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

184

0.92

0.07

1.1

—

(3024932) HLA-DR beta [Type]

1.03

0.07

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1353

13593

0.99

0.07

3.0

3.4

7.07

6.92

mmol/l

0.75

1121

11299

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

639

1.03

0.07

1.4

0.81

0.83

nmol/l

0.09

534

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

118

1.10

0.07

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

118

1.10

0.07

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

118

1.10

0.07

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

118

1.10

0.07

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1004

0.98

0.07

1.2

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

122

0.90

0.07

1.3

1.5

2.79

3.14

mmol/l

0.14

115

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

531

1.04

0.07

1.3

174.71

157.15

au/ml

—

150

(3004809) Band form neutrophils/Leukocytes in Blood

711

0.97

0.07

3.3

3.9

1.77

1.57

0.21

635

(3052851) Hemolysis interference index of Serum or Plasma

103

1054

0.98

0.06

3.2

3.6

3.83

1.99

index

0.52

548

(3023419) Bacteria identified in Sputum by Culture

561

1.03

0.06

2.3

2.6

—

(3025159) Blasts/Leukocytes in Blood

335

3387

0.99

0.06

4.4

4.6

0.09

0.18

0.53

912

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

236

1.06

0.06

1.3

26.39

40.92

u/l

1.01

192

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

256

1.06

0.06

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

335

1.05

0.06

2.3

1.4

—

(3008295) Osmolality of Serum or Plasma

446

0.96

0.06

1.4

1.3

271.51

274.30

mosm/kgh2o

0.28

339

(3016879) Cocaine [Presence] in Urine

306

1.05

0.05

2.3

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

333

3361

0.99

0.05

4.1

4.5

0.11

0.12

0.15

961

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

109

1070

1.02

0.05

1.2

5.08

38.57

u/ml

—

(3017704) Immunofixation for Urine

228

1.05

0.05

1.5

1.6

—

(4211845) Urine protein measurement

179

1.06

0.05

3.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

140

0.93

0.04

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

209

1.05

0.04

1.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

422

4246

0.99

0.04

1.6

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

249

2511

0.99

0.03

1.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

121

1.07

0.03

1.2

15.80

10.80

pmol/l

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

681

6782

1.01

0.03

2.6

3.2

0.83

0.81

mmol/l

5.63

641

6359

(3016650) Hepatitis A virus Ab [Presence] in Serum

522

0.98

0.03

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

320

1.03

0.03

1.1

1.3

95.36

105.13

pmol/l

0.65

320

(3027944) Amphetamines [Presence] in Urine

330

0.97

0.03

2.3

1.3

—

(3000991) Gas panel - Venous blood

349

3509

0.99

0.03

6.3

8.6

—

(3016502) Oxygen saturation in Arterial blood

428

4300

0.99

0.03

6.1

7.7

96.18

95.61

1.73

416

4158

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

128

0.94

0.02

1.8

2.8

9.58

10.22

kpa

0.44

128

(3017181) Myelocytes/Leukocytes in Blood

349

3508

0.99

0.02

4.1

4.4

0.87

0.91

0.11

105

1105

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

132

1.06

0.02

1.0

1.1

—

2.70

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

192

1.04

0.02

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

192

1.04

0.02

1.2

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

232

1.03

0.02

1.1

80.84

79.54

u/l

0.04

205

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.08

0.02

7.6

6.17

6.02

kpa

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

278

0.97

0.02

1.1

0.50

1.39

u/ml

0.99

146

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

127

0.94

0.01

1.8

2.8

4.56

4.93

kpa

1.13

127

(3000093) Morphology [Interpretation] in Blood Narrative

382

1.02

0.01

1.3

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

398

0.98

0.01

2.9

3.4

11.50

11.82

index

0.12

207

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

223

1.03

0.01

2.7

4.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

778

0.99

0.01

2.3

2.8

29.06

35.76

umol/l

2.06

701

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

938

0.99

0.01

2.3

1.9

4.99

4.02

iu/l

0.40

355

(3027008) Opiates [Presence] in Urine

333

1.02

0.01

2.2

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

140

1392

1.01

0.01

1.3

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

104

1.06

0.01

1.2

1.4

41.67

35.27

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

114

1.05

0.00

1.3

1.6

0.33

0.37

ug/l

—

(3002179) Metamyelocytes/Leukocytes in Blood

336

3352

1.00

0.00

3.8

4.3

0.70

0.69

0.01

1047

(3003396) Base excess in Arterial blood by calculation

479

4796

1.00

0.00

5.7

7.4

1.20

1.00

mmol/l

0.61

405

3994

(3019977) pH of Arterial blood

482

4826

1.00

0.00

5.8

7.5

7.42

0.84

262

2572

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

108

1.02

0.00

1.3

1.1

—

(4015189) Microbial culture of sputum

112

0.98

0.00

2.1

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

142

0.99

0.00

1.1

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

442

1.00

0.00

3.6

4.0

58.60

57.79

0.09

378

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

718

1.00

0.00

4.0

5.1

474.00

2630.89

iu/ml

—

104

(3019230) Fractional oxyhemoglobin in Venous blood

862

1.00

0.00

1.8

2.4

64.00

61.02

0.65

857

(4146454) Self-monitoring of blood glucose

465

0.99

0.00

2.2

2.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

482

4825

1.00

0.00

5.8

7.5

5.04

5.11

kpa

1.21

464

4643

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

131

0.99

0.00

1.1

1.0

1666.46

1585.11

miu/ml

0.09

131

(3003888) Timothy IgE Ab [Units/volume] in Serum

319

1.00

0.00

1.1

1.0

1.71

2.48

u/ml

0.21

149

(3005719) IgG [Mass/volume] in Serum or Plasma

278

2784

1.00

0.00

2.9

10.19

10.65

g/l

0.92

250

2559

(3027801) Oxygen [Partial pressure] in Arterial blood

482

4824

1.00

0.00

5.8

7.5

12.82

12.21

kpa

1.61

464

4641

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

196

1.02

0.00

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

126

1.03

0.00

1.7

2.1

17.45

81.86

ug/l

0.53

115

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

969

1.00

0.00

2.6

1.9

11.71

12.28

mg/l

0.32

894

(3004451) EKG impression Narrative

263

0.99

0.00

1.2

1.3

—

(44806420) Estimation of glomerular filtration rate

313

0.99

0.00

3.1

2.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

333

0.99

0.00

1.2

1.5

23.06

31.27

0.73

207

(3000012) Reticulocyte production index

613

1.00

0.00

2.6

2.1

0.97

0.90

0.27

414

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

108

1077

1.00

0.00

1.8

1.6

1.17

1.19

g/l

0.32

103

1022

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

203

0.99

0.00

1.0

0.11

0.30

u/ml

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.1

—

133.11

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3028433) Virus identified in Specimen by Culture

110

1.00

-0.00

1.7

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.49

—

(3036670) Protein [Mass/volume] in Synovial fluid

130

1.00

-0.00

1.1

1.3

48.36

39.87

g/l

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.5

—

43.05

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.94

-0.00

1.4

1.0

13.08

33.76

iu/ml

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.10

—

(3024471) HLA-A [Type]

1.00

-0.00

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.98

-0.00

1.4

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.92

-0.00

2.8

2.9

—

71.26

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2718.17

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

350

1.00

-0.00

2.3

3.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.00

-0.00

2.8

2.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.91

-0.00

1.6

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.95

-0.00

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.97

-0.00

5.1

6.9

8.50

8.20

mmol/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.88

-0.00

2.2

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.02

-0.00

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

1.67

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

314.44

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

230

1.00

-0.00

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.01

-0.00

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.89

-0.00

3.1

1.7

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

0.46

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.19

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.01

-0.00

1.3

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AMN2 – Transient global amnesia

GWS hits: 9

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Transient global amnesia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Transient global amnesia (AMN2)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Relationships between endpoints